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1. Introduction 
 
 
Environmental Chemistry is a diverse and highly interdisciplinary field that focus on the 
chemical processes influencing the composition and chemical speciation of natural 
systems (air, water and soils), the chemical fate and mobility of contaminants in the 
environment, chemical processes that affect the toxicity and bioavailability of 
contaminants and chemical aspects of contaminant remediation and pollution 
prevention. 
In this context the term Green Chemistry has gained increasing importance and prestige 
in the last two decades. In fact the emergence of green and sustainable chemistry has 
been one the most significant developments in the chemical science in recent years. 
Green chemistry is now accepted worldwide as the term to describe the developments of 
environmentally friendly, sustainable chemical processes and products. Green 
Chemistry can be described as a chemical philosophy encouraging the design of 
products and processes that reduce or eliminate the use and generation of hazardous 
substances. Whereas environmental chemistry is the chemistry of the natural 
environment, and of pollutant chemicals in nature, green chemistry seeks to reduce and 
prevent pollution at its source. For this purpose the Twelve Principles of Green 
Chemistry has been developed, which helps to explain what the definition means in 
practice. The principles cover such concepts as the design of processes to maximize the 
amount of raw material that ends up in the product, the use of safe, environment-benign 
substances, including solvents, whenever possible, the design of energy efficient 
processes, and the best form of waste disposal: do not create it in the first place. In 
particular this PhD thesis will focus his attention on two of these principles: 
 
Use renewable feedstock: Use raw materials and feedstock that are renewable rather 
than depleting. Renewable feedstock is often made from agricultural products or is the 
wastes of other processes. 
 
Use catalysts, not stoichiometric reagents: Minimize waste by using catalytic reactions. 
Catalysts are used in small amounts and can carry out a single reaction many times. 
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They are preferable to stoichiometric reagents, which are used in excess and work only 
once.  
 
The use of catalytic systems has further arose considerable advantage from an 
environmental level. It is well known in fact that catalytic processes are characterized 
by a higher ecocompatibility than those based on the use of stoichiometric quantities 
reactants. The use of methodologies based on catalytic systems has considerably aided 
the development of more efficient and convenient synthetic procedures than the 
“classical” one, making possible the reduction of cost production of several fine 
chemicals. Among these, the catalytic processes that involve the use of copper and 
palladium are for sure of unquestioning importance. Such a relevance is due to the high 
versatility of these metals. In fact the possibilities of controlling the reactivity varying a 
number of parameters such as the temperature, nature of solvents, nature of ligands, 
nature of bases and additives make these two metals unique. 
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2. Catalysis and renewable materials 
 
 
2.1. Catalysis  
In this section, the main features of the palladium and cooper catalyzed processes used 
in this thesis will be discussed. 
2.1.1. Heck reaction 
Around 1970, Mizoroki1e et al. and Heck and Nolley1f independently designed and 
executed the first Pd-catalyzed coupling reactions of aryl and alkenyl halide with 
alkenes. In subsequent investigations Dieck and Heck demonstrated the usefulness and 
rather broad scope of this new catalytic transformation. The real drive to utilize this 
powerful C-C bond forming process, however, began only in the second half of the 
1980s, and by now an impressive number of publications have established the so-called 
Heck reaction as a indispensable method in organic synthesis1.  
The Heck reaction is a reaction in which the formation of a new C-C bond takes place, 
starting from an aryl or vinyl halide or triflate and an alkene, in presence of a base and 
palladium, to give the vinylic substitution product (Scheme 1). 
 
X H
HX+ +Pd(0), base
 
Scheme 1 
 
Application of the Heck reaction range from the preparation of a large variety of 
hydrocarbons, novel polymers, as new materials for optoelectronic devices, and other 
unsaturated compounds, many of which are useful as UV screen, pharmaceuticals, etc. 
Although the potential of this Pd-catalyzed process has not yet been fully explored, it is 
appropriate to say, even at this stage, the carbometallation reactions are true “power 
tools” in contemporary organic synthesis. 
The Pd-catalyzed reaction proceeded smoothly in general with terminal alkenes 
substituted with electron-withdrawing groups, but electronically neutral alkenes or 
electron-rich alkenes were less suitable as substrates. With the latter class of non-
electron-poor alkenes, diarylated products, regioisomers, double bond isomers, mixtures 
of cis- and trans- isomers, products in which a heteroatom substituent bonded to the 
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alkene had been eliminated, or sometimes even tar were encountered under the 
traditional conditions (Scheme 2 and 3). 
 
ArX + EWG EWGAr
Pd(0)
EWG = COOR, COR, Ph, etc.  
Scheme 2 
 
ArX + EDG
EDG
Ar
Pd(0)
EDG = heteroatom, alkyl,, etc.
+ EDG
Ar
+ EDG
Ar
Ar
Ar
+
Ar
 
Scheme 3 
 
Today, efficient methods have been developed that also make possible regiocontrolled 
functionalizations of electron-rich alkenes, and frequently efficient double bond 
migration control has been achieved with both cyclic and acyclic systems. Pd catalytic 
systems have emerged after considerable experimentation with palladium, ligands and 
solvents; very high turnover numbers and short reaction times have accomplished. 
Though in specific areas other palladium-catalyzed transformations such as allylic 
substitution of cross-coupling may seem to be more advanced, none can match Heck 
chemistry in resourceful versatility, the overwhelming ability to spawn new, hitherto 
unexpected applications, and resolving challenges. Heck chemistry is still intriguingly 
flexible, expandable, adaptable, and unpredictable. Indeed, most organic reactions, 
particularly catalytic ones, are well defined and specific to require some particular 
reagents and catalysts, to operate within a confined domain, the definition of which 
includes a more or less limited scope and optimal conditions, solvents, ligands, etc. 
Several general procedures cover almost all conceivable applications. Yields for similar 
substrates can be extrapolated. Nothing like that is true for Heck chemistry. The limits 
of scope are blurred, the substrates which yesterday had been considered as 
“unheckable” are being cracked on need with yet another improvement. The catalyst is 
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often anything containing palladium, even in homeopathic doses, and other metals can 
perform the task in the absence of palladium. As far as the solvent type, almost any 
media seems to have been already tried and none has been altogether discarded. On the 
other hand, often a small variation of substrate structure, nature of base, ligands, 
temperature, pressure, etc., leads to unpredictable results. Trends in reactivity and 
selectivity are uneven and often break when nobody would expect. An obvious question 
of what is the best catalyst and procedure remains unanswered even for the simplest 
cases, though studied in hundreds of works. Heck chemistry continues to be a 
fascinating puzzle. It is multidimensional and along each of its dimensions intersects 
with the domains of other palladium-catalyzed processes with common steps, ideas, 
techniques. Tuning Heck chemistry reciprocates in palladium catalysis as a whole. 
The most frequently used catalyst system for Heck-type coupling reactions consist of 
commercially available palladium compounds in the presence of various ligands. The 
first chance is often the air-stable and relatively inexpensive palladium acetate; 
however, several of other published variants can be preferable for certain applications. It 
is commonly assumed that the palladium(II) species is reduced in situ by the solvent, the 
alkene, the amine or the added ligand.  
Initially, only dipolar aprotic solvents such as tertiary amines, acetonitrile, 
dimethyilformamide, N-methylpirrolidone, and dimethylsulfoxide, were used. However, 
as originally observed by Heck, the presence of water can generate certain coupling 
reactions. 
A further achievement was the discovery that Heck reactions are greatly accelerated in 
the presence of quaternary ammonium salts (“Jeffery” conditions: Pd(OAc)2, K2CO3, n-
Bu4NX, DMF). In these conditions iodoarenes and iodoalkenes can be coupled to 
alkenes at room temperature. The assistance of tetraalkylammoniun salts in the 
regeneration of the catalytically active palladium(0) species apparently plays the major 
role. 
The Heck reaction2 can be used to couple alkenyl , aryl, allyl, benzyl, methyl, 
alkoxycarbonylmethyl, alkynyl, certain alkyl and silyl fragments to a variety of alkenes. 
The nature of the leaving group greatly affects the reaction rate: aryl iodides react faster 
than bromides, and aryl chlorides are notoriously unreactive unless special catalysts or 
ligands and elevated temperatures are used to enhance the reaction rate. This has been 
taken to indicate that the oxidative addition of the haloarene to palladium(0) is the rate-
determining step. The Heck-type reactivity, one of the basic types of reactivity in 
 9
palladium-driven catalytic cycles, comes from the ability of Pd(0) species to undergo 
oxidative addition to various C-X bonds and the addition of this formed RPdX 
intermediates to unsaturated bonds. The reaction can be catalyzed by palladium 
complexes with or without phosphine ligands (phosphine assisted vs phosphine-free 
catalysis). A primary role of phosphine ligands is to support palladium in its zero 
oxidation state in the form of stable PdL4 or PdL3 species. The phosphine-assisted 
method may be regarded as conservative, as it relies not on a priori unknown reactivity 
of palladium catalyst in a given catalytic cycle, but rather on ligands which can sustain 
the catalytically active species even outside of the catalytic cycle. The phosphine-
assisted approach is the classical and well-established method which gives excellent 
results in a majority of cases, but, for economical and chemical reasons, research was 
addressed in seeking for anything else. Phosphine ligands are expensive, toxic, and 
unrecoverable. In large-scale applications on industrial and semi-industrial scale, the 
phosphines might be a more serious economical burden than even palladium itself, 
which can be recovered at any stage of production or from wastes. The chemical reason 
is lower reactivity of fully ligated complexes of palladium, the main result of which is 
the need for higher loads of catalyst to achieve appropriate rates of reaction and 
therefore further aggravation of procedure cost. Both underligated and phosphine-free 
catalysis are opposite to the phosphine-assisted conservative methodology. It relies not 
on the intrinsic stability of properly ligated isolable complexes, but rather on making 
zerovalent palladium species run for life within the Heck catalytic cycle or die as 
inactive black sediments. Underligated Pd(0) species (the term underligated means that 
a given palladium complex bears less strongly bonded ligands than is required to form a 
stable complex) are intrinsically unstable to survive outside of the cycle but are likely to 
have higher reactivity; therefore, their stationary concentration in a catalytic system is 
much lower. Unlike phosphine-assisted systems which are based on thoughtful design 
and knowledge of intimate details of coordination chemistry, phosphine-free systems 
are not so predictable yet.  
The entry into the catalytic cycle includes the reduction of Pd(II) complexes to Pd(0) 
and the generation of active species through multiple ligand exchange equilibria. In 
kinetic measurements, this stage is revealed by a latent (inductive) period (Scheme 4). 
Due to the labile character of Pd(0) complexes, in most cases there must be a manifold 
of more and less reactive species with varying coordination shells. The primary 
reduction of Pd(II) to Pd(0) is most likely accomplished by phosphine in the phosphine 
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assisted catalytic cycles. The reduction is assisted by hard nucleophiles, of which the 
most common are hydroxide and alkoxide ions, water, and acetate ion, though in special 
cases even fluoride in the presence of water can play the role. 
 
-HX
RX
H
R'
H
R'R'
R R'
H
PdXL2H
R
R'
R'
H
PdXL2R
R'
H
R'
H
PdL2
oxidative addition
sin-β elimination
base
rotation
Pd
R
L
X
Pd
R
L
L
X
H R'
H R'
Pd
R
L
X
LPd
H
L
X
L
carbopalladation
 
Scheme 4 
 
In phosphine-free systems, the primary reduction of Pd(II) can be effected by amines, if 
these are used as base, or olefin. It is interesting to note that neither Et3N nor olefin have 
any detectable influence on the reduction rate in the presence of phosphine. Still, it is 
well-known that in the absence of phosphine, olefins are oxidized by Pd(II) via the first 
turn of a Waker-type catalytic cycle. This process may be a serious yield-decreasing 
factor in the reactions with high initial loads of palladium salts in phosphine-free 
systems if the olefin is taken in an equimolar amount with respect to the electrophilic 
substrate (that is the by-default case in the intramolecular Heck cyclizations). 
2.1.2. C-H activation, direct arylation 
In the past several decades, much attention has been paid to green and sustainable 
chemistry as more and more environmental problems have appeared due to the use of 
chemical processes. Synthetic chemists started changing organic synthetic pathways to 
avoid unfriendly chemicals and developing new, straightforward methods for 
approaching final goals. Hydrocarbons are considered one of the best carbon sources in 
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organic synthesis, since they are easily available and relatively sustainable. In this 
respect, C–H activations have been utilized as the key starting stage for many efficient 
transformations. During these transformations, transition-metal complexes have played 
vital roles in the approach to efficient methods for realizing the C–H activation of inert 
hydrocarbons3. 
While the coupling of an aryl halide or pseudohalide with an organometallic reagent is 
commonly referred to as a cross-coupling reaction, several terms such as C-H (bond) 
activation, C-H (bond) functionalization, cross-dehalogenative coupling, and catalytic 
direct arylation have been used to describe the corresponding coupling of an aryl halide 
or pseudohalide with a simple arene. Although the former two terms are more prevalent 
in the literature, the term direct arylation is now the most used, and can be described as 
the direct coupling of a nonactivated aryl C-H bond with an activated arene. This term 
best describes the overall process, while additionally preventing any erroneous 
implications regarding the mechanistic pathway by which the process occurs. 
Although there exist a variety of routes for the construction of aryl-aryl bonds, arguably 
the most common method is through the use of transition-metalmediated reactions. 
While earlier reports focused on the use of stoichiometric quantities of a transition metal 
to carry out the desired transformation, modern methods of transition metal-catalyzed 
aryl-aryl coupling have focused on the development of high-yielding reactions achieved 
with excellent selectivity and high functional group tolerance under mild reaction 
conditions. Typically, these reactions involve either the coupling of an aryl halide or 
pseudohalide with an organometallic reagent (Scheme 5), or the homocoupling of two 
aryl halides or two organometallic reagents. Although a number of improvements have 
developed the former process into an industrially very useful and attractive method for 
the construction of aryl-aryl bonds, the need still exists for more efficient routes 
whereby the same outcome is accomplished, but with reduced waste and in fewer steps. 
 
M X
R1 R2
M = B, Sn, Si, Mg, Zn X = I, Br, Cl, OTf
R1
R2
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Scheme 5 
 
In particular, the obligation to use coupling partners that are both activated is wasteful 
since it necessitates the installation and then subsequent disposal of stoichiometric 
activating agents. Furthermore, preparation of preactivated aryl substrates often requires 
several steps, which in itself can be a time-consuming and economically inefficient 
process. An attractive alternative to this approach is to treat the aryl C-H bond as a 
functional group, in analogy to a carbon-metal or carbon-halogen bond. The simplest 
approach would involve the coupling of two aryl C-H bonds to give the corresponding 
biaryl product (Scheme 5), although this process is unfavorable from a thermodynamic 
perspective due to the high bond strength of an aryl C-H bond (e.g., the homocoupling 
of benzene to give biphenyl and hydrogen is thermodynamically disfavored by 13.8 
kJ/mol). Furthermore, while such an approach is alluring, the ubiquitous and diverse 
nature of C-H bonds in complex organic compounds makes a regioselective oxidative 
coupling of this type a formidable challenge. 
One solution which addresses the thermodynamic issue as well as the need for 
stoichiometric activating agents on both coupling partners is to use a preactivated aryl 
substrate as one coupling partner and a simple unactivated aryl substrate as the other 
(Scheme 5). Although the advantages of this strategy for aryl-aryl coupling have made 
it a popular topic of research since the first reports over 20 years ago, the more subtle 
issue of C-H bond regioselectivity remains unsolved in some systems. 
Although a variety of transition metals have been used for the formation of aryl-aryl 
bonds, second-row transition metals in low oxidation states (Rh, Ru, Pd) have emerged 
as the preferred catalysts in catalytic direct arylation reactions. In some cases, the high 
reactivity of the transition-metal complexes employed in direct arylation reactions has 
allowed for the use of extremely low catalyst loadings (as low as 0.1 mol %), making 
 13
them industrially attractive. The ligands used in direct arylation depend on the nature of 
the aryl halide being used. For more reactive aryl iodides, moderately electron-rich 
monodentate phosphines such as PPh3 are typically used. These same phosphines have 
also been successfully utilized for aryl bromides, although in some systems far superior 
yields have been obtained using palladium and more sterically bulky and electron-rich 
trialkylphosphine or Buchwald’s biphenylphosphines. Recently, the use of aryl 
chlorides in a palladium-catalyzed direct arylation reaction has also been reported. 
However, as in other cross-coupling reactions, the low reactivity of the C-Cl bond to 
oxidative addition necessitated the use of electron-rich and sterically-hindered 
trialkylphosphines, Buchwald’s biphenylphosphines, or N-heterocyclic carbene ligands 
to achieve synthetically useful yields of the direct arylation product. It should also be 
noted that ligand-free conditions (Jeffery’s conditions) have also been successfully used 
in palladium-catalyzed direct arylation reactions for a variety of aryl halides. While base 
is generally required in direct arylation reactions, in most cases the exact role of the 
base remains unclear. Some recent evidence, however, suggests that in some systems 
the base may be intimately involved in the formation of the diarylpalladium(II) species 
(and not simply as a bystander whose role is to regenerate the active catalyst). 
Typically, inorganic bases such as K2CO3, Cs2CO3, KOAc, t-BuOK, and CsOPiv are 
used. In particular, cesium carbonate and cesium pivalate have proven to be very 
effective in many cases due to increased solubility in organic solvents. While polar, 
aprotic solvents such as DMF, DMA, CH3CN, NMP, and DMSO are commonly used, 
nonpolar solvents such as toluene and xylene have also been employed successfully. In 
addition, temperatures >100 °C are typically used, and in most cases heating for several 
hours to days is necessary. 
Direct arylation reactions can take place in either an intermolecular or an intramolecular 
fashion. While intramolecular direct arylation reactions employ tethers to limit the 
degree of freedom in a system, thereby controlling the regioselectivity of the reaction, 
intermolecular direct arylation reactions present a more formidable task since the 
catalyst has a greater degree of freedom when reacting at the C-H bond. Two factors 
that influence the regioselectivity of the intermolecular direct arylation are the 
electronics of the arene being functionalized, for example the reaction occurs ortho or 
para to the electrondonating group via an electrophilic aromatic substitution process, 
and more commonly the directing group. Typically, directing group-assisted reactions 
employ nitrogen- and oxygen-coordinating functional groups to direct the arylation, 
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although in some cases external alkenes or alkynes in a cascade process have been used 
to create a “directing” alkyl- or alkenylmetal species in situ. 
Mechanistically, the intramolecular and intermolecular direct arylation of arenes is 
proposed to occur via oxidative addition of the transition metal into the aryl halide, 
followed by one of a number of possible key carbon-carbon bond-forming steps: 
(1) electrophilic aromatic substitution at the metal (SEAr) 
(2) a concerted SE3 process 
(3) a σ-bond metathesis 
(4) a Heck-type (or carbometalation) process through a formal anti β-hydride 
elimination that involves an isomerization step followed by a syn β-hydride elimination 
(5) a C-H bond oxidative addition. 
While the exact nature of this step has been investigated for some systems, it should be 
noted that the exact mechanism for any given example depends heavily on the substrate, 
transition metal, solvent, base, and ligand used. 
2.1.3. Sonogashira cross-coupling reaction 4 
Over the past few decades, the Pd-catalyzed alkynylation has emerged as one of the 
most general and reliable methods for the synthesis of alkynes. Currently, the most 
widely used by far is a hybrid of the Cu-promoted Castro-Stephens reaction and the 
alkyne version of the Heck reaction, which is known as the Sonogashira reaction 
originally reported in 1975 (Scheme 6). 
 
The Castro-Stephens reaction:
R1C CCu XR2 CR2R1C
The Heck-Cassar alkynylation reaction:
CH XR2R1C CR2R1C
cat. PdLn, base
The Sonogashira alkynylation reaction:
CH XR2R1C CR2R1Ccat. PdLn, cat. CuI
base  
Scheme 6 
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This reaction is considered generally superior to either the Castro-Stephens reaction or 
the Heck protocol without the use of a Cu salt, and it is normally used without checking 
the comparative merits among them, even though the Heck protocol, which is inherently 
simpler than the Sonogashira reaction, has been shown to be highly unsatisfactory in a 
number of cases. Moreover, despite its wide applicability, convenience, and overall 
excellence, the Sonogashira reaction has also revealed some significant limitations. 
The Sonogashira cross-coupling reaction can be explained by the following mechanism. 
At first CuI activates 1-alkynes by forming the Cu-acetylides which undergo 
transmetallation with arylpalladium halides to form the alkynilarylpalladium species, 
followed by reductive elimination to give the arylalkyne in the final step (Scheme 7). 
 
Pd LL
Ph
O
Cl
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L
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Cu PhCuCl
Et3NH Ph
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NEt3 H Ph
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L Ph
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Scheme 7 
 
Typically, two catalysts are needed for this reaction: a zerovalent palladium complex 
and a halide salt of copper(I). The palladium complex activates the organic halides by 
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oxidative addition into the carbon-halogen bond. Phosphine-palladium complexes such 
as tetrakis(triphenylphosphine)palladium(0) are used for this reaction, but palladium(II) 
complexes are also available because they are reduced to the palladium(0) species by 
the consumption of terminal alkynes in the reaction medium such as PdCl2(PPh3)2. The 
oxidation of triphenylphosphine to triphenylphosphine oxide can also lead to the 
formation of Pd(0) in situ when catalysts such as bis(triphenylphoshine)palladium(II) 
chloride are used. In contrast, copper(I) halides react with the terminal alkyne and 
produce copper(I) acetylide, which acts as an activated species for the coupling 
reactions. 
The reaction medium must be basic to neutralize the hydrogen halide produced as the 
byproduct of this coupling reaction, so alkylamine compounds such as triethylamine 
and diethylamine are sometimes used as solvents, but also DMF, THF or ether can be 
used as solvent. In addition, deoxygenated conditions are formally needed for 
Sonogashira coupling reactions because the palladium(0) complexes are unstable in the 
air, and oxygen promotes the formation of homocoupled acetylenes. Recently, 
development of air-stable organopalladium catalysts enable this reaction to be 
conducted in the ambient atmosphere. 
As in the other Pd-catalyzed cross-coupling reactions, the general order of reactivity of 
organic electrophiles with respect to leaving groups is on the same trends as mentioned 
in Heck preface: I ≥ OTf ≥ Br > Cl. For the substituents is: EWG > H > EDG. These 
orders are in line with those observed in the oxidative addition of Pd(0) complexes to 
organic electrophiles. Some other important features of organic electrophiles include 
steric effects and chelation. 
2.1.4. Copper 5 
The cross-coupling is so closely associated today with palladium catalysis, that both 
terms are often regarded as inseparable parts of an idiom. Tremendous development of 
palladium catalyzed methods of C-C and C-heteroatom bond formation during the last 
three decades is the basis of such a way of thinking. A certain effort is required to 
realize that the cross-coupling chemistry is actually much older, and that another metal, 
copper, has been the ancestor of palladium in this domain. Classical Ullmann chemistry 
along with closely related methods have been known for a full century and served well 
for C-N, C-S, C-O and some other bond formation reactions. C-C bond formation has 
been excellently serviced by organocuprate chemistry. However, after the discovery of 
palladium catalyzed cross-coupling reactions copper has been suffering an increasing 
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degree of neglect. A critical point was the discovery and fast development of palladium 
catalyzed amination, which conquered the last stronghold of copper – the synthesis of 
arylamines in which the classical Ullmann and Goldberg reactions had kept an exclusive 
and unshakable position. Since then the only use for old chemistry could be to become a 
target of criticism in describing new advanced procedures, even though palladium 
chemistry itself has a number of inborn deficiencies (not only high cost, Pd=$ 1000 per 
ounce; Cu=$ 0.1 per ounce, but also essential restrictions in scope). However, it turned 
out that copper is not too easy to get rid of. The last years witness a steady increase of 
interest in copper assisted cross-coupling chemistry with dozens of new effective 
procedures emerging in all areas. In the recent years, a number of excellent reviews on 
various aspects of copper-assisted reactions appeared, covering various aspects of this 
chemistry. Cross-coupling is a generic term used to denote a σ–bond metathesis reaction 
between a nucleophilic and electrophilic reagent as mentioned in previous chapter, and 
thus can be regarded as a generalization of nucleophilic substitution. Many such 
reactions take place only in the presence of catalyst. The role of catalyst is generally 
believed to take part in successive oxidative addition, transmetallation, and reductive 
elimination reactions. 
The overall evidence gained so far tells us that copper can take part in cross-coupling 
chemistry in a way strikingly similar to palladium. Moreover, copper is apparently more 
versatile and productive than its closest neighbor in the Periodic System, nickel, a 
lighter and much less capable brother of palladium. The most important difference of 
copper is an easy accessibility of four oxidation states from 0 to +3, while palladium has 
at its disposal only two stable oxidation states 0 and +2. There are indeed +1, +3 and +4 
oxidation states for palladium, but these are either extremely rare or play no 
unambiguously identifiable role in cross-coupling reactions. Most likely, the cross-
coupling catalytic cycle with copper is serviced by +1/+3 oxidation states. A rough 
picture of the possible catalytic cycle driven by Cu is given, omitting all details, such as 
ancillary ligands etc. This is not a mechanism, but rather an approximate presentation of 
what may happen, based on analogies and general considerations, and not on actual 
mechanistic studies. Therefore, any refinements of this scheme, which may occasionally 
be met in the literature, are mostly speculative. This is not an indication of the poor state 
of copper catalysis, as the current status of understanding of mechanism of palladium 
catalyzed cross-coupling is not much better, that apparently not being a serious 
handicap in the development of Pd catalyzed methods. Unlike Pd-driven cross-coupling 
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in which an oxidative addition step is believed to precede the transmetallation, the 
ordering of oxidative addition and transmetallation steps in the copper cycle is 
unknown, so either of two possibilities can take place (ways A or B). The other notable 
difference between copper and palladium is the accessibility of odd-electron states in 
copper, implying that copper can take part in redox single-electron transfer processes, 
and thus an alternative free-radical mechanism should be taken into consideration. As 
Cu is much cheaper than Pd, almost nobody bothers to optimize the amount of copper, 
as soon as the required yield of target products is achieved, while in the case of 
palladium-driven reaction the cost of palladium makes the optimization of catalytic 
efficiency a vital task. For possible industrial applications the cost of copper is not 
negligible, so that a reaction cannot have an industrial perspective without being made 
catalytic on copper. 
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The formal mechanism (Scheme 8) reveals that Cu(I) is regenerated at the product 
forming reductive elimination step as a compound CuX, which may bear different 
ligands than the compound CuY which entered the catalytic cycle. Therefore, the 
regeneration, in this case, means the regeneration of oxidation state, and not exactly of 
the form used to initiate the cycle. This form may or may not be reactive, it may or may 
not undergo ligand exchange to form the active species that enters the second turn of the 
catalytic cycle. If this form is not reactive, the cycle is disrupted, and we cannot regard 
the reaction as catalytic, though the chemistry involved in a single turn is exactly the 
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same as it would be if the reaction were catalytic, capable of two or more turns. In fact, 
this means that the factors effecting the deactivation of copper catalysts remain poorly 
understood. These considerations show that in the cross-coupling reaction Cu(I) 
effectively serves as the catalyst, while the turnover number (TON), a criterion of 
catalysis, is in many cases equal to or even higher than unity. TON criterion is not 
critical for the current state of copper assisted cross-coupling chemistry, and shall not 
distinguish the reactions by this parameter. It is most likely that any of the reactions to 
be discussed can be made catalytic if proper attention is paid to the optimization of 
reaction conditions, proper choice of copper compounds and ligands, investigation of 
chemistry which accounts for the activation and deactivation of copper catalysts. 
Copper-promoted arylation of aromatic amines, originally diarylamines, has been 
known for a century as the classical Ullmann reaction. The reaction requires harsh 
prolonged heating at 200 °C or higher, in the presence of simple Cu(I) or Cu(II) salts or 
oxides, or Cu bronze, etc., in the presence of base in polar high-boiling solvents. In spite 
of modest yields and severe limitations imposed on both amine and aryl halide reagents, 
this reaction has until recently been regarded as the only viable approach to 
triarylamines, compounds with rich and versatile practical potential. The discovery of 
Pd catalyzed amination (the Buchwald–Hartwig reaction) has been a major 
breakthrough in the chemistry of amines, opening access to huge numbers of previously 
inaccessible compounds. A new interest in much cheaper and more practical copper 
catalyzed chemistry has been brought about by the observations that appropriate ligands 
can modulate the reactivity of catalyst, and thus enable us to achieve more effective and 
more versatile catalytic systems. Unlike the classical Ullmann method, the reactions 
with copper complexes are best performed in non-polar solvents, such as toluene, at 
reflux or lower temperatures. Bidentate ligands, including aliphatic diamines, 1,10-
phenanthroline and its derivatives, 2,2’-bipyridine, 8-hydroxyquinoline, bidentate 
phosphines such as dppm, dppe, dppp, etc. The readily available ligand 1,10-
phenanthroline is the most practical choice for arylation by aryl iodides. Both 
monoarylation and diarylation can be successfully achieved in the system CuCl/phen, 
KOH, PhMe. Aminoacids with secondary amino-group, e.g. N-methylglycine or proline 
are also effective as ligands, and allow for the use of weaker bases such as K2CO3 in 
DMSO. Alternatively, the soluble complexes of Cu(I) with 1,10-phenanthroline, 
neocuproine, or 2,2’-bipyridine CuL(PPh3)Br, can be employed. Such complexes are 
convenient due to good stability towards air and moisture, and solubility in common 
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organic solvents (dichloromethane, chloroform, toluene, benzene, NMP, DMF, and 
DMSO). The activity of such complexes is apparently higher, allowing for the use not 
only of aryl iodides, but also of aryl bromides to perform arylation of diphenylamine in 
the presence of t- BuOK base. Moreover, yields up to 50% can be obtained with 
chlorobenzene as arylating agent. t-BuONa and Cs2CO3 are less effective, while weaker 
bases are altogether ineffective. So far, copper-catalyzed cross-coupling chemistry has 
been restricted to iodo and bromo derivatives, while chloro derivatives have been 
considered as unlikely targets for this chemistry with only a few exclusions. This 
situation vividly remember what had been going on in palladium catalysis. Since then a 
number of highly effective and practically useful catalytic systems have been proposed 
for virtually all sorts of cross-coupling reactions involving chloroarenes. It should thus 
be expected that we should not wait too long for the development of potent copper-
based catalytic systems, tailored to chlorides. The first steps in this direction have 
already appeared. It turns out that some monodentate phosphines, such as tri-o- 
tolylphosphine P(o-tol)3 and tri-n-butylphosphine PBu3 are highly effective ligands for 
the arylation of anilines by aryl halides from iodides to chlorides, in sharp contrast to 
PPh3, which is practically ineffective even for aryl iodides. While P(o-tol)3 is one of the 
most widely used and valuable ligands in Pd catalyzed cross-coupling reactions, PBu3, 
as other simple trialkyl phosphines, is not useful for common palladium catalyzed cross-
coupling chemistry, which shows that any parallels with palladium catalysis should be 
drawn with due care in order not to discard valuable approaches. 
 
2.2. Renewable materials 
Renewable materials are substances derived from a living tree, plant, animal or 
ecosystem which has the ability to regenerate itself. A renewable material can be 
produced again and again. Earth's mineral resources on the contrary are finite, and 
often energy-intensive, but timber resources can be produced indefinitely, with strong 
environmental benefits. 
Chemicals may be produced economically from waste biomass that has a negative 
impact on the environment, such as municipal solid waste, sewage sludge, and 
agricultural waste. Typically, these wastes are landfilled or incinerated, which incurs a 
disposal cost while contributing to land or air pollution. By producing chemicals from 
biomass, nonrenewable resources such as petroleum and natural gas, are conserved for 
later generations. One of the goals of Green Chemistry is to use renewable resources as 
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feedstocks for the chemical industry, in place of fossil derived starting materials, 
especially if they are by-products of other production processes. Glycerol can be 
regarded as an example of such a feedstock, as it is formed in large quantities as the by-
product in the saponification of triglycerides in the production of free fatty acids for 
detergents, and of fatty esters for biofuels. In fact, glycerol is becoming a cheap, large 
volume market product, and the ability to use it as a source of organic carbon, and as a 
starting material for chemical transformations, is very appealing. 
In the context the disposal of olive oil mill wastewaters6 (OMWs) is one of the main 
environmental problems in the Mediterranean area, where the greatest quantities of 
olive oil are produced with a large volume of wastewaters within only a few months 
(from November to February). The high polluting activity of OMWs is linked with their 
high content of organic molecules, especially polyphenolic mixtures (1-10 g/L) with 
different molecular weights, as well as their acidity and high concentrations of 
potassium, magnesium, and phosphate salts. Besides aromatic compounds, OMWs 
contain other organic molecules, including nitrogen compounds, sugars, organic acids, 
tannins and pectins, that increase their organic load (COD= 80-200 g/L; BOD= 50-100 
g/L). Furthermore, the physicochemical characteristics of OMWs are rather variable, 
depending on climatic conditions, olive cultivars, degree of fruit maturation, storage 
time, and extraction procedure. Because of these characteristics, the disposal of OMWs 
in urban sewage treatment plants is not practicable. Several pretreatment techniques 
have been worked out to reduce the impact of OMWs on municipal plants and on the 
receiving waterbodies by using microrganisms and chemical or physicochemical 
methods. However, at present, Italian regulations allow the spreading of OMWs on 
agricultural soil, subject to certain limitations, because of the expense of new 
technologies for pretreatments and the difficulty of conventional treatment methods. 
This practice causes extensive pollution of the soil and even transfers harmful 
compounds into other media, such as groundwaters and surface waters. 
The most important biophenols present in olives are cinnamic and benzoic acids 
(vanillic, caffeic, syringic acids), phenyl acids (3,4-dihydroxyphenylacetic acid), phenyl 
alcohol (hydroxytyrosol, tyrosol), secoiridois (oleuropein), and flavonoids as shown in 
Scheme 9. 
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R1 = R2 = H  4-Hydroxybenzoic acid 
R1 = OH R2 = H 4-Protocatechuic acid 
R1 = OMe R2 = H Vanillic acid 
R1 = R2 = OMe 4-Hydroxy-3,5-dimethoxybenzoic acid 
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R1 = R2 = H  p-coumaric acid 
R1 = OH R2 = H caffeic acid 
R1 = OMe R2 = H ferulic acid 
R1 = R2 = OMe sinaptic acid 
 
Scheme 9 
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3. Aim of this study 
 
 
The aim of this research is to develop novel synthetic strategies and procedures using, 
as starting materials, some chemicals present in agricultural waste waters. In details, we 
focused our attention on carboxylic acid derivatives that can be found in olive oil mill 
waste waters1. 
Our purpose is the utilization of such benzoic and cinnamic acid and their derivatives as 
starting materials for the synthesis of biologically and pharmaceutically interest 
compounds. 
In particular we developed new synthetic approaches to molecules containing 
heterocyclic core such as indoles, quinolines, quinolones, and phenantridinones 
(Scheme 1). All these compounds and all the starting materials have been usually 
obtained taking advantage of catalytic processes. 
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Scheme 1 
 
In particular we focused our attention on one-pot chemistry that can be defined as 
follows:  
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A one-pot synthesis is a strategy to improve the efficiency of a chemical reaction 
whereby a reactant is subjected to successive chemical reactions in just one reactor. 
This is much desired by chemists because avoiding lengthy separation processes and 
purification of reaction intermediates would save time and resources while increasing 
the yield. 
Furthermore, we explored in some cases the utilization of domino reactions. 
A domino reaction is a process involving two or more bond-forming transformations 
(usually C-C bonds, but C-N and in general C-heteroatom) which take place under the 
same reaction conditions without adding additional reagents and catalysts, and in 
which the subsequent reaction results as a consequence of the functionality formed in 
the previous step2. 
The usual procedure for the synthesis of organic compounds is the stepwise formation 
of the individual bonds of the target molecule. However, it would be much more 
efficient if one could form several bonds in one sequence without isolating the 
intermediates, changing the reaction conditions, or adding reagents. It is obvious that 
this type of reaction would allow the minimization of waste, thus making the waste 
management unnecessary since the amount of solvents, reagents, adsorbents, and energy 
would be dramatically decreased in comparison to stepwise reactions. In addition the 
amount of operative steps would decrease dramatically. Thus, these reactions would 
allow an ecologically and economically favourable production.  
The name - domino reaction - was chosen from the game where one puts up several 
domino pieces in one row and in agreement with the time-resolved succession of 
reactions, if one knocks over the first domino, all the others follow without changing the 
conditions.  
The expression cascade has also been used for this type of transformation. However, 
this word does not describe exactly the events that one would refer to. It is also used in 
several scientific areas to describe other phenomena. Thus, using the expression domino 
reaction appears more appropriate. 
The usefulness of a domino reaction is related to three main issues: 
- the number of bonds that are formed in one sequence (bond-forming efficiency 
or bond-forming economy); 
- the increase in structural complexity (structure economy); 
- its suitability for a general application. 
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The advantages of one-pot chemistry and domino reactions can be summarized as 
follow: 
- formation of several bonds in one sequence; 
- minimization of waste of solvents, reagents, adsorbents and energy. 
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4. Vinyl esters as substrates in cross-coupling reactions 
 
 
The first attempt concerning the utilization of carboxylic acid derivatives in palladium-
catalyzed reactions was the synthesis of vinyl esters 1. 
 
R2O
O
R1
1  
This class of compounds can be easily obtained via ruthenium-catalyzed addition of 
carboxylic acids to terminal alkynes1 (Scheme 1). 
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Scheme 1 
 
In particular, vinyl esthers derived from the addition of benzoic acid (R1 = Ph) to 1-
hexyne (1a, R2 = C4H9) and propyne (1b, R2 = Me) were regioselectively obtained in 91 
and 99 % yield, respectively, using 1 equiv of benzoic acid, 1,3 equiv of alkyne in the 
presence of 0.004 mol% of [(p-cumene)RuCl2]2, 0.008 mol% of P(2-Fur)3, and 0,016 
mol% of Na2CO3 in toluene at 50 °C (18 h). Under the same conditions, 
phenylacetylene (1c, R2 = Ph) gave a mixture of regio- and stereoisomers (Scheme 2). 
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Scheme 2 
 
According to the working hypothesis summarized in Scheme 3, our aim was to perform 
a palladium-catalyzed β-vinylation of the esters using vinyl triflates to develop a new 
entry to 1,3-dienes or, in case of reduction of the double bond, α,β-unsaturated ketones2. 
Compound 1b has been treated in the presence of 4,4-diphenylcyclohexa-1,5-dienyl 
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triflate 2 (Scheme 4) under a variety of reaction conditions (Table 1). No evidence of 
the desired product formation has been ever attained. 
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Table 1a 
Base Ligand T (°C) Pdb 
N(Bu)3 1.5 eq PPh3 140 Pd(OAc)2 2% 
NH(i-Pr)2 PPh3 140 Pd(OAc)2 2% 
NEt3 PPh3 140 Pd(OAc)2 2% 
NH(i-Pr)2 Xphos 120 Pd(OAc)2 2% 
/ / 120 PdCl2(PPh3)2 1% 
/ PPh3 120 PdBr2 1% 
/ / 120 PdBr2 1% 
NH(i-Pr)2 / 100 PdCl2(PPh3)2 1% 
a Reactions were carried out at the indicated temperature on a 0.25 mmol scale using the indicated amount of [Pd], 0.05 equiv of 
phosphine, 2 equiv of base in 2.5 mL of solvent. 
b Yields are given for isolated products. 
 
Utilization of other vinyl trilfate s as well as aryl trilates in presence of a variety of salts 
(KBr, Bu4NCl) and solvents (DMF (DME, NMP, DMA) met with failure. Similar 
results were obtained even in presence of neutral, electron-rich and electron-poor aryl 
iodide.  
We next explored the feasibility of a hydroarylation reaction with aryl iodides to 
prepare branched esters3 (Scheme 5). However, even in this case no product formation 
was observed. In this case too the influence of solvents (DMF, DMA, NMP, DME), 
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ligands (PPh3, sterically hindred monophosphinic ligands such as Buchwald’s ligands, 
Herrmann Pd-complex), salts (KBr, Bu4NBr, Bu4NCl), temperature as well as the effect 
of aryl iodides was investigated. 
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Scheme 5 
 
An example of the reaction conditions used is described in Scheme 6. 
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Scheme 6 
 
We next moved to the Suzuki cross-coupling reaction (Scheme 7)4. 
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Scheme 7 
 
Even in this case we did not get any evidence of coupling products formation (Table 7). 
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Table 2a 
Base Ligand T (°C) Pdb 
K3PO4 L 80 Pd2dba3 
K3PO4 L 130 Pd2dba3 
/ L 100 Pd(OAc)2 
a Reactions were carried out at the indicated temperature on a 0.25 mmol scale using 0.05 equiv of [Pd], 0.05 equiv of phosphine, 2 
equiv of base in 2.5 mL of solvent. 
b Yields are given for isolated products. 
 
Summarizing, all the conditions screened led to unsatisfactory results. In practice, it 
turned out that vinyl esters 1, although readily available, could not be used for the 
transformations planned. 
 
 33
References 
 
1. L. J. Goossen, J. Paetzold, and D. Koley, Chem. Commun., 2003, 706-707. 
2. C-M. Andersson, A. Hallberg, J. Org. Chem., 1989, 54, 1502-1505; C-M. 
Andersson, A. Hallberg, J. Org. Chem., 1988, 53, 235-239; J. Mo, L. Xu, J. Xiao, J. 
Am. Chem. Soc, 2005, 127, 751-760; C-M. Andersson, A. Hallberg, J. Org. Chem., 
1988, 53, 2112-2114; W. Cabri, I. Candiani, A. Bedeschi, J. Org. Chem., 1992, 57, 
3558-3563; P. G. Ciattini, E. Morera, G. Ortar, Terahedron Lett., 1991, 32, 1579-
1582. 
3. A. Arcadi, F. Marinelli, E. Bernocchi, S. Cacchi, G. Ortar, J. Organomet. Chem, 
1989, 368, 249-256; S. Cacchi, A.Arcadi, J. Org. Chem, 1983, 48, 4236-4240; A. 
Arcadi, F. Marinelli, S. Cacchi, J. Organomet. Chem, 1986, 312, C27-C32; S. 
Cacchi, F. La Torre, G. Plmieri, J. Organomet. Chem, 1984, 268, C48-C51. 
4. T. E. Barder, S. D. Walker, J. R. Martinelli and S. L. Bachwald, J. Am. Chem. Soc, 
2005, 127, 4685-4696. 
 34
5. 4-Aryl-2-quinolones via a Domino Heck reaction/cyclization process 
 
 
During our studies on the Heck reaction of β-substituted α,β-unsaturated carbonyl 
compounds we have found that an appropriate choice of reaction conditions may favor 
the formation of vinylic substitution products with the original β-substituent on the 
same side of the carbon-carbon double bond as the carbonyl group.1 Because of this, β-
substituted α,β-unsaturated carbonyl compounds containing a nucleophile at the ortho 
position of the β substituent can give rise to cyclization reactions following the vinylic 
substitution step and the whole process can be used as a useful tool for the preparation 
of cyclic derivatives (Scheme 1). We have taken advantage of this synthetic strategy to 
develop new syntheses of quinolines,2 coumarins,2,3 butenolides4 and cardenolides.1c 
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Scheme 1 
 
Since many 2-quinolones show interesting biological activities5 - including tipifarnid, a 
4-aryl-2-quinolone derivative which exhibits anticancer activity6 - and are also useful 
synthetic intermediates,7 it appeared of interest to us to explore the preparation of 4-
aryl-2-quinolones from readily available methyl β-arylacrylates containing a nitrogen 
nucleophile in the ortho position of the β-substituent through a domino Heck/cyclization 
reaction (Scheme 2). 
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Scheme 2 
 
p-Iodoanisole and methyl β-(o-aminophenyl)acrylate 1a were initially selected as the 
model system and the first attempt was carried out in the presence of 0.05 equiv of 
Pd(OAc)2 as the source of Pd(0) using a molten Bu4NOAc/Bu4NBr mixture as the 
reaction medium at 100 °C. 
These conditions were successfully used by us in the diastereoselective synthesis of β,β-
diarylacrylates from cinnamate esters and aryl iodides1d and in the formation of 
coumarins from 3-(o-hydroxyaryl)acrylate esters and aryl iodides or bromides.3 
Unfortunately, no formation of the desired 4-substituted quinolone product was 
observed, the main product being the parent quinolone 5 (Scheme 3), most probably 
derived from 1a via an E/Z isomerization/cyclization reaction which is faster than the 
desired Heck/cyclization reaction. 
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Surmising that the easy E/Z isomerization might be favoured by the presence of the free, 
strongly electron-donating amino group, we switched to the acetyl derivative 1b, 
prepared in 80% overall isolated yield from commercially available o-iodoaniline via 
acetylation and palladium catalyzed vinylic substitution with methyl acrylate (Scheme 
4) as the olefin partner. 
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Indeed, subjecting 1b to the same conditions used for 1a led to the isolation of the free 
NH quinolone derivative 4a, but only in 15% yield (Table 1, Entry 1). No evidence of 
(5) or its N-acetyl derivative was attained in this case. We next conducted the model 
reaction in DMF in the presence of mixtures of KOAc and Bu4NCl (Table 1, Entry 2) or 
KOAc and KCl (Table 1, Entry 3) and found that the quinolone product could be 
isolated in 45 and 40% yield, respectively. By omitting chloride salts, 4a was isolated in 
36% yield with Bu4NOAc (Table 1, Entry 4) and 50% yield in the presence of KOAc 
(Table 1, Entry 5) suggesting that chloride source is unnecessary for this transformation. 
An increase of the reaction temperature to 120 °C resulted in the formation of 4a in 
39% yield with Bu4NOAc (Table 1, Entry 6) and in a satisfactory 60% yield by using 
KOAc (Table 1, Entry 7). A further increase of temperature caused a drop in the yield of 
4a (Table 1, Entry 8). This reaction was subsequently carried out using other solvents 
such as NMP and DMA. NMP gave a slightly lower yield (Table 1, Entry 9) whereas 
with DMA the yield was only moderate (Table 1, Entry 10). Lower yields were also 
obtained when NaOAc was used instead of KOAc (Table 1, Entries 11 and 12). 
Interestingly, a result comparable to that obtained with KOAc at 120 °C was obtained 
when the reaction was carried out in Et3N at 100 °C (Table 1, Entry 13). These 
conditions, however, proved unsatisfactory when they were applied to other aryl iodides 
(see Table 2, footnote c). 
In conclusion, the “optimal” reaction conditions for this domino reaction utilize 0.05 
equiv of Pd(OAc)2 and 2 equiv of KOAc in DMF at 120 °C. No evidence of the vinylic 
substitution intermediate 3a was attained by monitoring the reaction mixture by TLC or 
HPLC, suggesting that under these conditions the Heck reaction is followed by a fast 
cyclization step. 
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Table 1a 
Entry Base Additive Solvent T (°C) t (h) Yield % 
of 4ab 
1 − − Bu4NOAc (2.1 eq) Bu4NBr (1.5 eq) 100 15 15 
2 KOAc Bu4NCl (1 eq) DMF 100 48 45 
3 KOAc KCl (1 eq) DMF 100 24 40 
4 Bu4NOAc − DMF 100 24 36 
5 KOAc − DMF 100 48 50 
6 Bu4NOAc − DMF 120 24 39 
7 KOAc − DMF 120 48 60 
8 KOAc − DMF 140 48 52 
9 KOAc − NMP 120 48 57 
10 KOAc − DMA 120 48 33 
11 NaOAc − NMP 120 48 30 
12 NaOAc − DMF 120 48 45 
13 Et3N (2 eq) − − 100 24 59 
14 Et3N (5 eq) − DMF 100 48 30 
15 Bu3N (5 eq) − − 120 24 55 
a Unless otherwise stated, reactions were carried out on a 0.4 mmol scale in 1.5 mL of solvent using 1 equiv of (1b), 1.5 equiv of p-
iodoanisole, 2 equiv of acetate base and 0.05 equiv of Pd(OAc)2 under argon. 
b Yields are given for isolated products. 
 
Formation of 3a was observed at lower reaction temperatures. At 80 °C (48 h) it was 
isolated in 25% yield along with 8% of 4a and a 30% yield of the recovered 1b. 
Decreasing further the reaction temperature to 60 °C led to the isolation of 3a in 30% 
yield after 48 h. The quinolone derivative 4a was not formed and the starting material 
was recovered in 50% yield (Scheme 5). 
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The results obtained subjecting a variety of aryl iodides and methyl β-(o-
acetamidoaryl)acrylates to the optimal conditions are shown in Table 2. 
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Table 2a 
Entry Methyl β-(o-Acetamidophenyl)acrylate 1 Aryl Iodide 2 t (h) 
Yield % of 
4b 
1 
NHCOMe
CO2Me
1b
p-MeO-C6H4-I 48 60 
2 1b p-Me-C6H4-I 24 62 
3 1b m-MeO-C6H4-I 24 62 
4 1b o-MeO-C6H4-I 24 − 
5 1b I
Me
Me  
48 80 
6 1b p-MeCONH-C6H4-I 48 55c 
7 1b m-Me-C6H4-I 24 61 
8 1b PhI 24 51 
9 1b o-F-C6H4-I 24 11 
10 1b m-F-C6H4-I 48 30 
11 1b p-F-C6H4-I 24 65 
12 1b p-Cl-C6H4-I 24 51 
13 1b m-CHO-C6H4-I 48 − 
14 1b 
I
O
O
 
24 53 
15 1b p-MeCO-C6H4-I 48 − 
16 1b I
Me
O
O
 
48 52 
17 NHCOMe
Cl
Me CO2Me
1c 
p-MeO-C6H4-I 24 62 
18 1c p-Me-C6H4-I 24 55 
19 NHCOMe
Me
Me CO2Me
1d 
p-MeO-C6H4-I 48 59 
20 1d p-Me-C6H4-I 48 55 
21 1d p-F-C6H4-I 48 48 
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22 NHCOMe
NO2
Me CO2Me
1e 
p-MeO-C6H4-I 48 40 
23 1e p-Me-C6H4-I 48 42 
24 
NHCOMe
MeCO CO2Me
1f 
p-MeO-C6H4-I 48 41 
a Reactions were carried out on a 0.4 mmol scale in 1.5 mL of DMF using 1 equiv of (1), 1.5 equiv of aryl iodide, 2 equiv of KOAc 
and 0.05 equiv of Pd(OAc)2 under argon at 120 °C.  
b Yields are given for isolated products. 
c Compound (4e) was isolated only in 10% yield when the reaction was carried out in Et3N, according to the conditions shown in 
Table 1, Entry 13. 
 
4-Aryl-2-quinolones were isolated in allowable to good yields with a variety of methyl 
β-(o-acetamidoaryl)acrylates and aryl iodides. p-Iodobenzaldehyde and p-
iodoacetophenone did not afford the corresponding 2-quinolone products under our 
standard conditions (Table 2, Entries 13 and 15). However, appropriately protected 
aldehydic and ketonic aryl iodides gave the desired products in satisfactory yields 
(Table 2, Entries 14 and 16). 
In conclusion, we have developed a new straightforward approach to 4-aryl-2-
quinolones from readily available starting materials providing a simple approach to this 
class of compounds and a simple approach for the utilization of benzoyl chloride, using 
a phosphine free palladium-based catalyst system which may represent a convenient 
alternative to known olefine-based9 palladium catalyzed syntheses of this class of 
compounds. 
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6. Phenanthridinones via Palladium-Catalyzed Intramolecular Direct 
Arene Arylation 
 
 
Direct arylation of arenes through C-H bond cleavage with arylmetals, usually formed 
in situ, has recently attracted considerable attention as a mean to achieve clean and 
economically convenient preparations of polyaryl units.1 Palladium, rhodium and 
ruthenium catalysis have been used in this chemistry1a which has undergone significant 
advances of late. Palladium catalyzed C-H activation processes have provided some of 
the most general arylation methods.2,3,4 
In this context, and as part of a program devoted to the conversion of carboxylic acids 
present in agricultural byproducts5 into more complex fine chemicals by transition 
metal-catalyzed transformations, we decided to explore a general palladium-catalyzed 
synthesis of phenanthridinones, a class of compounds which exhibit interesting 
biological activities,6 from o-iodoanilides 1 through a direct intramolecular arylation at 
one of the positions ortho to the electron-withdrawing CO group (Scheme 1). 
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Pd cat
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4  
Scheme 1 
 
Known palladium catalyzed approaches to the construction of the phenanthridinone 
frame are based on the intramolecular cyclization of N-(o-halobenzoyl)- or N-(o-
triflyloxybenzoyl)anilides,7 a domino process which includes aryl-aryl coupling 
between two o-bromobenzamide units and C-N bond formations concomitant with a 
deamidation reaction,8 a one-pot consecutive aryl-aryl and N-aryl coupling from 
iodoarenes bearing ortho electron-releasing substituents and o-bromobenzamides,9 and 
an Ullmann cross-coupling/reductive cyclization sequence from 1-bromo-2-
nitrobenzene and its derivatives with a range of α-halo-enals, -enones or -esters.10 The 
 43
palladium-catalyzed cyclization of N-(o-iodophenyl)benzanilides was also reported. 
However, the study was limited to investigating the effect of oxygen substituents in the 
meta position of the benzoyl fragment on the regiochemistry of the arene arylation.11 
Because of our own current interest in this type of cyclization process, we have 
explored the scope and limitations of this chemistry. 
Compounds 1 can be readily prepared from o-iodoanilines and activated carboxylic 
acids in excellent yields as shown in Scheme 2. 
 
NH
O
I
Cl
O NH2
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88 %
1a
 
Scheme 2 
 
The cyclization of 1a (R1 = R2 = H) was studied as a model system for optimizing the 
formation of phenanthridinones. Some of the results of our screening studies are 
summarized in Table 1.  
Using 1 mol% Pd2(dba)3 as the Pd(0) source, CsOAc2e or Bu4OAc as bases, and 
monodentate and bidentate phosphine ligands such as PPh3, dppm, dppp and Xanthphos 
afforded phenanthridinone 2a in low yields (Table 1, entries 1-6). One common 
byproduct that we identified, along with variable amounts of the reduction product 
5a,12,13 was the benzoxazole 6a (Scheme 3), very likely derived from the intramolecular 
palladium-catalyzed C-O bond forming reaction involving the amide oxygen and the 
ortho-iodo fragment.14 
 
6a5a
NH
O
O
N
 
Scheme 3 
 
Using dppe as ligand and CsOAc or K2CO3 gave 2a in 50 and 52% yield, but 6a was 
still isolated in 22 and 11% yield, respectively (Table 1, entries 7 and 10). Similar 
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results were achieved with the Pd(OAc)2/pivalic acid combination in the presence of 
K2CO3 and Davephos (Table 1, entries 11-13), reported to have a beneficial effect on 
the direct arylation of simple arenes.4 Switching to Pd(OAc)2 and dppe in the presence 
of Li2CO3 led to a significant increase of the phenanthridinone/benzoxazole selectivity, 
but the same yield of 2a was obtained (Table 1, entry 14). The utilization of K2CO3 as 
the base under the same reaction conditions led to the isolation of 2a in 44% yield 
combined with a poorer phenanthridinone/benzoxazole ratio (Table 1, entry 15). 
Somewhat surprisingly, using Cs2CO3 completely reversed the 
phenanthridinone/benzoxazole selectivity, 6a being isolated in 61% yield. No 
phenathridinone product was formed. (Table 1, entry 16).  
A slight increase of the yield of 2a was observed upon addition of LiCl (Table 1, entry 
17). Finally, 2a was isolated in a satisfactory 65% yield subjecting 1a to Pd(OAc)2, 
dppe, K2CO3 and LiCl at 120 °C in DMF for 7 h (Table 1, entry 18). 
 
Table 1a 
Entry [Pd] Ligandb Base Additive Solvent T (°C) t (h) 2a % yieldc 
6a % 
yieldc 
1 Pd2(dba)3 PPh3 CsOAc − DMF 100 48 15 5 
2 Pd2(dba)3 dppm CsOAc − DMF 100 48 10 − 
3 Pd2(dba)3 dppm Bu4OAc − DMF 100 24 38 15 
4 Pd2(dba)3 dppp CsOAc − DMF 100 48 19 4 
5 Pd2(dba)3 dppp CsOAc − NMP 100 48 30 12 
6 Pd2(dba)3 Xphos CsOAc − DMF 100 48 11 − 
7 Pd2(dba)3 dppe CsOAc − DMF 100 24 50 22 
8 Pd2(dba)3 dppe CsOAc − NMP 100 48 41 19 
9 Pd2(dba)3 dppe NaOtBu − Toluene 100 48 − − 
10 Pd2(dba)3 dppe K2CO3 − DMF 100 48 52 11 
11 Pd(OAc)2 Davephos Na2CO3d t-BuCO2H NMP 120 16 51 11 
12 Pd(OAc)2 Davephos K2CO3d t-BuCO2H NMP 120 12 46 16 
13 Pd(OAc)2 Davephos K2CO3d t-BuCO2H DMA 120 12 48 17 
14 Pd(OAc)2 dppe Li2CO3 − DMF 100 24 50 − 
15 Pd(OAc)2 dppe K2CO3 − DMF 100 48 44 25 
16 Pd(OAc)2 dppe Cs2CO3 − DMF 100 8 − 61 
17 Pd(OAc)2 dppe K2CO3 LiCl DMF 100 12 55 − 
18 Pd(OAc)2 dppe K2CO3d LiCl DMF 120 7 65 − 
a Unless otherwise stated, reactions were carried out under argon on a 0.25 mmol scale in 4 mL of solvent using 0.01 equiv 
Pd2(dba)3  or 0.05 equiv of Pd(OAc)2, 0.02 equiv of bidentate phosphine ligands with Pd2(dba)3 and 0.05 equiv of bidentate 
phosphine ligands with Pd(OAc)2, 2 equiv of base, 0.3 equiv of pivalic acid (when used), and 2 equiv of LiCl (when used).   
b 0.04 equiv of PPh3. 
c Yields are given for isolated products. 
d 2.5 equiv of base. 
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However, when we applied these optimized conditions to other o-iodoanilides (1b, R1 = 
p-MeO, R2 = H; 1c, R1 = m-F; R2 = H; 1d, R1 = m-MeO; R2 = H) reaction mixtures 
were found to contain mostly very polar compounds that we did not investigate further 
and the corresponding phenanthridinones 2b-d were isolated in low to moderate yields 
(Scheme 4). 
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Scheme 4 
 
Of note is that with 1d, bearing a methoxy substituent meta to the carbonyl group, the 
new C-C bond was formed regioselectively at the less crowded ortho position of the 
benzoyl moiety to give 2d. No evidence of the regioisomeric derivative 2d’ was 
attained. This high level of regioselectivity is interesting in view of the known tendency 
of meta oxygen substituents to direct the formation of the C-C bond to the more 
crowded ortho position in this type of reaction.11 Such a behavior was suggested to be 
due to the oxygen coordination to the palladium atom of the arylpalladium complex 
formed in situ via oxidative addition. The resultant intermediate 7 (Scheme 5) would 
exert a strong directing effect on the cyclization step.  
A possible explanation to account for the result obtained with 1d is that in the presence 
of the NH free amide the coordination of nitrogen to palladium to afford 8 (Scheme 5) 
is likely to prevail over oxygen coordination. As a result of the absence of the oxygen 
directing effect, the usual trend favoring the cyclization at the less crowded ortho 
position is observed and 2d is formed regioselectively. 
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Though the results obtained with N-benzoyl-o-iodoanilides 1 might provide some useful 
applications, we thought that further optimization was needed to develop a generally 
applicable synthetically effective reaction protocol. As we felt that the free NH group 
could be at the origin of the unsatisfactory yields obtained with some of the o-
iodoanilides that we had investigated, we turned our attention to the utilization of N-
benzyl derivatives 3 as the starting material. 
The benzyl protecting group appeared particularly suited for the purpose: it can be 
introduced in excellent yield via reaction of benzyl bromide with 1 (DMSO, NaH, room 
temperature) and can be readily and almost quantitatively removed in the presence of 
trifluoroacetic acid to give NH free phenanthridinones.7 
Nevertheless, utilization of N-benzyl derivatives 3 poses the problem of which aromatic 
ring is involved in the cyclization process (Scheme 6). 
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An electrophilic aromatic substitution - a mechanism initially proposed by Miura et al.15 
which, since then, has been usually favored in palladium-catalyzed arylations2c,2e,3e,16 - 
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is expected to afford the phenanthridine derivative 9 because of the higher 
nucleophilicity of the ring B. A proton abstraction mechanism, as proposed by 
Echavarren, Maseras et al.2k,17 for the intramolecular arylation of electron-poor arenes 
and more recently shown by Fagnou et al.3k to be operating in intermolecular palladium 
catalyzed arylation of pefluorobenzenes, should give the phenathridinone product 4. 
Arene arylation might also occur via an Heck-like mechanism involving the 
carbopalladation of the aromatic ring followed by the anti elimination of HPdX (or 
isomerization and syn elimination of HPdX).18 However, recent work indicates that this 
process is rather unlikely.19 
After some experimentation, we found that the desired 4a was smoothly formed and 
isolated in 85% yield subjecting 3a (R1 = R2 = H) to Pd(OAc)2, dppe, K2CO3, in DMF 
at 100 °C for 20 min. No isomeric phenanthridine 9 was observed.  
Attempting to gain more insight into the factors influencing the benzoyl to benzyl 
arylation ratio in this cyclization process, we decided to explore the reaction of the N-
(m-methoxyphenyl)methyl derivative 10, containing an electron-donating substituent. 
Notably, treatment of this substrate under the above conditions afforded an 
approximately 84:16 phenanthridinone:phenanthridine mixture (Scheme 7). 
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Though only a speculative discussion is possible at this stage, the implication that can 
be drawn from the outcome of these reactions is that the substitution pattern of the 
benzyl protecting group may influence the benzoyl/benzyl selectivitys through an 
electronic bias. 
With benzyl derivatives 3 the direct intramolecular arene arylation process involves 
selectively one of the ortho positions of the electron-poor aryl fragment. This appears to 
be consistent with a cyclization controlled by the acidity of the C-H bond rather than by 
the nucleophilicity of the arene and proceeding through a proton abstraction mechanism. 
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When the N-(m-methoxyphenyl)methyl derivative 10 is used as substrate, a competing 
cyclization at the less crowded ortho position of the electron-rich aromatic ring can take 
place to give the phenanthridine derivative 12, the formation of which being compatible 
with an electrophilic aromatic substitution mechanism.  
The structure of 12 was assigned by NOESY experiments. 
Having established the reaction conditions and the basic substrate requirements for the 
preparation of phenanthridinones, we next extended the procedure to a variety of 
anilides 3. Our preparative results are summarized in Table 2. Phenanthridinones 4, 
incorporating a wide range of substituents both in the benzoyl and the aniline moiety, 
were usually isolated in good to high yields. Some steric hindrance is tolerated (Table 2, 
entry 10). The presence of electron-donating groups on the benzoyl fragment, which 
might be expected to weaken the electron-withdrawing effect of the carbonyl group and 
consequently influence the benzoyl/benzyl selectivity, does not change the general trend 
favoring the cyclization to phenanthridinones over the formation of phenanthridines, at 
least with the substrates that we have investigated. For example, the cyclization of 3l 
which gave 4l in 57% isolated yield along with a mixture of tarry polar material (Table 
2, entry 12), did not provide any evidence of a phenanthridine (or dehalogenated) 
product.  
 
Table 2a 
Entry Anilide 3  Time (min) Phenanthridinone 4  
Yield 
%b 
1 
N
O
Bn
I
 
3a 10 
N
O
Bn
 
4a 85 
2 
N
O
Bn
I
Cl
 
3b 20 
N
O
Bn
Cl
 
4b 69 
3 
N
O
Bn
I
F
 
3c 20 
N
O
Bn
F
 
4c 82 
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4 
N
O
Bn
I
MeO
 
3d 10 
N
O
Bn
MeO
 
4d 71 
5 
N
O
Bn
I
Me2N
 
3e 25 
N
O
Bn
Me2N
 
4e 72 
6 
N
O
Bn
I
Ph
 
3f 20 
N
O
Bn
Ph
 
4f 72 
7 
N
O
Bn
I
F  
3g 20 
N
O
BnF
 
4g 83 
8 
N
O
Bn
I
Cl
 
3h 300 
N
O
Bn
Cl
 
4h 61 
9 
N
O
Bn
I
MeO
OMe  
3i 30 
N
O
Bn
OMe
MeO
 
4i 87 
10 
N
O
BnMeO
OMe
Me
I
Me  
3j 30 
N
O
Bn
OMe
MeO
Me
Me  
4j 88 
11 
N
O
Bn
Me
I
Me
F
 
3k 30 
N
O
Bn
Me
Me
F
 
4k 73 
12 
N
O
Bn
Me
I
Me
MeO
 
3l 30 
N
O
Bn
Me
Me
MeO
 
4l 57 
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13 
N
O
Bn
I
Me
Ph
 
3m 30 
N
O
Bn
Me
Ph
 
4m 77 
14 
N
O
Bn
I
Me
Cl
 
3n 20 
N
O
Bn
Me
Cl
 
4n 75 
15 
N
O
Bn
I
COMe
F
 
3o 30 
N
O
COMe
F
Bn
 
4o 82 
16 
N
O
Bn
Cl
MeO
I
 
3p 20 
N
O
Bn
MeO
Cl  
4p 66 
17 
N
O
Bn
Cl
F
I
 
3q 20 
N
O
Bn
F
Cl  
4q 72 
18 
N
O
Bn
Cl
I
 
3r 20 
N
O
Bn
Cl  
4r 76 
a Reactions were carried out on a 0.25 mmol scale under an argon atmosphere at 100 °C in 3 mL of DMF using 0.05 equiv. of 
Pd(OAc)2, 0.05 equiv. of dppe and 2 equiv of K2CO3. 
b Yields are given for isolated products. 
 
NH free phenanthridinones 2 can be readily obtained from the N-benzyl derivatives 4 by 
treatment with trifluoroacetic acid.7 As an example, 2a was isolated in 95% yield upon 
treatment of 4a with trfluoroacetic acid at 100 °C for 24 h (Scheme 8). 
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In conclusion, we have demonstrated that readily available N-benzyl derivatives of N-
benzoyl-o-iodoanilides can be converted into the corresponding phenathridinones 
usually in good to high yields, providing a simple approach to this class of compounds 
and a simple approach for the utilization of benzoyl chloride. The scope of this 
transformation seems to be rather broad. The benzyl protecting group can be almost 
quantitatively removed by treatment with trifluoroacetic acid and does not interfere with 
the desired cyclization to phenanthidinones. Overall, this procedure complements other 
palladium-based strategies for phenantridinone formation which require N-(o-
halobenzoyl)- or N-(o-triflyloxybenzoyl)anilides as substrates. 
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7. Enaminones as Building Blocks for the Synthesis of Heterocycles 
 
 
7.1. α,β-ynones 
α,β-Ynones are highly electrophilic species easily available via Sonogashira cross-
coupling of aroyl chlorides with terminal alkynes (Scheme 1)1. 
 
O
Cl
2% PdCl2(PPh3)2
4% CuI
1.1 eq Et3N
THF, rt
O
1 eq 1 eq (92%)  
Scheme 1 
 
The reaction proceeds smoothly at room temperature and tolerates electron-withdrawing 
and electron-donating groups on both of the coupling partners. These compounds 
undergo fast Michael addition in presence of amines giving rise to multisubstituted 
enaminones (Scheme 2). 
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Scheme 2 
 
The reaction is quite general: R3 can be aryl or alkyl; R2 can be aryl or alkyl; R1 can be 
an electron-withdrawing or an electron-donating group2. 
 
7.2. 1,2-Disubstituted 4-Quinolones via Copper-Catalyzed Cyclization of 1-(2-
Halophenyl)-3-enaminones 
Because of their multifunctional character, 3-enaminones are useful synthetic 
intermediates.3 They have been used in a variety of intra-4 and intermolecular5 reactions. 
A number of transition metal-promoted6 and catalyzed7 processes have also been 
described. Recently, we reported on the utilization of N-propargylic 3-enaminones as 
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common intermediates for the synthesis of polysubstituted pyrroles and pyridines8 
(Scheme 3). 
 
NHR1 N
H
R1
O
R2 R3
N
R2
O
R1
R3 Cs2CO3
DMSO
rt
CuBr
DMSO
60-80 °C O
R2
R3  
Scheme 3 
 
Following this study, we decided to investigate the potential of 1-(2-halophenyl)-3-
enaminones 1 as building blocks for the construction of the 3-unsubstituted 4-quinolone 
skeleton 2 according to the intramolecular C-N bond forming reaction shown in Scheme 
4. 
 
O
HN R2
R1
1
N
O
R1
R2
2
X
X =Br, Cl  
Scheme 4 
 
4-Quinolone derivatives are abundant in many biologically active compounds.9 Some of 
them have been investigated as antiviral10 and antidiabetic11 agents. Compounds 
containing the 3-unsubstituted 2-aryl-4-quinolone motif (structurally similar to flavones 
with, in addition, a nitrogen group that is available for increasing molecular complexity) 
have been shown to have positive cardiac effects12 and exhibit antimitotic,13 
antiplatelet,14 and antiviral15 activity. Despite the existence of a variety of synthetic 
routes for the synthesis of the quinolone scaffold,16 the utility of 4-quinolone derivatives 
justifies efforts to develop new and more versatile methods. In this context, the 
transition metal-catalyzed cyclization of readily available multifunctional precursors is a 
promising synthetic strategy. 
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1-(2-Bromophenyl)- and 1-(2-chlorophenyl)-3-enaminones 1 were prepared via 
Sonogashira cross-coupling of terminal alkynes with commercially available 2-bromo- 
and 2-chlorobenzoyl chlorides,1 followed by the conjugate addition of primary amines 
with the resultant α,β-ynones 32 (Scheme 5). 
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Scheme 5 
 
Compounds 1 have always been isolated as single isomers. The Z stereochemistry of 1a 
(R1 = R2 = Ph) has been assigned by NOESY experiments, which showed also the 
presence of an intramolecular hydrogen bond (N-H···O). That of the other 1-(2-
halophenyl)-3-enaminones has been assigned based on these data.  
We started our study by examining the conversion of 1a (R1 = R2 = Ph, X = Br) into the 
corresponding quinolone derivative 2a in the presence of CuI17 and K2CO3. The 
influence of ligands and solvents on the reaction outcome was investigated. 
Representative optimization experiments are summarized in Table 1. Best results were 
obtained when the cyclization was carried out using 0.05 equiv of CuI, 0.05 equiv of 
N,N’-dimethylethylendiamine (DMEDA), 2 equiv of K2CO3, in DMSO at 80 °C (Table 
1, entry 8). Compound 2a was isolated only in 40% yield when the reaction was carried 
out under the same conditions omitting CuI and DMEDA (Table 1, entry 9). There are 
examples in literature of cyclizations promoted by base of related enaminones. 
However, higher reaction temperatures (110 °C)16e,h and/or stronger bases (NaOEt,16c 
KO-t-Bu,16d NaH16f) are usually required. In addition, fused 4-quinolones16c,f,h or 
quinolone derivatives bearing EtO2C or CN groups at the C-316e,f,h,i have been prepared. 
No examples of 3-unsubstituted 4-quinolones have been described. 
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Table 1a 
Entry Ligand Solvent t (h) Yield % of 2ab 
1 1,10-phenanthroline DMF 8 60 
2 N
H
CO2H
 
DMF 48 72c 
3 
NH2
NH2
 
DMF 6 69 
4 
NH2
NH2
 
DMF 4 78 
5 N NMe Me
Me
Me
(TMEDA) 
DMF 4 79 
6 N
H
H
NMe
Me
 
DMF 6 82 
7 N
H
H
NMe
Me
(DMEDA) 
1,4-dioxane 12 –d 
8 N
H
H
NMe
Me
 
DMSO 2.5 93 
9 – DMSO 2.5 40e 
a Unless otherwise stated, reactions were carried out on a 0.25 mmol scale using 0.05 equiv of  copper salt, 0.05 equiv of ligand, 2 
equiv of K2CO3  in 2.5 mL of solvent at 80 °C. 
b Yields are given for isolated products. 
c 0.1 equiv of proline were used. 
d The starting material was recovered in 95% yield. 
e In the absence of CuI. 
 
Using the optimized conditions, we next explored the scope and generality of the 
process. Our preparative results are summarized in Table 2. A variety of quinolone 
products containing neutral, electron-rich, and electron-poor aryl substituents were 
usually isolated in high to excellent yields. Alkyl substituents are also tolerated. 
However, our method shows some limitations with them. Indeed, enaminones derived 
from primary alkylamines require a stronger base (Table 2, entries 10,11,12). In 
addition, the bulkiness of the alkyl substituent appears to have a detrimental effect on 
the cyclization process: with the N-cyclohexyl derivative 1l the desired quinolone was 
isolated in low yield (Table 2, entry 12) whereas in the presence of the t-butyl group the 
starting enaminone was recovered in almost quantitative yield (Table 2, entry 13). No 
quinolone formation was observed when R1 is an alkyl substituent (Table 2, entries 22 
and 23). 
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Table 2a 
Enaminone 1 (X = Br) Entry 
R2 R1  
Time 
(h) 
Yield % of 
2b 
1 Ph 1a 2.5 2a 93 
2 3-CF3-C6H4 1b 1.5 2b 92 
3 4-MeO-C6H4 1c 2 2c 89 
4 4-MeCO-C6H4 1d 1.5 2d 87 
5 
Cl
 
1e 2 2e 92 
6 4-CN-C6H4 1f 25 2f 82 
7 2,4-F2-C6H3 1g 1.5 2g 72 
8 3,4,5-(MeO)3-C6H2 1h 2 2h 81 
9 4-Cl-C6H4 1i 2 2i 91 
10 n-Bu 1j 1 2j 86c 
11 PhCH2 1k 1 2k 55c 
12 Cy 1l 2 2l 36c 
13 
Ph 
t-Bu 1m 5 2m –d 
14 3-MeO-C6H4 1n 2.5 2n 87 
15 4-Me-C6H4 1o 1.5 2o 85 
16 
4-Cl-C6H4 
4-F-C6H4 1p 2 2p 87 
17 4-MeO2C-C6H4 1q 2.5 2q 75 
18 3-CF3-C6H4 1r 2.5 2r 72 
19 
3-MeO-C6H4 
4-F-C6H4 1s 4 2s 83 
20 4-Cl-C6H4 1t 2 2t 81 
21 4-MeCO-C6H4 4-MeO-C6H4 1u 2.5 2u 70 
22 Ph 1v  2v –c,e 
23 n-C5H11 4-MeO-C6H4 1w  2w –c,f 
a Unless otherwise stated, reactions were carried out on a 0.25 mmol scale using 0.05 equiv of CuI, 0.05 equiv of DMEDA, 2 equiv 
of K2CO3 in 2.5 mL of DMSO at 80 °C.  
b Yields are given for isolated products.  
c NaO-t-Bu (2 equiv) was used instead of K2CO3. 
d 1m was recovered in 90% yield. 
e 1v was recoverd in 92% yield. 
f 1w was recoverd in 91% yield. 
 
1-(2-Chlorophenyl)-3-enaminones can also be used in this chemistry under the same 
conditions. Reaction rates are lower, but yields are equally high to excellent, at least 
with the examples that we have tested (Table 3). 
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Table 3a 
Entry Enaminone 1 (X = Cl) 
 R2 R1  Time(h) Yield % of 2
b
1 Ph 1x 6 2a 95 
2 4-MeO-C6H4 1y 7 2c 83 
3 4-MeCO-C6H4 1z 3 2d 83 
4 4-Cl-C6H4 1za 3 2i 92 
5 
Ph 
n-Bu 1zb 4 2j 89c 
a Unless otherwise stated, reactions were carried out on a 0.25 mmol scale using 0.05 equiv of CuI, 0.05 equiv of DMEDA, 2 equiv 
of K2CO3 in 2.5 mL of DMSO at 80 °C. 
b Yields are given for isolated products.  
c NaO-t-Bu (2 equiv) was used instead of K2CO3. 
 
To make this overall approach to 4-quinolones more attractive from a synthetic 
standpoint, we explored their formation through a process that would omit the isolation 
of the enaminone intermediates. Adding DMSO and the reagents required for the 
cyclization step to the crude methanolic mixture resulting from the reaction of the 
primary amine and the α,β-ynone led to moderate yields. For example, 2a was isolated 
only in 47% overall yield using this protocol (in comparison with the 87% overall yield 
in the stepwise process). In addition, no quinolone product was formed when the overall 
process was carried out using MeOH or DMSO as the sole solvents for the two steps. 
Control experiments revealed that the cyclization does not proceed in MeOH and that 
the enaminone product is formed in low yields in DMSO. Finally, we found that 
excellent results could be obtained by adding DMSO, CuI, DMEDA, and K2CO3 to the 
crude mixture derived from the reaction of primary amines with α,β-ynones after 
evaporation of the volatile materials. Under these conditions, 2a was isolated in 88% 
overall yield (Scheme 6). 
 
Ph
OBr
1. H2NPh
    MeOH, 80 °C, 1 h
2. CuI, K2CO3, DMEDA, 
    DMSO, 80 °C, 3 h
N
O
Ph
Ph
2a (88%)  
Scheme 6 
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On the basis of the recently reported tendency of N-aryl enaminones to coordinate to 
palladium(II) electrophiles,18 the lack of reactivity of the bromo substituent at the 4 
position under copper-catalyzed conditions,19 and previous observations on related Cu-
catalyzed heterocyclizations involving Caromatic–X bonds,20 a plausible mechanism for 
this quinolone ring formation begins with the initial coordination of nitrogen with 
copper (Scheme 7). The resulting complex A undergoes an oxidative addition of the C–
X bond to copper to afford the Cu(III) intermediate B. Subsequent reductive elimination 
releases the product with concomitant regeneration of the Cu(I) species. 
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Scheme 7 
 
To sum up, an efficient approach to the construction of the 3-unsubstituted 1,2-
disubstituted 4-quinolone skeleton from readily available 1-(2-bromophenyl)- and 1-(2-
chlorophenyl)-3-enaminones has been developed. The new method tolerates a variety of 
useful functionalities including ester, keto, cyano, and chloro substituents. Quinolones 
can be prepared from α,β-ynones and primary amines via a sequential process that 
omits the isolation of the 1-(2-halophenyl)-3-enaminone intermediates. Since 3-
unsubstituted 1,2-disubstituted 4-quinolones are essentially formed by assembling 2-
haloaroyl chorides, terminal alkynes, and primary amines, a wide variety of quinolone 
derivatives can be synthesized by using this protocol that can be particularly useful for 
the preparation of libraries. 
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7.3. 3-Acylindoles via Copper-Catalyzed Cyclization of N-(2-Iodoaryl)enaminones 
3-Acylindoles are important therapeutic agents21 and useful intermediates for the 
preparation of pyridocarbazole alkaloids.22 A variety of methods have been used for 
their preparation. The vast majority of them rely on the acylation of preformed indole 
derivatives.23 Direct construction of the 3-acylindole skeleton from acyclic precursors 
has received less attention. This protocol has been used in the palladium catalyzed 
cyclization of 2-(alkynyl)trifluoroacetanilides in the presence of carbon monoxide and 
aryl halides or vinyl triflates24 and in the copper-promoted25 cyclization of N-(2-
haloaryl)enaminones. As to the latter, two N-(2-haloaryl)enaminones, derived from 
acyclic β-diketones, were converted into the corresponding 3-acylindoles using 1.5-2.0 
equiv of CuI and NaH as the base in HMPA at 100-170 °C. During the past few years 
there have been remarkable advances in the use of copper in organic synthesis.26 
Particularly, it has been shown that by using appropriate ligands a large number of 
reactions can be carried out in the presence of catalytic amounts of copper, often 
providing an economic alternative to palladium catalyzed reactions. Therefore, because 
of our continuing interest in indole synthesis27, 28 and our recent studies on the chemistry 
of enaminones,8 we became interested in investigating the feasibility of a copper-
catalyzed cyclization of N-(2-haloaryl)enaminones via substitution of the C-C bond for 
the C-halogen bond (Scheme 8). 
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N-(2-Haloaryl)enaminones 1 were prepared via Sonogashira cross-coupling of terminal 
alkynes with aroyl chlorides1 followed by the conjugate addition of 2-haloanilines with 
the resultant α,β-ynones2 (Scheme 9). N-(2-Haloaryl)enaminones 1 have always been 
isolated as single isomers. The Z stereochemistry of 1 has been assigned by NOESY 
experiments which showed also the presence of an intramolecular hydrogen bond (N-
H···O). 
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Scheme 9 
 
We started our study by examining the conversion of 1a (Ar = R1 = Ph, R2 = H, X = I) 
into the corresponding indole derivative 2a using K2CO3  as the base at 100 °C and 
exploring the influence of solvents and ligands on the reaction outcome. No indole 
formation was observed omitting copper and ligands (Table 4, entry 1) whereas 
moderate to good yields were obtained with 0.05 equiv of CuI and omitting ligands in 
DMSO and DMF (Table 4, entry 2 and 3). Utilization of phosphine ligands (Table 4, 
entries 5-7) showed that 2a could form in high yield with dppp (Table 4, entry 7) but the 
best result in terms of yield and reaction time was achieved using 0.05 equiv of CuI and 
0.05 equiv of 1,10-phenantroline: 2a was isolated in 92% yield after 2.5 h at 100 °C in 
DMF (Table 4, entry 11). 
 
Table 4a 
Entry Ligand (equiv) Solvent Time (h) Yield % of 2ab 
1 – DMF 12 –c,d 
2 – DMSO 8 51 
3 – DMF 8 69 
4 – 1,4-dioxane 8 –e 
5 PPh3 (0.05) DMF 6 67 
6 dppef (0.05) DMF 7 47 
7 dpppg (0.05) DMF 7 80 
8 TMEDA (0.05) DMF 7 65 
9 DMEDA (0.05) DMF 7 69 
10 L-proline (0.1) DMF 20 63 
11 1,10-phenanthroline (0.05) DMF 2.5 92 
a Unless otherwise stated, reactions were carried out at 100 °C on a 0.25 mmol scale using 0.05 equiv of CuI, 2 equiv of K2CO3, in 
2,5 mL of solvent. 
b Yields are given for isolated products. 
c In the absence of CuI. 
d 1a was recovered in 91 % yield. 
e 1a was recovered in 93% yield. 
f dppe = 1,2-bis(diphenylphosphino)ethane. 
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g dppp = 1,2-bis(diphenylphosphino)propane. 
 
Using the optimized conditions, we next explored the scope and generality of the 
process. As shown by Table 5, a variety of indoles can be prepared in high to excellent 
yields: several useful functionalities are tolerated, including ether, keto, cyano, ester, 
bromo and chloro substituents.  
 
Table 5a 
Entry Product  Time (h) Yield %b 
1 
N
H
Ph
Ph
O
 
2a 2.5 92 
2 
N
H
Ph
O
F
 
2b 5 95 
3 
N
H
Ph
O
CF3
 
2c 3.5 93 
4 
N
H
O
OMe
F
 
2d 10 96 
5 
N
H
Ph
O
Cl
 
2e 10 91 
6 
N
H
n-C5H11
Ph
O
 
2f 3 87 
7 
N
H
Ph
O
F CF3
 
2g 4 89 
8 
N
H
Ph
O
F Me
 
2h 13 86 
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9 
N
H
Ph
O
Me
Cl
 
2i 8 88 
10 
N
H
Ph
O
Me OMe
 
2j 4 96 
11 
N
H
Ph
O
Me
Ph
 
2k 8 88 
12 
N
H
Ph
O
Cl OMe
 
2l 3 91 
13 
N
H
Ph
O
Cl
CN
 
2m 2 93 
14 
N
H
Ph
O
Br
Cl
 
2n 6 92 
a Reactions were carried out at 100 °C on a 0.25 mmol scale using 0.05 equiv of CuI, 0.05 equiv of 1,10-phenathroline, 2 equiv of 
K2CO3 in 2.5 mL of DMF. 
b Yields are given for isolated products. 
 
When this indole synthesis was applied to the N-(2-bromoaryl)enaminone 1a’ (R1 = Ar 
= Ph; R2 = H; X = Br), we were surprised to find that the formation of the expected 
indole product was accompanied by the formation of the benzoxazepine derivative 3, 
most probably via an intramolecular copper-catalyzed substitution of the C-O bond for 
the C-Br bond (Scheme 10).29 No such a competition between the C- and O-cyclization 
was observed with the iodo derivatives that we have investigated.  
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This indole synthesis can also be carried out through a process that omits the isolation 
of the enaminone intermediates. In practice, excellent results can be obtained by adding 
CuI, 1,10-phenanthroline, K2CO3, and DMF to the crude mixture derived from the 
reaction of 2-iodoanilines with α,β-ynones after evaporation of the volatile materials. 
Under these conditions, 2a was isolated in 76% overall yield (Scheme 11). 
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On the basis of the recently reported tendency of N-aryl enaminones to coordinate to 
palladium(II) electrophiles and previous observations on related Cu-catalyzed 
heterocyclizations involving Caromatic–X bonds, a plausible mechanism for this indole 
ring formation begins with the initial coordination of carbon with copper (Scheme 12). 
The resulting complex A undergoes an oxidative addition of the C–X bond to copper to 
afford the Cu(III) intermediate B. Subsequent reductive elimination releases the product 
with concomitant regeneration of the Cu(I) species. 
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In conclusion, we have shown that N-(2-iodoaryl)enaminones can be converted into the 
corresponding 3-acylindoles in the presence of catalytic amounts of CuI. The new 
method tolerates a variety of useful functionalities including ether, keto, cyano, and 
chloro substituents. The substituted indoles can also be prepared via a sequential 
process from α,β-ynones and 2-iodoanilines, omitting the isolation of the enaminone 
intermediates. Since multisubstituted indoles are essentially formed by assembling 2-
iodoanilines, aroyl chlorides, and terminal alkynes, a wide variety of indole derivatives 
can be synthesized by using this protocol that can be particularly useful for the 
preparation of libraries. 
 
7.4. Multisubstituted Indoles from Enaminones via Copper-Catalyzed C-C Bond 
Formation/ C-H Functionalization 
Because of the economic attractiveness and good functional tolerance of copper-
catalyzed methods and hence of their potential in large scale applications, during the 
past few years there have been remarkable advances in the use of copper catalysis in 
organic synthesis. An impressive number of Ullman coupling reactions has been 
described starting from aryl halides and suitable reagents.30 Recent reports31 have 
shown that copper catalysis can be successfully used also in the formation of C-
heteroatom and C-C bonds via selective catalytic activation of aryl C-H bonds, a topic 
of intense current interest that, for the most part, has witnessed the use of palladium-, 
rhodium-, and ruthenium-based catalysts.32 In particular, intramolecular copper-
catalyzed ortho C-H functionalizations via C-N and C-O bond forming reactions have 
been shown to form benzimidazoles31c and benzoxazoles31d from amidines and anilides, 
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respectively. We disclose a new synthesis of multisubstituted indoles from enaminones 
that involves an intramolecular copper-catalyzed aryl C-H functionalization via C-C 
bond formation.  
Enaminones were readily prepared through Sonogashira cross-coupling of terminal 
alkynes with aroyl chlorides2 followed by the conjugate addition of anilines with the 
resultant α,β-ynones3 (Scheme 13). 
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80-95%
HN Ar2
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MeOH, 80 °C, 1-4 h
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Ar1
O
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Ar3
 
Scheme 13 
 
We initiated our study by examining whether the enaminone 1a could be converted into 
the corresponding indole 2a (Scheme 13). 
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Ph
O Ph
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3.5 equiv phen
N
H
Ph
1a 2a
4 equiv base
Ph
O
 
Scheme 13 
 
After an initial screen of copper catalysts [CuSO4, CuCl2, CuI], we found that 2a could 
be isolated in 63% yield by using CuI and 1,10-phenanthroline (phen) in DMA after 48 
h (Table 6, entry 1). Utilization of DMSO gave a similar yield but in half the time 
(Table 6, entry 2) while 1,4-dioxane led to the recovery of the starting enaminone in 
almost quantitative yield (Table 6, entry 3). A satisfactory result was obtained when 
DMF was used as solvent: 2a was isolated in 80% yield (Table 6, entry 4). Using 
K2CO3 (Table 6, entry 5) or Cs2CO3 (Table 6, entry 6) resulted in lower yields as well as 
decreasing the reaction temperature (Table 6, entry 7) or the excess 1,10-phenanthroline 
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(Table 6, entry 8). No indole formation was observed omitting 1,10-phenanthroline 
even increasing the amount of CuI to 30 mol% and the reaction temperature to 120 °C 
(Table 6, entry 8). 
 
Table 6a 
Entry Base Solvent T [°C] t [h] Yield % of 2ab 
1 Li2CO3 DMA 100 48 63 
2 Li2CO3 DMSO 100 24 66 
3 Li2CO3 1,4-dioxane 100 24 –[c] 
4 Li2CO3 DMF 100 24 80 
5 K2CO3 DMF 100 72 48 
6 Cs2CO3 DMF 100 24 51 
7 Li2CO3 DMF 80 48 42[d] 
8 Li2CO3 DMF 100 30 61[e] 
9 Li2CO3 DMF 120 24 –[f] 
a Reactions were carried out on a 0,25 mmol scale using 0.05 equiv of CuI, 0.175 equiv of 1,10-phenathroline, 2 equiv of base in 2,5 
mL of solvent. 
b Yields are given for isolated products. 
c 1a was recovered in 94% yield. 
d 1a was recovered in 44% yield. 
e With 5 mol% of phen. 
f Without 1,10-phenanthroline, in the presence of 30% CuI. 1a was recovered in 90 % yield. 
 
The scope and generality of the process was next explored using the optimized 
conditions. As shown in Table 7, a great variety of enaminones can be converted into 
the corresponding indoles. Several useful functional groups are tolerated both in the 
enone and the N-aryl ring fragment, including the whole range of halogen substituents. 
The ability to incorporate the latters makes this reaction particularly attractive for 
increasing the molecular complexity for example via transition metal-catalyzed 
coupling reactions. The presence of substituents at both meta positions of the aniline 
fragment does not hamper the reaction (Table 7, entries 15 and 19). However, when 
there is only one substituent meta to the nitrogen, the cyclization affords regioisomeric 
derivatives both with electron-donating (Table 7, entry 5) and electron-withdrawing 
(Table 7, entry 14) groups. No indole formation was observed when the enaminone 
containing an acetyl group para to the nitrogen (Table 7, entry 6) was subjected to our 
standard conditions. However, the appropriately protected derivative afforded the 
desired product in good yield (Table 7, entries 7). 
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Table 7a 
Entry Product [Yield %]b Entry Product [Yield %]b 
1 
N
H
Ph
Ph
O
 
2a [80] 
14 
2l [82] 
6-EtO2C/4-EtO2C 
64:36 
2 N
H
Ph
Ph
O
MeO
Me  
2b [84] 
15 
N
H
O
MeO
Me
OMe
MeO
Br
 
2m [68] 
3 
N
H
Ph
Ph
O
MeO
 
2c [76] 
16 N
H
Ph
O
Me
F
OMe
 
2n [72] 
4 
N
H
Ph
Ph
O
Me
 
2c [84] 
17 
N
H
O
Me
Ph
F3C
 
2o [80] 
5 
2d [79] 
6-MeO/4-MeO 
50:50 
18 
N
H
O
Me
OMePh
F
 
2p [83] 
6 N
H
Ph
Ph
O
Me
O
 
[–] 
19 
N
H
Ph
Ph
OMe
Me
 
2q [78] 
7 
N
H
Ph
Ph
OOO
 
2e [57] 
20 
N
H
O
Ph
OMe
Cl
 
2r [58] 
8 
N
H
Ph
Ph
O
F
 
2f [75] 
21 
N
H
Ph
O
MeO
 
2s [76] 
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9 
N
H
Ph
Ph
O
Cl
 
2g [53] 
22 
N
H
Ph
O
NC
 
2t [56] 
10 
N
H
Ph
Ph
O
Br
 
2h [60] 
24 
N
H
Ph
O
CN
 
2u [66] 
11 
N
H
Ph
Ph
O
I
 
2i [72] 
24 
N
H
Ph
O
OMe
 
2v [75] 
12 N
H
Ph
Ph
O
Br  
2j [51] 
25 
N
H
Ph
O
MeO
CO2Me
 
2w [66] 
13 
N
H
Ph
O
Br
Cl
 
2k [65] 
26 
N
H
O
Ph
COMe
 
2y [55] 
a Reactions were carried out at 100 °C on a 0.25 mmol scale using 0.05 equiv of CuI, 0.175 equiv of 1,10-phenathroline, 2 equiv of 
Li2CO3 in 2.5 mL of DMF. 
b Yields are given for isolated products. 
 
The formation of 2j from the corresponding N-(2-bromophenyl)enaminone 1j (Table 7, 
entry 12) is remarkable in that 7-bromoindoles are key intermediates in the preparation 
of biologically active compounds via Suzuki-Miyaura cross-couplings. Its formation is 
the result of a C-H activation process that is favored over the possible indolization via 
substitution of the C-C bond for the C-Br bond. This C-H bond vs C-Br bond selectivity 
represents a distinct advantage of the present method and was found to depend on a 
subtle combination of base and halide effects (Scheme 14). Control experiments 
revealed that indolization occurs preferentially at the carbon bound to Br when the 
copper-catalyzed cyclization of 1j is carried out using K2CO3. Under these conditions, 
the dehalogenated indole 3 was isolated in 30% yield. Interestingly, the benzoxazepine 
product 4, derived from an intramolecular C-Br functionalization via C-O bond forming 
reaction, was also isolated in 36% yield. When the enaminone 1j’, bearing an o-iodo 
substituent on the aniline fragment, was used as the starting substrate, only part of the 
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reaction was found to proceed through the C-H functionalization pathway in the 
presence of Li2CO3. Indeed, the corresponding 7-iodoindole was obtained in 27% yield, 
the main product being the indole product 3. Using K2CO3 in the indolization of 1j’ led 
to the isolation of the indole 3 in excellent yield and no evidence of benzoxazepine 
formation was attained.  
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X
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N
O
Ph
Ph
N
H
Ph
Ph
O
X
2j (51%)
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2z (27%) 3 (51%)
 3 (92%)
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K2CO3
Br
Br
I
I  
Scheme 14 
 
At the present time we are unsure of the mechanism of this indolization process. An 
intramolecular competition experiment using ortho-deuterium labeled 1a allowed us to 
determine an isotope effect of kH/kD = 1.5 (100 °C). These values are in the direction 
expected for a mechanism in which the hydrogen-abstraction step occurs in the rate-
limiting step. However, further studies are needed to clear up the mechanistic details of 
this indolization process. 
To make this overall approach to indoles more attractive from a synthetic standpoint, 
we explored their formation through a process that omits the isolation of the enaminone 
intermediates. Adding DMF and the reagents required for the cyclization step to the 
crude methanolic mixture resulting from the conjugate addition of the aniline to the α,β-
ynone led to moderate yields. For example, 2a was isolated only in 50% overall yield 
after 48 h using this protocol. In addition, no indole product was formed when the 
overall process was carried out using MeOH or DMF as the sole solvents for the two 
steps. Control experiments revealed that the cyclization does not proceed in MeOH and 
that the enaminone product is not formed in DMF. Finally, we found that good results 
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could be obtained by adding DMF, CuI, phen, and Li2CO3 to the crude mixture derived 
from the reaction of anilines with α,β-ynones after evaporation of the volatile materials. 
Under these conditions, 2a was isolated in 66% overall yield (Scheme 15). 
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Scheme 15 
 
In conclusion, an efficient copper-catalyzed approach to the construction of the 
multisubstituted indole skeleton from readily available enaminones has been developed. 
The new method tolerates a variety of useful functionalities including the whole range 
of halogen substituents. With N-(2-bromophenyl)enaminone a remarkable selectivity 
was observed that favors the C-H functionalization in comparison to the C-Br 
functionalization and affords 7-bromoindoles, key intermediates in the synthesis of 
biologically active compounds. Indole products can also be prepared from α,β-ynones 
and primary amines via a sequential process that omits the isolation of the enaminone 
intermediates. Since multisubstituted indoles are essentially formed by assembling 2-
haloaroyl chorides, terminal alkynes, and primary amines, a wide variety of indole 
derivatives can be synthesized by using this protocol that can be particularly useful for 
the preparation of libraries. 
 
7.5. Multisubstituted Quinolines through a One-Pot Process from Anilines and α,β-
Ynones 
The quinoline nucleus is prevalent in a variety of biologically active compounds. In 
particular the 2-substituted quinoline subunit is present in some naturally occurring 
substances33 and in a structurally simple class of peptidoleukotriene LTD4 antagonists, 
developed recently as antiashmatic tharapeutics34.  
Numerous approach to the construction of the quinoline skeleton have been reported35 
and metal-mediated synthesis have drawn considerable interest in recent years. In 
particular palladium catalysis in this area has been applied to the hydroarylation 
(hydrovinylation)/cyclization of 3,3-diethoxy-1-(o-acetamidophenyl)-1-propyne with 
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aryl and vinyl halides36; to the reaction of o-iodoanilides with substituted alkenes 
followed by a cyclization step37a-d; to the coupling/oxidation/cyclization of o-
iodoanilides with acetylenic carbinols38; and the carbonylative coupling/conjugate 
addition/cyclization of o-ethynylanilines with aryl iodides39. 
We start our approach to the quinoline ring considering the Sonogahira cross-coupling 
of terminal alkyne to the (E)-3-(2-iodophenylamino)-1,3-diphenylprop-2-en-1-one (1a) 
generating the highly functionalized (E)-1,3-diphenyl-3-(2-
(phenylethynyl)phenylamino)prop-2-en-1-one (2a) (Scheme 16). 
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Scheme 16 
 
The reaction works well with electron-donating and electron-withdrawing group on the 
alkyne moiety (R1 = H 92 %; 4-OMe 93 %; 4-Cl 81 %). 
After an initial screen of copper, palladium40 and gold41 salt in presence of base we 
found that in these conditions the principal tendency is the formation of the five 
member ring of indole instead that of quinoline (Scheme 17). 
 
Table 8a 
Entry Solvent Metal Base T (°C) Yield % of 
3 [t, (h)]b 
1 1,4-dioxane CuBr (10 %) Cs2CO3 (1 eq) 80 35 [4] 
2 MeCN PdCl2 (5 %) - 80 50 [8] 
3 MeOH - Cs2CO3 (1 eq) 35    - [12]c 
4 MeOH NaAuCl4 (10 %) - 60 98 [4] 
5 MeOH NaAuCl4 (10 %) Cs2CO3 (1 eq) 60 90 [1] 
a Unless otherwise stated, reactions were carried out on a 0.25 mmol scale using 2.5 ml of solvent. 
b Yields are given for isolated products. 
c 2a recovered in 94 % yield. 
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Scheme 17 
 
In all of these cases the only product isolated was the N-vinylic indole that is not usefull 
for our scope. Satisfactory results were obtained when metal salts were abandoned and 
the reaction was carried out only in presence of base (Table 9) ( Scheme 18). 
 
N
H Ph
O
Ph
Ph
2a N
Ph
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Ph 4a  
Scheme 18 
 
Table 9a 
Entry Solvent Base t (h) T (°C) Yield % of 
4ab 
1 DMSO Cs2CO3 (2 eq) 2 35 92 
2 MeOH Cs2CO3 (2 eq) 12 35 -c 
3 NMP Cs2CO3 (2 eq) 3 35 82 
a Reactions were carried out on a 0,25 mmol scale in 2,5 mL of solvent. 
b Yields are given for isolated products. 
c 2a was recovered in 94% yield. 
 
Under these conditions 2,3,4-trisubstituted quinolines were isolated in excellent yields. 
According to this stepwise synthesis, a one–pot protocol is not feasible. In fact the base 
catalyzed ring closure does not work under the condition of Sonogashira cross-coupling. 
So we decided to change the synthetic sequence and to performe the Sonogashira cross-
coupling before the Michael addition to the α,β-ynone as show in Scheme 19 and 20. 
Compound 5a undergo addition to the ynone at 120 °C in 48 h. 
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Scheme 20 
 
Table 10a 
Entry A B Yield % of 4ab 
1 MeOH, 120 °C, 48 h DMSO, Cs2CO3, rt, 1 h 60 
2 MeOH, 120 °C, 48 h NMP, Cs2CO3, 60 °C, 1 h 81 
3 MeOH, 120 °C, 48 h NMP, K2CO3, 60 °C, 24 h 82 
4 MeOH, 120 °C, 48 h DMA, Cs2CO3, 60 °C, 0,5 h 65 
5 MeOH, 120 °C, 48 h MeCN, Cs2CO3, 60 °C, 1,5 h 83 
a Reactions were carried out on a 0,25 mmol scale in 2,5 mL of solvent. 
b Yields are given for isolated products. 
 
We found that good results could be obtained by adding MeCN and Cs2CO3 to the crude 
mixture derived from the reaction of 5a with α,β-ynones after evaporation of the 
volatile materials. 
Using the optimized conditions, we next explored the scope and generality of the 
process. As shown in Table 11, a variety of quinolines can be prepared in good to high 
yields: several useful functionalities are tolerated, including ether, keto, cyano, ester, 
bromo and chloro substituents. 
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Table 11a 
Entry Product  Time (h) Yield %b 
1 
N
O
 
4a A : 48 h B : 1.5 h 83 
2 
N
O
OMeCl
 
4b A : 48 h B : 1.5 h 76 
3 
N
O
Cl
F
 
4c A : 48 h B : 0.5 h 74 
4 
N
O
Cl
 
4d A : 48 h B : 4 h 51 
5 
N
O
MeO
Br
 
4e A : 24 h B : 1 h 43 
6 
N
O
OMe
 
4f A : 48 h B : 24 h 42 
7 
N
O
Cl
 
4g A : 48 h B : 2 h 64 
8 
N
O
OMe Cl
 
4h A : 48 h B : 0.5 h 83 
 79
9 
N
O
CN
F
 
4i A : 48 h B : 0.5 h 65 
10 
N
O
F OMe
 
4j A : 48 h B : 1 h 77 
11 
N
O
CF3
 
4k A : 24 h B : 1.5 h 70 
12 
N
O
CF3
 
4l A : 72 h B : 1 h 70 
13 
N
O
CF3
Cl
 
4m A : 48 h B : 1 h 75 
14 
N
O
Cl
MeO
 
4n A : 24 h B : 2 h 70 
15 
N
O
Me
 
40 A : 48 h B : 4.5 h 43 
16 
N
O
CO2Et F
OMe  
4p A : 48 h B : 1.5 h 63 
a Reactions were carried out at 120 °C on a 0.2 mmol scale in 1.0 mL of MeOH. After that period the mixture was cooled and the 
volatile materials evaporated at reduced pressure. Then 2 equiv of Cs2CO3 in 1.0 mL of MeCN were added. 
b Yields are given for isolated products. 
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In conclusion, an efficient base-catalyzed approach to the construction of the 
multisubstituted quinoline skeleton from readily available enaminones has been 
developed. The new method tolerates a variety of useful functionalities including the 
whole range of halogen substituents. 
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8. Experimental section 
 
 
8.1. Reagents and methods 
Melting points were determined with a Büchi B-545 apparatus and are uncorrected. All 
the reagents and solvents are commercially available and were used as purchased, 
without further purification. All the compounds were purified on axially compressed 
columns, packed with SiO2 25-40 µm (Macherey Nagel), connected to a Gilson solvent 
delivery system and to a Gilson refractive index detector, and eluting with n-
hexane/AcOEt mixtures. 1H NMR (400.13 MHz), 13C NMR (100.6 MHz) and 19F NMR 
(376.5 MHz) spectra were recorded with a Bruker Avance 400 spectrometer. Infrared 
(IR) spectra were recorded on a JASCO FT/IR-430 spectrophotometer. Mass spectra 
were determined with a QP2010 Gas Chromatograph Mass spectrometer (EI ion source) 
and a Thermo Finnigan LXQ spectrometer (ESI ion source). 
 
8.2. Characterization of synthesized compounds 
8.2.1. Typical Procedure for the Synthesis of Methyl β-(o-Acetamidophenyl)acrylates. 
To a stirred solution of N-(2-iodophenyl)acetamide (2.05 g, 7.85 mmol), methyl acrylate 
(2.12 ml, 23.56 mmol), KOAc (0.77 g, 7.85 mmol), K2CO3 (1.35 g, 9.81 mmol) at 80 
°C in DMF (8 ml), Pd(OAc)2 (0.044 g, 0.196 mmol) was added. The mixture was stirred 
for 1 h. After cooling, the mixture was diluted with AcOEt and washed with water. The 
organic layer was dried over Na2SO4 and concentrated under reduced pressure. The 
residue was purified by chromatography (silica gel; 30/70 v/v n-hexane/AcOEt) to give 
1.55 g (90 % yield) of (E)-methyl 3-(2-acetamidophenyl)acrylate: white solid, mp 137-
138 °C; 1H NMR (CDCl3) δ 7.83 (d, J = 15.8 Hz, 1H), 7.73 (m, 1H), 7.55 (m, 1H), 7.48 
(bs, 1H), 7.39 (m, 1H), 7.21 (m, 1H), 6.40 (d, J = 15.8 Hz, 1H), 3.81 (s, 3H), 2.24 (s, 
3H); 13C NMR (CDCl3) δ 168.4, 166.6, 139.1, 135.4, 130.3, 127.2, 126.6, 125.4, 124.8, 
119.7, 51.3, 23.6; IR (KBr) 3275, 1723, 1658 cm-1; MS m/z (relative intensity) 146 (100 
%), 118 (94 %), 117 (95%) 219 (M+ 23 %). 
 
8.2.2 Typical Procedure for the Synthesis of 4-Aryl-2-quinolones. 
An oven dried Schlenk tube equipped with a magnetic stir bar and a Teflon cap was 
charged with methyl β-(o-acetamidophenyl)acrylate (0.088 g, 0.40 mmol), p-
iodoanisole (0.140 g, 0.60 mmol), KOAc (0.078 g, 0.8 mmol), Pd(OAc)2 (0.0045 g, 
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0.020 mmol) and DMF (1.5 ml). The tube was sealed and stirred at 120 °C for 48 h. 
After cooling, the mixture was diluted with AcOEt and washed with water. The organic 
layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was 
purified by chromatography (silica gel; 25/75 v/v n-hexane/AcOEt) to give 0.061 g (60 
% yield) of 4-(4-methoxyphenyl)quinolin-2(1H)-one. 
 
N
H
O
OMe
 
4-(4-methoxyphenyl)quinolin-2(1H)-one, white solid, m.p.: 196-198 °C; 1H NMR 
(CDCl3) δ 12.83 (bs, 1H), 7.64-7.62 (m, 1H), 7.57-7.51 (m, 2H), 7.45-7.43 (m, 2H), 
7.20-7.18 (m, 1H), 7.06 (m, 2H), 6.35 (s, 1H), 3.91 (s, 3H); 13C NMR (CDCl3) δ 164.4, 
160.2, 153.2, 139.1, 130.7, 130.3, 129.5, 126.8, 122.5, 120.6, 119.8, 116.8, 114.2, 55.6; 
IR (KBr) 3131, 1672 cm-1; MS m/z (relative intensity) 251 (M+, 100 %), 252 (40 %), 
236 (30%) 208 (50 %). 
 
N
H
O
Me
 
4-(4-tolyl)quinolin-2(1H)-one, white solid, m.p.: 229-231 °C; 1H NMR (CDCl3) δ 12.53 
(bs, 1H), 7.61-7.59 (m, 3H), 7.54-7.27 (m, 4H), 7.18 (t, J = 8 Hz, 1H), 6.70 (s, 1H), 2.47 
(s, 3H);13C NMR (DMSOd6) δ 161.9, 152.0, 139.9, 138.8, 134.4, 131.0, 129.8, 129.1, 
126.7, 122.3, 121.6, 118.9, 116.3, 21.4; IR (KBr) 3140, 1667 cm-1; MS m/z (relative 
intensity) 235 (M+, 100 %), 236 (17%), 220 (20 %) 220 (50 %). 
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N
H
O
OMe
 
4-(3-methoxyphenyl)quinolin-2(1H)-one, white solid, m.p.: 189-192 °C; 1H NMR 
(CDCl3) δ 12.58 (bs, 1H), 7.62-7.60 (m, 1H), 7.56 (m, 2H), 7.45-7.43 (m, 1H), 7.19 (m, 
1H), 7.09-7.03 (m, 3H), 6.74 (s, 1H), 3.88 (s, 3H); 13C NMR (DMSOd6) δ 161.3, 159.3, 
151.3, 139.2, 138.0, 130.5, 129.8, 126.2, 121.9, 121.1, 120.8, 118.3, 115.7, 114.4, 
114.1, 55.2; IR (KBr) 3138, 1661 cm-1; MS m/z (relative intensity) 251 (M+, 100 %), 
252 (25 %), 236 (15%) 220 (45 %). 
 
N
H
O
 
4-(3,5-dimethylphenyl)quinolin-2(1H)-one, white solid, m.p.: 256-257 °C; 1H NMR 
(CDCl3) δ 12.90 (bs, 1H), 7.61-7.53 (m, 3H), 7.20-7.11 (m, 4H), 6.71 (s, 1H), 2.43 (s, 
6H); 13C NMR (CDCl3) δ 164.3, 153.8, 138.9, 138.2, 137.1, 130.6, 130.4, 126.9, 126.6, 
122.4, 120.5, 119.7, 116.7, 21.3; IR (KBr) 3058, 1664 cm-1; MS m/z (relative intensity) 
249 (M+, 100 %), 234 (46 %), 250 (20%). 
 
N
H
O
NH
O
 
N-(4-(2-oxo-1,2-dihydroquinolin-4-yl)phenyl)acetamide, white solid, m.p.: 304-305 °C; 
1H NMR (DMSOd6) δ 11.82 (bs, 1H), 10.14 (bs, 1H), 7.75-7.73 (m, 2H), 7.52-7.38 (m, 
5H), 7.17-7.13 (m, 1H), 6.37 (s, 1H), 2.10 (s, 3H); 13C NMR (DMSOd6) δ 168.5, 161.3, 
151.1, 139.8, 139.3, 131.0, 130.5, 129.2, 126.2, 121.8, 120.9, 118.9, 118.3, 115.7, 24.0; 
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IR (KBr) 3283, 1664 cm-1; MS m/z (relative intensity) 279 (M+, 100 %), 280 (34 %), 
261 (22%) 219 (18 %). 
 
N
H
O
 
4-m-tolylquinolin-2(1H)-one, white solid, m.p.: 199-200 °C; 1H NMR (CDCl3) δ 12.84 
(bs, 1H), 7.60-7.55 (m, 3H), 7.43-7.41 (m, 1H), 7.34-7.28 (m, 3H), 7.21-7.17 (m, 1H), 
6.71 (s, 1H), 2.47 (s, 3H);13C NMR (CDCl3) δ 164.2, 153.7, 138.9, 138.3, 137.1, 130.6, 
129.5, 129.4, 128.5, 126.8, 125.9, 122.5, 120.6, 119.7, 116.7, 21.5; IR (KBr) 3326, 1662 
cm-1; MS m/z (relative intensity) 235 (M+, 100 %), 220 (31 %), 234 (23%) 236 (21 %). 
 
N
H
O
 
4-phenylquinolin-2(1H)-one, white solid, m.p: 252-254 °C; 1H NMR (CDCl3) δ 12.69 
(bs, 1H), 7.59-7.48 (m, 8H), 7.21-7.17 (m, 1H), 6.73 (s, 1H); 13C NMR (CDCl3) δ 
164.1, 153.5, 139.0, 137.2, 130.7, 129.0, 128.9, 128.7, 128.5, 127.3, 126.8, 122.6, 
120.9, 119.7, 116.7; IR (KBr) 3170, 1624 cm-1; MS m/z (relative intensity) 221 (M+, 
100 %), 222 (27%), 220 (36 %), 207 (38 %). 
 
N
H
O
F
 
4-(2-fluorophenyl)quinolin-2(1H)-one, white solid, m.p.: 201-203 °C; 1H NMR (CDCl3) 
δ 11.96 (bs, 1H), 7.60-7.49 (m, 3H), 7.50-7.36 (m, 3H), 7.14-7.13, (m, 2H), 6.47 (s, 
1H); 13C NMR (CDCl3) δ  163.9, 159.5(d, J = 248 Hz), 148.0, 138.6, 131.1 (d, J = 3.1 
Hz), 131.0, 130.9, 126.6, 124.7(d, J = 15.9 Hz), 124.6 (d, J = 3.6 Hz), 122.8, 122.3, 
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119.6, 116.6, 116.1 (d, J = 21.4 Hz); 19F NMR (  -111.7; IR (KBr) 3066, 1668 cm-1; 
MS m/z (relative intensity) 239 (M+, 100 %), 240 (12 %), 211 (60%), 183 (75%). 
 
N
H
O
F
 
4-(3-fluorophenyl)quinolin-2(1H)-one, white solid, m.p.: 235-237°C; 1H NMR 
(DMSOd6) δ 11.92 (bs, 1H), 7.58-7.54 (m, 2H), 7.42-7.18 (m, 5H), 7.17-7.16 (m, 1H),  
6.44 (s, 1H), 13C NMR (CDCl3) δ 163.7, 162.7 (d, J = 247 Hz), 151.9, 139.3 (d, J = 7.8 
Hz), 139.0, 130.9, 130.4 (d, J = 8.3 Hz), 126.6, 124.7(d, J = 2.9 Hz), 122.7, 121.2, 
119.3, 116.7, 116.4 (d, J = 20.7 Hz), 115.8 (d, J = 19.4 Hz); 19F NMR  -112.4; IR 
(KBr) 3063, 1670 cm-1; MS m/z (relative intensity) 239 (M+, 100 %), 241 (16 %), 211 
(85 %), 183(65%).  
 
N
H
O
F
 
4-(4-fluorophenyl)quinolin-2(1H)-one, white solid, m.p.: 243-244 °C; 1H NMR (CDCl3) 
δ 12.76 (bs, 1H), 7.57-7.44 (m, 5H), 7.26-7.11 (m, 3H), 6.71 (s, 1H); 13C NMR (CDCl3) 
δ 163.6, 162.6 (d, J = 249 Hz), 152.0, 138.4, 132.6 (d, J = 3.3 Hz), 130.4, 130.2 (d, J = 
8.3 Hz), 126.0, 122.3, 120.4, 119.1, 116.3, 115.3 (d, J = 21.7 Hz); 19F NMR   ; IR 
(KBr) 2852, 1671 cm-1; MS m/z (relative intensity) 239 (M+, 100 %), 238 (30 %), 183 
(26%), 211 (23%). 
 
N
H
O
Cl
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4-(4-chlorophenyl)quinolin-2(1H)-one, white solid, m.p.: 248-249 °C; 1H NMR 
(CDCl3) δ 12.48 (bs, 1H), 7.59-7.49 (m, 7H), 7.26-7.19 (m, 1H), 6.69 (s, 1H); 13C NMR 
(CDCl3) δ 161.6, 150.7, 139.7, 135.9, 134.1, 131.1, 131.0, 129.2, 126.4, 122.4, 121.9, 
118.6, 116.3; IR (KBr) 3398, 1663 cm-1; MS m/z (relative intensity) 255 (M+, 100 %), 
257 (34 %), 254 (23%), 256 (22%), 227 (16 %). 
 
N
H
O
O
O
 
4-(3-(1,3-dioxolan-2-yl)phenyl)quinolin-2(1H)-one, white solid, m.p.: 191-193 °C; 1H 
NMR (CDCl3 ) δ 12.69 (bs, 1H), 7.65-7.64 (m, 2H), 7.63-7.50 (m, 5H), 7.20-7.18 (m, 
1H), 6.74 (s, 1H), 5.92 (s, 1H), 4.20-4.07(m, 4H); 13C NMR (CDCl3 ) δ 164.2, 153.3, 
139.0, 138.7, 137.3, 130.9, 129.8, 128.8, 127.2, 127.1, 126.8, 122.8, 121.0, 119.7, 
116.8, 103.5, 65.5; IR (KBr) 3138, 1669cm-1; MS m/z (relative intensity) 292 (M+, 100 
%), 293 (100 %), 294 (19,8%). 
 
N
H
O
O
O
 
4-(4-(2-methyl-1,3-dioxolan-2-yl)phenyl)quinolin-2(1H)-one, white solid, m.p.: 119-
120 °C; 1H NMR (DMSOd6) δ 11.87 (bs, 1H), 7.59-7.37 (m, 7H), 7.14 (t, J = 7.22, 1H), 
6.40 (s, 1H), 4.02-3.75 (m, 4H) 1.62 (s, 3H); 13C NMR (DMSOd6) δ 161.2, 151.1, 143.8, 
139.3, 136.1, 130.5, 128.6, 126.1, 125.4, 121.9, 121.2, 118.2, 115.8, 107.9, 64.2, 27.2; 
IR (KBr) 3133, 1667cm-1; MS m/z (relative intensity): 307 (M+, 100%), 308 (21%). 
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N
H
O
OMe
Cl  
8-chloro-4-(4-methoxyphenyl)-6-methylquinolin-2(1H)-one, white solid, m.p.: 206-207 
°C; 1H NMR (CDCl3) δ 9.14 (bs, 1H), 7.42-7.41 (m, 1H), 7.41-7.38 (m, 2H), 7.37-7.36 
(m, 1H), 7.06-7.04 (m, 2H), 6.60 (s, 1H), 3.90 (s, 3H) 2.33 (s, 3H); 13C NMR (CDCl3) δ 
161.4, 160.1, 152.2, 132.7, 132.2, 131.2, 129.9, 128.8, 125.7, 121.8, 120.8, 119.1, 
114.1, 55.3, 20.8; IR (KBr) 3163, 1606 cm-1; MS m/z (relative intensity): 299 (M+, 
100%), 301 (34%), 300 (24 %). 
 
N
H
O
Me
Cl  
8-chloro-6-methyl-4-p-tolylquinolin-2(1H)-one, white solid, m.p.: 228-229 °C; 1H 
NMR (CDCl3) δ 9.25 (bs, 1H), 7.42 (m, 1H), 7.33-7.31 (m, 4H), 7.26 (m,1H), 6.61 (s, 
1H), 2.47 (s, 3H) 2.33 (s, 3H); 13C NMR (CDCl3) δ 161.5, 152.7, 139.0, 133.7, 132.7, 
132.3, 131.3, 129.4, 128.6, 125.8, 122.0, 120.9, 119.2, 21.3, 20.8; IR (KBr) 3171, 1656 
cm-1; MS m/z (relative intensity): 283 (M+, 100%), 285 (32%), 268 (13 %). 
 
N
H
O
OMe
 
4-(4-methoxyphenyl)-6,8-dimethylquinolin-2(1H)-one, white solid, m.p.: 231-233 °C; 
1H NMR (CDCl3) δ 9.80 (bs, 1H), 7.40-7.38 (m, 2H), 7.23-7.22 (m, 2H), 7.06-7.04 
(m,2H), 6.60 (s, 1H), 3.91 (s, 3H) 2.54 (s, 3H), 2.32 (s, 3H); 13C NMR (CDCl3) δ 162.7, 
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160.0, 153.1, 135.1, 133.3, 131.4, 130.1, 129.8, 124.7, 123.1, 120.6, 119.7, 114.0, 55.4, 
20.9, 17.0; IR (KBr) 3166, 1647, 1604 cm-1; MS m/z (relative intensity): 279 (100 %), 
263 (34%), 248 (20 %). 
 
N
H
O
 
6,8-dimethyl-4-p-tolylquinolin-2(1H)-one, white solid, m.p.: 253-255 °C; 1H NMR 
(CDCl3) δ 9.66 (bs, 1H), 7.36-7.32 (m, 4H), 7.28-7.16 (m, 2H), 6.61 (s, 1H), 2.53 (s, 
3H),2.46 (s, 3H), 2.31 (s, 3H); 13C NMR (CDCl3) δ 162.7, 153.5, 138.6, 135.1, 134.6, 
133.3, 131.4, 129.2, 128.7, 124.7, 123.1, 120.6, 119.6, 21.3, 20.9, 17.0; IR (KBr) 3171, 
1656 cm-1; MS m/z (relative intensity): 263 (M+, 100%), 207 (27%), 248 (22 %). 
 
N
H
O
F
 
4-(4-fluorophenyl)-6,8-dimethylquinolin-2(1H)-one, white solid, m.p.: 282-284 °C; 1H 
NMR (CDCl3) δ 10.38 (bs, 1H), 7.44-7.40 (m, 2H), 7.23-7.19 (m, 3H), 7.11 (m,1H), 
6.60 (s, 1H), 2.57 (s, 3H) 2.31 (s, 3H); 13C NMR (CDCl3) δ  162.8, 162.9 (d, J = 246 
Hz), 152.3, 135.3, 133.5, 132.4, 131.6, 130.6 (d, J = 8.2 Hz), 124.3, 123.7, 121.1, 119.4, 
115.6 (d, J = 19.6 Hz), 20.9, 17.2; 19F NMR  -112.1; IR (KBr) 3174, 1656, 1604 cm-1; 
MS m/z (relative intensity): 267 (M+, 100%), 252 (20%), 268 (19 %), 266 (18 %). 
 
N
H
O
OMe
NO2  
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4-(4-methoxyphenyl)-6-methyl-8-nitroquinolin-2(1H)-one, white solid, m.p.: 154-155 
°C; 1H NMR (CDCl3) δ 11.31 (bs, 1H), 8.34 (m, 1H), 7.71 (m, 1H), 7.36-7.34 (m,2H), 
7.08-7.06 (m, 2H), 6.65 (s, 1H), 3.92 (s, 3H) 2.42 (s, 3H); 13C NMR (CDCl3) δ 161.2, 
160.5, 151.9, 135.3, 133.1, 132.2, 131.1, 130.1, 128.5, 128.4, 122.5, 122.4, 114.4, 55.4, 
20.7; IR (KBr) 3354, 3066, 1681 cm-1; MS m/z (relative intensity): 310 (M+, 100%), 
311 (19%), 207 (17 %). 
 
N
H
O
Me
NO2  
6-methyl-8-nitro-4-p-tolylquinolin-2(1H)-one, white solid, m.p.: 179-180 °C; 1H NMR 
(CDCl3) δ 11.39 (bs, 1H), 8.35-8.34 (m, 1H), 7.69 (m, 1H), 7.37-7.29 (m, 4H), 6.67 (s, 
1H), 2.48 (s, 3H) 2.43 (s, 3H); 13C NMR (CDCl3) δ 161.2, 152.2, 139.5, 135.3, 133.3, 
133.2, 132.2, 131.1, 129.6, 128.6, 128.5, 122.7, 122.3, 21.3, 20.7; IR (KBr) 3349, 3051, 
1657 cm-1; MS m/z (relative intensity): 294 (M+, 100%), 295 (19 %), 205 (11 %). 
 
N
H
O
OMe
O
 
6-acetyl-4-(4-methoxyphenyl)quinolin-2(1H)-one, white solid, m.p.: 260-261 °C; 1H 
NMR (DMSOd6) δ 12.12 (bs, 1H), 8.13-8.06 (m, 2H), 7.48-7.45 (m, 3H), 7.14-7.12 
(m,2H), 6.44 (s, 1H), 3.86 (s, 3H) 2.50 (s, 3H); 13C NMR (DMSOd6) δ 196.7, 161.9, 
160.4, 151.8, 143.0, 130.9, 130.7, 130.6, 128.7, 127.5, 122.1, 118.5, 116.3, 144.7, 55.7, 
26.9; IR (KBr) 2838, 1664 cm-1; MS m/z (relative intensity): 294 (M+, 100%), 295 
(34%), 276 (19 %). 
 
8.2.3. Typical Procedure for the Synthesis of substituted N-benzyl-N-(3-
iodophenyl)benzamides. 
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A solution of NaH (60 % in mineral oil, 26 mg, 1.077 mmol) was washed three time 
with dry pentane. Then anhydrous DMSO (4 ml), benzylbromide (80 µl, 0.673 mmol) 
and N-(3-iodophenyl)benzamide (145 mg, 0.449 mmol) were added under an argon 
athmosphere. The mixture was stirred for 1 h at roon temperature. After cooling, the 
mixture was diluted with AcOEt and washed with water. The organic layer was dried 
over Na2SO4 and concentrated under reduced pressure. The residue was purified by 
chromatography (silica gel; 90/10 v/v n-hexane/AcOEt) to give 0.176 g (95 % yield) of 
N-benzyl-N-(3-iodophenyl)benzamide: white solid, mp 94-95 °C; 1H NMR (CDCl3) δ 
7.79 (d, J = 7.9 Hz, 1H), 7.39 (m, 2H), 7.30-7.14 (m, 8H), 7.04 (t, J = 7.7 Hz, 1H), 6.87 
(t, J = 7.9 Hz, 1H), 6.64 (d, J = 7.7 Hz, 1H), 5.85 (d, J = 14.3 Hz, 1H), 4.30 (d, J = 14.3 
Hz, 1H); 13C NMR (CDCl3) δ 170.5, 144.5, 140.1, 136.8, 135.9, 132.2, 129.7, 129.6, 
129.2, 128.6, 128.5, 128.3, 127.7, 127.6, 100.0, 52.4; IR (KBr) 3028, 1623, 1467, 1389, 
1307 cm-1. 
 
8.2.4. Typical procedure the synthesis of N-Benzyl-phenanthridinone. 
An oven dried Schlenk tube equipped with a magnetic stir bar and a Teflon cap was 
charged with N-benzyl-N-(3-iodophenyl)benzamide (103 mg, 0.25 mmol), Pd(OAc)2 
(2.8 mg, 0.0125 mmol), dppe (5.1 mg, 0.0125 mmol), K2CO3 (69 mg, 0.5 mmol) and 
DMF (3 mL) under an argon atmosphere. The tube was sealed and stirred at 100 °C for 
30 minutes. After this time, the reaction mixture was cooled, diluted with Et2O and 
washed with HCl 2 N and brine. The organic layer was dried over Na2SO4 and 
concentrated under reduced pressure. The residue was purified by chromatography 
(silica gel; 90/10 v/v n-hexane/AcOEt) to give the corresponding phenantridinone. 
 
N
O
Ph
 
5-benzylphenanthridin-6(5H)-one, white solid, m.p.: 112-113 °C; 1H NMR (CDCl3, 
400.13 MHz) 8.66 (d, J = 7.4 Hz, 1H), 8.31 (t, J = 7.9 Hz, 2H), 7.79 (t, J = 8.2 Hz, 1H), 
7.65 (t, J = 8.4 Hz, 1H), 7.39 (m, 1H), 7.34-7.25 (m, 7H), 5.69 (bs, 2H); 13C NMR 
(CDCl3, 100.3 MHz) 162.0, 137.4, 136.7, 133.9, 132.8, 129.6, 129.2, 128.9, 128.1, 
127.3, 126.6, 125.5, 123.4, 122.6, 121.7, 119.6, 116.1, 46.5; IR (KBr) 1650, 1489, 752, 
 97
723 cm-1; MS (EI, 70 ev): m/z (%) = 91 (100), 285 (M+, 90), 179 (37), 284 (32); Anal. 
Calcd for C20H15NO: C, 84.19; H, 5.30; N, 4.91; Found C, 83.80; H, 5.69, N 4.66. 
 
N
O
Ph
Cl
 
5-benzyl-9-chlorophenanthridin-6(5H)-one, white solid, m.p.: 184-185 °C; 1H NMR 
(CDCl3) 8.57 (d, J = 8.5 Hz, 1H), 8.27 (s, 1H), 8.21 (d, J = 8.0 Hz, 1H), 7.58 (d, J = 8.9 
Hz, 1H), 7.43 (m, 1H), 7.34-7.26 (m, 7H), 5.66 (bs, 2H); 13C NMR (CDCl3): 161.3, 
139.6, 137.8, 136.4, 123.4, 131.1, 130.3, 128.9, 128.5, 127.4, 126.6, 123.9, 123.5, 
122.8, 121.7, 118.5, 116.2, 46.6; IR (KBr): 1639, 1601, 1439, 1324, 746, 708 cm-1; MS 
(EI, 70 ev): m/z (%) = 91 (100), 319 (M+, 30), 213 (18), 65 (17); Anal. Calcd for 
C20H14ClNO: C, 75.12; H, 4.41; N, 4.38; Found C, 74.88; H, 4.66, N 4.89. 
 
N
O
Ph
F
 
5-benzyl-9-fluorophenanthridin-6(5H)-one, white solid, m.p.: 157-158 °C; 1H NMR 
(CDCl3) 8.65 (m, 1H), 8.15 (d, J = 7.6 Hz, 1H), 7.91 (d, J = 8.8 Hz, 1H), 7.42 (m, 1H), 
7.35-7.26 (m, 8H), 5.66 (bs, 2H); 13C NMR (CDCl3) 165.8 (d, J = 252.5 Hz), 161.2, 
137.9, 136.6, 136.5, 132.5 (d, J = 9.8 Hz), 130.4, 128.9, 127.3, 126.6, 123.6, 122.7, 
122.1, 118.8, 116.5, 116.2, 107.7 (d, J = 23.3 Hz), 46.5; 19F NMR (CDCl3) -105.9; IR 
(KBr) 1644, 1608, 1443, 1185, 745 cm-1; MS (EI, 70 ev): m/z (%) = 91 (100), 303 (M+, 
39), 197 (26), 65 (81); Anal. Calcd for C20H14FNO: C, 79.19; H, 4.65; N, 4.62; Found 
C, 78.80; H, 3.99, N 4.69. 
 
N
O
Ph
MeO
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5-benzyl-9-methoxyphenanthridin-6(5H)-one, white solid, m.p.: 159-160 °C; 1H NMR 
(CDCl3) 8.58 (d, J = 8.8 Hz, 1H), 8.21 (d, J= 7.9 Hz, 1H), 7.67 (s, 1H), 7.40-7.18 (m, 
9H), 5.66 (bs, 2H), 4.01 (s 3H); 13C NMR (CDCl3) 163.1, 161.6, 137.8, 136.7, 135.7, 
131.3, 129.6, 128.7, 127.1, 126.5, 123.3, 122.3, 119.3, 119.1, 116.0, 115.9, 104.5, 55.5, 
46.3; IR (KBr) 1639, 1608, 1452, 1439, 750 cm-1; MS (EI, 70 ev): m/z (%) = 91 (100), 
315 (M+, 65), 314 (44), 209 (36); Anal. Calcd for C21H17NO2: C, 79.98; H, 5.43; N, 
4.44; Found C, 79.80; H, 5.31, N 4.69. 
 
N
O
Ph
Me2N
 
5-benzyl-9-(dimethylamino)phenanthridin-6(5H)-one, white solid, m.p.: 231-232 °C; 1H 
NMR (CDCl3): 8.47 (d, J = 8.9 Hz, 1H), 8.25 (d, J = 7.8 Hz, 1H), 7.37-7.22 (m, 9H), 
7.03 (d, J = 8.9 Hz 1H), 5.66 (bs, 2H), 3.20 (s, 6H); 13C NMR (CDCl3): 162.1, 153.1, 
138.0, 137.3, 135.2, 130.7, 129.2, 128.8, 127.0, 126.6, 123.1, 122.0, 119.9, 116.0, 114.9, 
113.5, 102.6, 46.1, 40.4; IR (KBr): 1632, 1609, 1354, 1314, 748 cm-1; MS (EI, 70 ev): 
m/z (%) = 328 (M+, 100), 327 (73), 91 (60), 222 (32); Anal. Calcd for C22H20N2O: C, 
80.46; H, 6.14; N, 8.53; Found C, 84.11; H, 5.99, N 8.41. 
 
N
O
Ph
 
5-benzyl-9-phenylphenanthridin-6(5H)-one, white solid, m.p.: 170171 °C; 1H NMR 
(CDCl3): 8.71 (d, J = 8.3 Hz, 1H), 8.51 (s, 1H), 8.40 (d, J = 7.5 Hz, 1H), 7.87 (d, J = 7.9 
Hz 1H), 7.78 (m, 2H), 7.58-7.26 (m, 11H), 5.72 (bs, 2H); 13C NMR (CDCl3): 161.9, 
145.6, 140.5, 137.7, 134.2, 129.9, 129.7, 129.1, 128.9, 128.4, 127.6, 127.3, 127.26, 
126.6, 124.4, 123.4, 122.6, 120.3, 119.6, 116.2, 46.5; IR (KBr): 1638, 1612, 1440, 751, 
700 cm-1; MS (EI, 70 ev): m/z (%) = 91 (100), 361 (M+, 60), 360 (37), 255 (36); Anal. 
Calcd for C26H19NO: C, 86.40; H, 5.30; N, 3.88; Found C, 86.11; H, 5.12, N 3.89. 
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5-benzyl-8-fluorophenanthridin-6(5H)-one, white solid, m.p.:125-126 °C; 1H NMR 
(CDCl3): 8.75 (dd, J1 =2.7 Hz, J2 = 8.0 Hz,  1H), 8.52 (d, J = 8.8 Hz, 1H), 7.56 (m, 2H), 
7,42 (m, 2H), 7.36- 7.24 (m, 7H), 5.69 (bs, 2H); 13C NMR (CDCl3): 160.9 (d, J = 3.0 
Hz), 160.0 (d, J = 253.9 Hz), 137.2, 136.4, 129.7 (d, J = 2.2 Hz), 128.9, 128.3 (d, J = 
2.8 Hz), 128.2 (d, J = 17.9 Hz), 127.8 (d, J = 3.3 Hz), 127.3, 126.5, 125.3 (d, J = 3.4 
Hz), 123.0, 122,7 (d, J = 8.7 Hz), 120.2 (d, J = 24.4 Hz), 117.3(d, J = 5.5 Hz), 115.8, 
46.9; 19F NMR (CDCl3): -110.8; IR (KBr): 1655, 1301, 1232, 752 cm-1; MS (EI, 70 ev): 
m/z (%) = 91 (100), 303 (M+, 43), 197 (24), 65 (16); Anal. Calcd for C20H14FNO: C, 
79.19; H, 4.65; N, 4.62; Found C, 78.89; H, 4.55, N 4.51. 
 
N
O
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Cl
 
5-benzyl-7-chlorophenanthridin-6(5H)-one, white solid, m.p.: 170-171 °C; 1H NMR 
(CDCl3): 8.26 (t, J = 7.9 Hz, 2H), 7.66 (m,  2H), 7.42 (m, 1H), 7.32-7.25 (m, 7H); 13C 
NMR (CDCl3): 160.9, 138.8, 137.6, 136.2, 136.1, 132.7, 130.9, 130.1, 128.9, 127.7, 
125.4, 123.9, 123.7, 121.6, 121.4, 118.8, 117.7, 48.2; IR (KBr): 1643, 1597, 1306, 745, 
734 cm-1; MS (EI, 70 ev): m/z (%) = 91 (100), 319 (M+, 43), 213 (35), 318 (15), 321 
(15); Anal. Calcd for C20H14ClNO: C, 75.12; H, 4.41; N, 4.38; Found C, 75.01; H, 4.48, 
N 4.23. 
 
N
O
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MeO
OMe  
5-benzyl-8,10-dimethoxyphenanthridin-6(5H)-one, white solid, m.p.: 162-163 °C; 1H 
NMR (CDCl3): 9.21 (d, J = 8.4 Hz, 1H), 7.82 (s, 1H), 7.33-7.23 (m, 7H), 6.91 (s, 1H), 
5.70 (bs, 2H), 4.05 (s, 3H), 3.99(s, 3H); 13C NMR (CDCl3): 161.5, 159.5, 158.9, 136.6, 
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135.8, 128.7, 128.4, 127.9, 127.6, 127.1, 126.5, 122.3, 119.6, 117.9, 115.2, 104.7, 101.9, 
55.9, 55.6, 47.0; IR (KBr): 1639, 1606, 1589, 1380, 1345, 1063, 747 cm-1; MS (EI, 70 
ev): m/z (%) = 91 (100), 345 (M+, 78), 226 (22), 344 (21), 239 (20); Anal. Calcd for 
C22H19NO3: C, 76.50; H, 5.54; N, 4.06; Found C, 76.11; H, 5.33, N 3.99. 
 
N
O
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5-benzyl-8,10-dimethoxy-2,4-dimethylphenanthridin-6(5H)-one, white solid, m.p.: 114-
115 °C; 1H NMR (CDCl3): 8.90 (s, 1H), 7.69 (s, 1H), 7.26 (t, J = 6.9 Hz, 2H), 7.18 (m, 
1H), 7.11 (d, J = 7.2 Hz, 2H), 7.03 (s, 1H), 6.89 (s, 1H), 5.61 (bs, 2H), 4.06 s, 3H), 3.95 
(s, 3H), 2.50 (s, 3H), 2.42 (s, 3H); 13C NMR (CDCl3): 164.02, 159.38, 158.62, 138.7, 
135.4, 133.4, 131.9, 129.0, 128.5, 126.6, 126.1, 125.7, 125.1, 122.0, 118.3, 104.9, 
101.9, 56.1, 55.7, 52.6, 23.9, 21.2; IR (KBr):1644, 1607, 1376, 1151, 729 cm-1; MS (EI, 
70 ev): m/z (%) = 282 (100), 91 (71), 267 (22), 344 (M-29, 4); Anal. Calcd for 
C24H23NO3: C, 77.19; H, 6.21; N, 3.75; Found C, 77.11; H, 6.33, N 3.78. 
 
N
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5-benzyl-9-fluoro-2,4-dimethylphenanthridin-6(5H)-one, white solid, m.p.: 170-171 °C; 
1H NMR (CDCl3): 8.54 (dd, J1 = 6.2 Hz, J2 = 8.8 Hz 1H), 7.89 (dd, J1 = 2.3 Hz, J2 = 
10.7 Hz, 1H), 7.85 (s, 1H), 7.31-7.21 (m, 4H), 7.13-7.11 (m, 3H), 5.66 (bs, 2H), 2.52 (s, 
3H), 2.43 (s, 3H); 13C NMR (CDCl3): 163.6 (d, J = 254.1 Hz), 163.5, 136.9, 136.4, 
136.1, 133.5 (d, J = 8.9 Hz), 131.6, 129.9 (d, J = 10.1 Hz), 128.3, 126.9, 124.7, 123.1, 
122.0, 117.8, 116.1, 113.0 (d, J = 23.3 Hz), 108.1 (d, J = 22.8 Hz), 48.5, 20.1, 24.8; 9F 
NMR (CDCl3): -105.8; IR (KBr): 1649, 1614, 1323, 858, 733 cm-1; MS (EI, 70 ev): m/z 
(%) = 91 (100), 240 (53), 331 (M+, 33), 225 (24); Anal. Calcd for C22H18FNO: C, 79.74; 
H, 5.47; N, 4.23; Found C, 79.89; H, 5.55, N 4.11. 
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5-benzyl-9-methoxy-2,4-dimethylphenanthridin-6(5H)-one, white solid, m.p.:108-81 
°C; 1H NMR (CDCl3): 8.46 (d, J = 8.8 Hz, 1H). 7.90 (s, 1H), 7.66 (s, 1H); 7.28 (t, J = 
5.8 Hz, 2H), 7.21-7.09 (m, 5H), 5.65 (bs, 2H); 4.02 (s, 3H), 2.51 (s, 3H), 2.43 (s, 3H); 
13C NMR (CDCl3): 163.9, 163.2, 138.9, 137.3, 136.2, 135.7, 132.0, 131.2, 128.5, 126.5, 
125.9, 125.8, 121.8, 121.3, 119.3, 115.7, 104.9, 55.6, 51.3, 23.9, 20.7; IR (KBr): 1636, 
1609, 1453, 1237 cm-1; MS (EI, 70 ev): m/z (%) = 252 (100), 91 (87), 343 (M+, 52), 237 
(33), 253 (18); Anal. Calcd for C23H21NO2: C, 80.44; H, 6.16; N, 4.08; Found C, 80.01; 
H, 6.09, N 4.21. 
 
N
O
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5-benzyl-2-methyl-9-phenylphenanthridin-6(5H)-one, white solid, m.p.: 158-159 °C; 1H 
NMR (CDCl3): 8.70 (d, J = 8.3 Hz, 1H), 8.48 (s, 1H), 8.16 (s, 1H), 7.85 (dd, J1 = 1.4 
Hz, J2 = 7.3 Hz, 1H), 7.79 (d, J = 7.2 Hz, 2H), 7.57 (t, J = 7.3 Hz, 2H), 7.49 (m, 2H), 
7.33-7.23 (m, 7H), 5.68 (bs, 2H), 2.47 (s, 3H); 13C NMR (CDCl3): 161.7, 145.5, 140.5, 
136.8, 135.5, 134.2, 132.1, 130.8, 129.9, 129.1, 128.9, 128.4, 127.7, 127.2, 127.1, 
126.6, 124.4, 123.5, 120.2, 119.4, 116.1, 46.5, 21.0; IR (KBr): 1650, 1613, 1328, 698 
cm-1; MS (EI, 70 ev): m/z (%) = 91 (100), 375 (M+, 68), 270 (33), 212 (19); Anal. Calcd 
for C27H21NO: C, 86.37; H, 5.64; N, 3.73; Found C, 86.99; H, 5.75, N 3.66. 
 
N
O
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5-benzyl-9-chloro-2-methylphenanthridin-6(5H)-one, white solid, m.p.: 159-160 °C; 1H 
NMR (CDCl3): 8.56 (d, J = 8.0 Hz, 1H), 8.27 (s, 1H), 8.00 (s, 1H), 7.57 (d, J = 7.2 Hz, 
1H), 7.33-7.20 (m, 7H), 5.65 (bs,2H), 2.46 (s, 3H); 13C NMR (CDCl3): 161.2, 139.4, 
136.5, 135.7, 135,2, 132.3, 131.4, 131.1, 128.9, 128.3, 127.3, 126.5, 123.9, 123.6, 
121.6, 118.3, 116.1, 46.4, 20.9; IR (KBr): 1645, 1602, 1327, 730; cm-1; MS (EI, 70 ev): 
m/z (%) = 91 (100), 333 (M+, 31), 227 (19), 332 (13); Anal. Calcd for C21H16ClNO: C, 
75.56; H, 4.83; N, 4.20; Found C, 75.69; H, 4.75, N 4.21. 
 
N
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2-acetyl-5-benzyl-9-fluorophenanthridin-6(5H)-one, white solid, m.p.: 179-180 °C; 1H 
NMR (CDCl3): 8.81 (s, 1H), 8.76 (dd, J1 = 1.2 Hz, J2 = 7.6 Hz, 1H); 7.99 (dd, J1 = 3.2 
Hz, J2 = 8.8 Hz, 2H), 7.39-7.25 (m, 7H), 5.69 (bs, 2H), 2.68 (s, 3H); 13C NMR (CDCl3): 
196.4, 167.3 (d, J = 254.3 Hz), 161.3, 141.2, 136.2 (d, J = 9.7 Hz), 135.9, 132,7 (d, J = 
10.1 Hz), 131.5, 130.2, 129.0, 127.6, 126.5, 124.2, 122.1, 118.7, 117.0 (d, J = 22.8 Hz), 
116.2, 108.1 (d, J = 23.6 Hz), 46.7, 26.5; 19F NMR (CDCl3): -104.2; IR (KBr)1679, 
1660, 1608, 1247 cm-1; MS (EI, 70 ev): m/z (%) = 91 (100), 345 (M+, 29), 239 (16); 
Anal. Calcd for C22H16FNO2: C, 76.51; H, 4.67; N, 4.06; Found C, 76.39; H, 4.55, N 
4.12. 
 
N
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5-benzyl-2-chloro-9-methoxyphenanthridin-6(5H)-one, white solid, m.p.: 195-196 °C; 
1H NMR (CDCl3): 8.55 (d, J = 8.8 Hz, 1H), 8.14 (s, 1H), 7.57 (s, 1H), 7.57-7.20 (m, 
8H), 5.63 (bs, 2H), 4.03 (s, 3H); 13C NMR (CDCl3):163.3, 161.3, 136.3, 136.28, 134.5, 
131.4, 129.4, 128.8, 127.9, 127.3, 126.4, 122.9, 120.7, 119.2, 117.4, 116.7, 104.5, 55.6, 
46.3; IR (KBr): 1648, 1610, 1239, 1021 cm-1; MS (EI, 70 ev): m/z (%) = 91 (100), 349 
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(M+, 33), 243 (20), 65 (16); Anal. Calcd for C21H16ClNO2: C, 72.10; H, 4.61; N, 4.00; 
Found C, 72.01; H, 4.39, N, 4.25. 
 
N
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5-benzyl-2-chloro-9-fluorophenanthridin-6(5H)-one, white solid, m.p.: 150-151 °C; 1H 
NMR (CDCl3): 8.64 (dd, J1 = 2.3 Hz, J2 = 7.6 Hz, 1H), 8.08 (s, 1H), 7.82 (dd, J1 = 1.1 
Hz, J2 = 7.9 Hz, 1H), 7.37-7.22 (m, 8H), 5.63 (bs, 2H), 4.05 (s, 3H), 3.99(s, 3H); 13C 
NMR (CDCl3): 165.9 (d, J = 253.5 Hz), 160.9, 136.4, 136.1, 135.3 (d, J = 9.5 Hz), 
132.6 (d, J = 9.6 Hz), 130.2, 129.0, 128.5, 127.5, 126.5, 123.3, 122.3, 120.1, 117.6, 
117.0 (d, J = 22.8 Hz), 107.9 (d, J = 23.5 Hz), 46.5; 19F NMR (CDCl3): -104.6; IR 
(KBr): 1656, 1617, 1589, 1431, 1345, 1327, 747 cm-1; MS (EI, 70 ev): m/z (%) = 91 
(100), 337 (M+, 24), 231 (14), 65 (14); Anal. Calcd for C20H13ClFNO: C, 71.12; H, 
3.88; N, 4.15; Found C, 71.54; H, 3.75, N, 4.55. 
 
N
O
Ph
Cl  
5-benzyl-2-chlorophenanthridin-6(5H)-one, white solid, m.p.: 167-168 °C; 1H NMR 
(CDCl3): 8.63 (d, J = 7.9 Hz, 1H), 8.22 (s, 2H), 7.80 (t, J = 7.5 Hz, 1H), 7.67 (t, J = 7.3 
Hz, 1H) 7.34-7.22 (m, 7H), 5.64 (bs, 2H); 13C NMR (CDCl3):161.6, 136.2, 135.9, 
133.0, 132.7, 129.4, 129.3, 129.0, 128.8, 128.3, 127.4, 126.5, 125.6, 123.1, 121.8, 
120.9, 117.5, 46.6; IR (KBr): 1639, 1579, 1310, 713 cm-1; MS (EI, 70 ev): m/z (%) = 91 
(100), 319 (M+, 27), 213 (15), 65 (15); Anal. Calcd for C20H14ClNO: C, 75.12; H, 4.41; 
N, 4.38; Found C, 75.25; H, 4.45, N, 4.65. 
 
8.2.5. Typical Procedure for the Preparation of α,β-Ynones. 
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Benzoyl chloride (168.7 mg, 1.2 mmol), PdCl2(PPh3)2 (14 mg, 0.02 mmol) and Et3N 
(167 µl, 1.2 mmol) in anhydrous THF (4 mL) were stirred for 10 min under argon 
atmosphere at room temperature. CuI (7.6 mg, 0.04 mmol) was added and the reaction 
mixture was stirred for other 10 min before adding ethynylbenzene (102.2 mg, 1.0 
mmol). After 2 h at room temperature, the reaction mixture was worked-up with ethyl 
acetate and washed with 0.1 N HCl and a saturated NH4Cl solution. The organic phase 
was separated, dried over Na2SO4, filtered and concentrated under reduced pressure. 
The residue was purified by chromatography on silica gel. 
 
O
 
1,3-diphenylprop-2-yn-1-one, yellow solid; mp 43-44 °C; 1H NMR (400 MHz, CDCl3) 
δ: 8.26 (d, J = 7.3 Hz, 2H), 7.71 (d, J = 7.2 Hz, 2H), 7.66 (t, J = 7.2 Hz, 1H), 7.57-7.43 
(m, 5H); 13C NMR (100 MHz, CDCl3) δ 178.1, 137.1, 134.2, 133.1, 130.8, 129.6, 128.8, 
128.7, 120.3, 93.1, 87.0; IR (KBr, cm-1): 2200, 1633, 1315, 1290, 690; MS m/z (relative 
intensity) 206 (M+, 76), 178 (100), 129 (98), 75 (39), 51 (39). Anal. Calcd. for C15H10O: 
C, 87.36; H, 4.89; Found: C, 87.27; H, 5.01. 
 
8.2.6. General Procedure for the Preparation of 1-(o-Halophenyl)-3-enaminones. 
An oven-dried Schlenk tube was charged with o-halophenyl-α,β-enones (1 mmol), the 
substituted amine (1 mmol) and anhydrous MeOH (1 mL). The tube was sealed and 
stirred at 80 °C. The reaction mixture was cooled to room temperature, the solvent was 
evaporated and the residue was purified by silica gel, eluting with hexane/ethyl acetate 
mixtures. 1-(2-Bromophenyl)-3-phenyl-3-(phenylamino)prop-2-en-1-one, pale yellow 
solid, mp 118-119 °C; 1H NMR (CDCl3): δ 12.66 (s, 1 H), 7.64 (d, J = 8.0 Hz, 1 H), 
7.57 (d, J = 7.6 Hz, 1 H), 7.42-7.31 (m, 6 H), 7.26 (t, J = 7.7 Hz, 1 H), 7.17 (t, J = 7.6 
Hz, 2 H), 7.04 (t, J = 7.4 Hz, 1 H), 6.85 (d, J = 8.0 Hz, 2 H), 5.78 (s, 1 H); 13C NMR 
(CDCl3): δ 191.7, 161.5, 143.1, 139.3, 135.3, 133.6, 130.6, 129.9, 129.4, 128.8, 128.6, 
128.5, 127.3, 124.5, 123.5, 119.6, 100.8; IR (KBr) 3448, 1608, 1587, 1569, 1479, 1325, 
758, 698 cm-1; Anal. Calcd. for C21H16BrNO: C, 66.68; H, 4.26. Found: C, 66.79; H, 
4.21. 
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8.2.7. General Procedure for the Preparation of 1,2-Disustituted 4-quinolones. 
An oven-dried Schlenk tube was charged with 1-(o-halophenyl)-3-enaminone (1 
equiv.), CuI (5 mol%), N,N’-dimethylethylenediamine (5 mol%), K2CO3 (2 equiv.), and 
DMSO (0.1 M). The tube was sealed and stirred at 80 °C. The reaction mixture was 
cooled to room temperature, diluted with diethyl ether and washed twice with HCl (1 N) 
and with a saturated NaCl solution. The organic phase was separated, dried over 
Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by 
silica gel, eluting with hexane/ethyl acetate mixtures. 
 
N
O
 
1,2-diphenylquinolin-4(1H)-one, white-brownish solid, mp 280-281 °C. 1H NMR (400 
MHz, CDCl3) δ: 8.50 (d, J = 7.4 Hz, 1H), 7.48 (d, J = 7.5 Hz, 1H), 7.39-7.35 (m, 4H), 
7.20-7.16 (m, 7H), 6.91 (d, J = 8.6 Hz, 1H), 6.45 (s, 1H); 13C NMR (100 MHz, CDCl3) 
δ: 178.0, 154.0, 142.6, 139.2, 135.7, 131.9, 130.0, 129.6, 129.2, 129.0, 128.6, 127.9, 
126.3, 126.1, 123.8, 118.1, 112.6; IR (KBr, cm-1): 1627, 1596, 1490, 1477, 1458, 1402, 
1314, 1135, 705; MS (EI, 70 ev): m/z 297, 269, 102; Anal. Calcd. for C21H15NO: C, 
84.82; H, 5.08; Found: C, 84.69; H, 4.99. 
 
N
O
CF3  
2-phenyl-1-(3-(trifluoromethyl)phenyl)quinolin-4(1H)-one, white solid, mp 235-236 °C. 
1H NMR (400 MHz, CDCl3) δ: 8.49 (d, J = 7.9 Hz, 1H), 7.59 (m, 1H), 7.55-7.48 (m, 
2H), 7.45-7.36 (m, 3H), 7.21-7.14 (m, 5H), 6.84 (d, J = 8.6 Hz, 1H), 6.44 (s, 1H); 13C 
NMR (100 MHz, CDCl3) δ: 177.9, 153.6, 142.3, 139.9, 135.2, 133.6, 132.3 (q, JCF = 33 
Hz), 132.2, 130.4, 129.1, 128.9, 128.2, 127.3 (q, JCF = 4 Hz), 126.6, 126.1, 125.6 (q, JCF 
= 4 Hz), 124.1, 123.2 (q, JCF = 271 Hz), 117.5, 112.8; 19F NMR (CDCl3) δ: -62.92; IR 
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(KBr, cm-1): 3042, 1629, 1329, 1116, 752, 706; MS (EI, 70 ev): m/z 365, 337; Anal. 
Calcd. for C22H14F3NO: C, 72.32; H, 3.86; Found: C, 72.19; H, 3.95. 
 
N
O
OMe  
1-(4-methoxyphenyl)-2-phenylquinolin-4(1H)-one, white solid, mp 201-202 °C. 1H 
NMR (400 MHz, CDCl3) δ: 8.49 (dd, J = 8.0 Hz, 1.2 Hz, 1H), 7.44 (t, J = 7.1 Hz, 1H), 
7.35 (t, J = 7.8 Hz, 1H), 7.21-7.16 (m, 5H), 7.05 (d, J = 8.8 Hz, 2H), 6.93 (d, J = 8.6 Hz, 
1H), 6.84 (d, J = 8.8 Hz, 2H), 6.42 (s, 1H), 3.78 (s, 3H); 13C NMR (100 MHz, CDCl3) 
δ: 178.0, 159.5, 154.4, 143.0, 135.9, 131.9, 131.8, 131.0, 129.2, 128.6, 128.0, 126.2, 
123.7, 118.2, 114.7, 112.5, 55.5; IR (KBr, cm-1): 1625, 1507, 1458, 1405, 1251, 1027, 
838, 758, 695; MS (EI, 70 ev): m/z 327, 299, 102; Anal. Calcd. for C22H17NO2: C, 
80.71; H, 5.23; Found: C, 80.80; H, 5.19. 
 
N
O
O  
1-(4-acetylphenyl)-2-phenylquinolin-4(1H)-one, white solid, mp 221-222 °C. 1H NMR 
(400 MHz, CDCl3) δ: 8.48 (dd, J = 7.9 Hz, 1.3 Hz, 1H), 7.95 (d, J = 8.4 Hz, 2H), 7.44 
(t, J = 7.7 Hz, 1H), 7.36 (t, J = 7.3 Hz, 1H), 7.29 (d, J = 8.5 Hz, 2H), 7.20-7.15 (m, 5H), 
6.84 (d, J = 8.5 Hz, 1H), 6.41 (s, 1H), 2.59 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 
196.7, 177.8, 153.5, 143.3, 142.2, 137.1, 135.3, 132.1, 130.5, 129.6, 129.1, 129.0, 
128.1, 126.4, 126.1, 124.0, 117.7, 112.8, 26.7; IR (KBr, cm-1): 1683, 1628, 1597, 1462, 
1400, 1262, 763, 707; MS (EI, 70 ev): m/z 339, 327, 331, 299; Anal. Calcd. for 
C23H17NO2: C, 81.40; H, 5.05; Found: C, 81.29; H, 4.99. 
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1-(4-chloronaphthalen-1-yl)-2-phenylquinolin-4(1H)-one, white solid, mp 239-240 °C. 
1H NMR (400 MHz, CDCl3) δ: 8.55 (m, 1H), 8.27 (d, J = 8.5 Hz, 1H), 7.62 (t, J = 7.4 
Hz, 1H), 7.52 (m, 2H), 7.43 (m, 1H), 7.36-7.29 (m, 3H), 7.10-699 (m, 5H), 6.43 (m, 
1H), 6.51 (s, 1H); 13C NMR (100 MHz, CDCl3) δ: 178.1, 154.7, 142.6, 135.3, 134.7, 
133.6, 132.3, 132.2, 131.4, 129.0, 128.8, 128.6, 128.4, 128.1, 127.8, 126.4, 126.1, 
125.6, 125.4, 124.1, 123.2, 118.1, 113.0; IR (KBr, cm-1): 1617, 1595, 1478, 1459, 1410, 
1383, 1319, 1278, 1136, 762, 702; MS (EI, 70 ev): m/z 381, 353, 327, 281; Anal. Calcd. 
for C25H16ClNO: C, 78.63; H, 4.22; Found: C, 78.75; H, 4.29. 
 
N
O
CN  
4-(4-oxo-2-phenylquinolin-1(4H)-yl)benzonitrile, white solid, mp 255-256 °C. 1H NMR 
(400 MHz, CDCl3) δ: 8.45 (d, J = 7.9 Hz, 1H), 7.67 (d, J = 8.3 Hz, 2H), 7.49 (t, J = 8.3 
Hz, 1H), 7.36 (m, 3H), 7.28-7.21 (m, 3H), 7.15 (m, 2H), 6.80 (d, J = 8.5 Hz, 1H), 6.40 
(s, 1H); 13C NMR (100 MHz, CDCl3) δ: 177.8, 153.2, 143.3, 142.0, 135.0, 133.5, 132.3, 
131.3, 129.2, 129.1, 128.4, 126.7, 126.1, 124.3, 117.5, 117.3, 113.2, 113.1; IR (KBr, cm-
1): 3038, 2234, 1628, 1600, 1508, 1481, 1466, 1413, 1318, 768, 748, 737, 707; MS (EI, 
70 ev): m/z 322, 294; Anal. Calcd. for C22H14N2O: C, 81.97; H, 4.38; Found: C, 81.79; 
H, 4.22. 
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1-(2,4-difluorophenyl)-2-phenylquinolin-4(1H)-one, white solid, mp 187-188 °C. 1H 
NMR (400 MHz, CDCl3) δ: 8.51 (d, J = 7.6 Hz, 1H), 7.52 (t, J = 7.7 Hz, 1H), 7.40 (t, J 
= 7.8 Hz, 1H), 7.29-7.17 (m, 6H), 6.91-6.83 (m, 3H), 6.43 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ: 178.0, 163.3 (dd, JCF = 252 Hz, JCF = 11 Hz), 158.7 (dd, JCF = 251 Hz, JCF = 
11 Hz), 154.0, 142.1, 135.0, 132.5 (d, JCF = 10 Hz), 132.3, 129.1, 128.4, 128.1, 126.5, 
126.0, 124.0, 123.4 (dd, JCF = 13 Hz, JCF = 4 Hz), 116.8, 112.8, 112.3 (dd, JCF = 22 Hz, 
JCF = 4 Hz), 105.2 (dd, JCF = 26 Hz, JCF = 23 Hz); 19F NMR (CDCl3) δ: -105.3, -113.4; 
IR (KBr, cm-1): 1683, 1628, 1597, 1462, 1400, 1262, 763, 707; MS (EI, 70 ev): m/z  
339, 327, 331, 299; Anal. Calcd. for C21H13F2NO: C, 75.67; H, 3.93; Found: C, 75.75; 
H, 3.99. 
 
N
O
OMe
MeO OMe
 
2-phenyl-1-(3,4,5-trimethoxyphenyl)quinolin-4(1H)-one, white solid, mp 222-223 °C. 
1H NMR (400 MHz, CDCl3) δ: 8.45 (d, J = 7.6 Hz, 1H), 7.49 (t, J = 7.7 Hz, 2H), 7.34 
(t, J = 7.9 Hz, 1H), 7.26-7.19 (m, 5H), 7.05 (d, J = 8.6 Hz, 1H), 6.38 (s, 3H), 3.81 (s, 
3H), 3.69 (s, 6H); 13C NMR (100 MHz, CDCl3) δ: 177.9, 153.9, 153.7, 142.5, 138.5, 
135.9, 134.4, 131.9, 128.9, 128.7, 127.9, 126.3, 126.1, 123.8, 118.1, 112.6, 107.8, 61.1, 
56.5; IR (KBr, cm-1): 1626, 1598, 1503, 1464, 1421, 1265, 1239, 1125, 753, 704; MS 
(EI, 70 ev): m/z 387; Anal. Calcd. for C24H21NO4: C, 74.40; H, 5.46; Found: C, 74.21; 
H, 5.23. 
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1-(4-chlorophenyl)-2-phenylquinolin-4(1H)-one, white solid, mp 206-207 °C. 1H NMR 
(400 MHz, CDCl3) δ: 8.47 (d, J = 7.4 Hz, 1H), 7.47 (dt, J = 7.1 Hz, 1.5 Hz, 1H), 7.37-
7.33 (m, 3H), 7.23-7.11 (m, 7H), 6.87 (d, J = 8.6 Hz, 1H), 6.40 (s, 1H); 13C NMR (100 
MHz, CDCl3) δ: 177.9, 153.8, 143.3, 142.5, 137.8, 135.4, 135.0, 132.1, 131.4, 129.9, 
129.2, 128.9, 128.2, 126.4, 126.1, 124.0, 117.8, 112.8; IR (KBr, cm-1): 3044, 1267, 
1599, 1487, 1466, 1413, 1318, 840, 748; MS (EI, 70 ev): m/z 373, 345, 330; Anal. 
Calcd. for C21H14ClNO: C, 76.02; H, 4.25; Found: C, 76.09; H, 4.32. 
 
N
O
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2-(4-chlorophenyl)-1-(3-methoxyphenyl)quinolin-4(1H)-one, white solid, mp 211-212 
°C. 1H NMR (400 MHz, CDCl3) δ: 8.47 (dd, J = 8.0 Hz, 1.3 Hz, 1H), 7.48 (dt, J = 7.1 
Hz, 1.4 Hz, 1H), 7.36 (t, J = 7.8 Hz, 1H), 7.30 (t, J = 8.1 Hz, 1H), 7.21-7.14 (m, 4H), 
6.96 (d, J = 8.6 Hz, 1H), 6.90 (dd, J = 8.3 Hz, 2.4 Hz, 1H),6.78 (dd, J = 8.3 Hz, 1.0 Hz, 
1H), 6.69 (m, 1H), 6.37 (s, 1H), 3.75 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 177.8, 
160.6, 152.6, 142.5, 139.9, 134.9, 134.2, 132.1, 130.4, 128.3, 126.3, 126.1, 124.0, 
122.2, 118.1, 115.8, 114.8, 112.7, 55.6; IR (KBr, cm-1): 1631, 1597, 1480, 1418, 1251, 
852, 828, 747; MS (EI, 70 ev): m/z 395, 367; Anal. Calcd. for C22H16ClNO2: C, 73.03; 
H, 4.46; Found: C, 74.88; H, 4.32. 
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2-(4-chlorophenyl)-1-p-tolylquinolin-4(1H)-one, white solid, mp 211-212 °C. 1H NMR 
(400 MHz, CDCl3) δ: 8.47 (dd, J = 8.0 Hz, 1.4 Hz, 1H), 7.45 (dt, J = 7.8 Hz, 1.5 Hz, 
1H), 7.34 (t, J = 7.8 Hz, 1H), 7.19-7.11 (m, 6H), 7.02 (d, J = 8.2 Hz, 2H), 6.90 (d, J = 
8.6 Hz, 1H), 6.37 (s, 1H), 2.36 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 177.8, 152.9, 
142.8, 139.3, 136.3, 134.8, 134.3, 132.0, 130.6, 130.5, 129.6, 128.3, 126.2, 126.1, 
123.9, 118.2, 112.6, 21.3; IR (KBr, cm-1): 3035, 1629, 1514, 1480, 1420, 1319, 1094, 
828, 747; MS (EI, 70 ev): m/z 345, 317, 281; Anal. Calcd. for C22H16ClNO: C, 76.41; H, 
4.66; Found: C, 76.29; H, 4.77. 
 
N
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2-(4-chlorophenyl)-1-(4-fluorophenyl)quinolin-4(1H)-one, white solid, mp 252-253 °C. 
1H NMR (400 MHz, CDCl3) δ: 8.44 (dd, J = 7.4 Hz, 1.2 Hz, 1H), 7.48 (dt, J = 7.2 Hz, 
1.4 Hz, 1H), 7.34 (t, J = 7.7 Hz, 1H), 7.21-7.07 (m, 8H), 6.86 (d, J = 8.6 Hz, 1H), 6.35 
(s, 1H); 13C NMR (100 MHz, CDCl3) δ 177.8, 162.3 (d, JCF = 250 Hz), 152.7, 142.7, 
135.1, 135.0 (d, JCF = 4 Hz), 134.0, 132.2, 131.8 (d, JCF = 8 Hz), 130.5, 128.5, 126.4, 
126.1, 124.1, 117.8, 117.0 (d, JCF = 23 Hz), 112.8; 19F NMR (CDCl3) δ: -110.3; IR 
(KBr, cm-1): 1630, 1510, 1480, 1419, 1230, 1159, 1092, 1021, 840, 819, 747; MS (EI, 
70 ev): m/z 349, 321, 285; Anal. Calcd. for C21H13ClFNO: C, 72.11; H, 3.75; Found: C, 
71.99; H, 3.58. 
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Methyl 4-(2-(3-methoxyphenyl)-4-oxoquinolin-1(4H)-yl)benzoate, white solid, mp 218-
219 °C. 1H NMR (400 MHz, CDCl3) δ: 8.47 (d, J = 7.9 Hz, 1H), 8.05 (d, J = 8.3 Hz, 
2H), 7.46 (t, J = 8.2 Hz, 1H), 7.36 (t, J = 7.6 Hz, 1H), 7.29 (d, J = 8.3 Hz, 2H), 7.09 (t, J 
= 7.9 Hz, 1H), 6.84 (d, J = 8.6 Hz, 1H), 6.76-6.72 (m, 3H), 6.34 (s, 1H), 3.92 (s, 3H), 
3.68 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 177.9, 165.8, 159.1, 153.3, 143.2, 142.2, 
136.5, 132.1, 130.9, 130.6, 130.2, 129.3, 126.5, 126.1, 124.0, 121.7, 117.7, 114.9, 114.6, 
112.8, 55.3, 52.5; IR (KBr, cm-1): 2953, 1726, 1626, 1598, 1464, 1408, 1280, 1115, 762; 
MS (EI, 70 ev): m/z 385, 357; Anal. Calcd. for C24H19NO4: C, 74.79; H, 4.97; Found: C, 
74.88; H, 4.78. 
 
N
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2-(3-methoxyphenyl)-1-(3-(trifluoromethyl)phenyl)quinolin-4(1H)-one, white solid, mp 
245-246 °C. 1H NMR (400 MHz, CDCl3) δ: 8.49 (d, J = 8.0 Hz, 1H), 7.62 (m, 1H), 
7.56-7.48 (m, 3H), 7.41-7.36 (m, 2H), 7.11 (t, J = 7.9 Hz, 1H), 6.84 (d, J = 8.6 Hz, 1H), 
6.74 (t, J = 8.4 Hz, 2H), 6.67 (s, 1H), 6.45 (s, 1H), 3.68 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ: 177.9, 159.1, 153.4, 142.3, 139.9, 136.3, 133.5, 132.3, 132.2 (q, JCF = 33 
Hz), 130.4, 129.4, 127.3 (q, JCF = 3 Hz), 126.6, 126.2, 125.8 (q, JCF = 3 Hz), 124.1, 
123.2 (q, JCF = 271 Hz), 121.6, 117.5, 115.0, 114.5, 112.8, 55.3; 19F NMR (CDCl3) δ: -
62.9; IR (KBr, cm-1): 3059, 1631, 1599, 1496, 1466, 1408, 1323, 1167, 1120, 752; MS 
(EI, 70 ev): m/z 395, 367; Anal. Calcd. for C23H16F3NO2: C, 69.87; H, 4.08; Found: C, 
69.69; H, 3.99. 
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1-(4-fluorophenyl)-2-(3-methoxyphenyl)quinolin-4(1H)-one, white solid, mp 188-189 
°C. 1H NMR (400 MHz, CDCl3) δ: 8.46 (dd, J = 7.4 Hz, 1.2 Hz, 1H), 7.48 (dt, J = 7.8 
Hz, 1.4 Hz, 1H), 7.35 (t, J = 7.7 Hz, 1H), 7.20-7.05 (m, 5H), 6.88 (d, J = 8.6 Hz, 1H), 6-
78-6.71 (m, 3H), 6.41 (s, 1H), 3.71 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 177.9, 
162.2 (d, JCF = 249 Hz), 159.0, 153.8, 142.7, 136.7, 135.2 (d, JCF = 4 Hz), 132.0, 131.8 
(d, JCF = 9 Hz), 129.2, 126.4, 126.2, 123.9, 121.7, 117.8, 116.7 (d, JCF = 23 Hz), 115.0, 
114.4, 112.6, 55.3; 19F NMR (CDCl3) δ: -110.9; IR (KBr, cm-1): 3042, 1631, 1597, 
1509, 1465, 1403, 1219, 1039, 849, 808, 748; MS (EI, 70 ev): m/z 345, 317; Anal. 
Calcd. for C22H16FNO2: C, 76.51; H, 4.67; Found: C, 76.39; H, 4.80. 
 
N
O
Cl
O
 
2-(4-acetylphenyl)-1-(4-chlorophenyl)quinolin-4(1H)-one, white solid, mp 248-249 °C. 
1H NMR (400 MHz, CDCl3) δ: 8.42 (d, J = 7.5 Hz, 1H), 7.80 (d, J = 7.2 Hz, 2H), 7.46 
(t, J = 7.0 Hz, 1H), 7.36-7.23 (m, 5H), 7.16 (d, J = 7.5 Hz, 2H), 6.86 (d, J = 8.1 Hz, 
1H), 6.35 (s, 1H), 2.55 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 197.2, 177.6, 152.5, 
142.4, 139.8, 137.4, 137.0, 135.3, 132.3, 131.3, 130.2, 129.5, 128.1, 126.4, 126.1, 
124.2, 117.8, 112.7, 26.6; IR (KBr, cm-1): 3056, 1690, 1625, 1598, 1490, 1410, 1266, 
1017, 832; MS (EI, 70 ev): m/z 373, 345, 330; Anal. Calcd. for C23H16ClNO2: C, 73.90; 
H, 4.31; Found: C, 73.77; H, 4.09. 
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2-(4-acetylphenyl)-1-(4-methoxyphenyl)quinolin-4(1H)-one, white solid, mp 236-237 
°C. 1H NMR (400 MHz, CDCl3) δ: 8.46 (d, J = 7.7 Hz, 1H), 7.79 (d, J = 8.0 Hz, 2H), 
7.47 (t, J = 7.1 Hz, 1H), 7.35 (t, J = 7.2 Hz, 1H), 7.29 (d, J = 7.7 Hz, 2H), 7.07 (d, J = 
8.5 Hz, 2H), 6.92 (d, J = 8.4 Hz, 1H), 6.84 (d, J = 8.5 Hz, 2H), 6.37 (s, 1H), 3.78 (s, 
3H), 2.55 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 197.3, 177.6, 159.6, 153.1, 142.9, 
140.2, 136.7, 132.0, 131.3, 130.8, 129.4, 127.8, 126.1, 126.1, 123.9, 118.0, 114.8, 112.3, 
55.4, 26.5; IR (KBr, cm-1): 1683, 1624, 1599, 1511, 1462, 1413, 1258, 833, 766; MS 
(EI, 70 ev): m/z 369, 341; Anal. Calcd. for C24H19NO3: C, 78.03; H, 5.18; Found: C, 
77.87; H, 5.00. 
 
N
O
 
1-butyl-2-phenylquinolin-4(1H)-one, pale brown crystals, mp 72-73 °C. 1H NMR (400 
MHz, CDCl3) δ: 8.51 (dd, J = 8.0 Hz, 1.1 Hz, 1H), 7.69 (dt, J = 7.7 Hz, 1.2 Hz, 1H), 
7.55 (m, 1H), 7.50-7.48 (m, 3H), 7.31-7.48 (m, 3H), 6.24 (s, 1H), 4.02 (t, J = 7.7 Hz, 
2H), 1.66 (m, 2H), 1.16 (m, 2H), 0.75 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 177.4, 154.6, 140.7, 136.1, 132.2, 129.4, 128.7, 128.3, 127.4, 127.1, 123.5, 116.3, 
112.9, 48.0, 30.8, 19.7, 13.4; IR (KBr, cm-1): 2963, 2933, 2874, 1626, 1594, 1483, 
1462, 1415, 1302, 1173, 763, 706; MS (EI, 70 ev): m/z 277, 234; Anal. Calcd. for 
C19H19NO: C, 82.28; H, 6.90; Found: C, 82.10; H, 6.97. 
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1-benzyl-2-phenylquinolin-4(1H)-one, white crystals, mp 118-119 °C. 1H NMR (400 
MHz, CDCl3) δ: 8.54 (d, J = 7.8 Hz, 1H), 7.54 (t, J = 7.1 Hz, 1H), 7.47-7.25 (m, 10H), 
7.01 (d, J = 7.2 Hz, 3H), 6.37 (s, 1H), 5.30 (s,1H); 13C NMR (100 MHz, CDCl3) δ 
177.7, 155.1, 141.2, 136.4, 135.7, 132.4, 129.7, 129.1, 128.7, 128.2, 127.7, 127.3, 
126.9, 125.5, 123.8, 117.3, 113.2, 52.2; IR (KBr, cm-1): 1626, 1599, 1484, 1416, 1312, 
1269, 737, 700; MS (EI, 70 ev): m/z 311; Anal. Calcd. for C22H17NO: C, 84.86; H, 5.50; 
Found: C, 84.90; H, 5.69. 
 
N
O
 
1-cyclohexyl-2-phenylquinolin-4(1H)-one, white crystals, mp 199-200 °C. 1H NMR 
(400 MHz, CDCl3) δ: 8.53 (d, J = 8.0 Hz, 1H), 7.98 (d, J = 8.8 Hz, 1H), 7.64 (t, J = 7.1 
Hz, 1.7 Hz, 1H), 7.51 (m, 3H), 7.42-7.37 (m, 3H), 6.23 (s, 1H), 4.17 (m,1H), 2.44 (m, 
2H), 1.86 (m, 4H), 1.63 (m, 1H), 1.22-1.00 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 
177.3, 155.7, 141.1, 137.4, 130.9, 129.4, 128.8, 128.2, 127.7, 127.2, 123.3, 118.9, 
113.4, 63.5, 31.1, 26.5, 25.2; IR (KBr, cm-1): 2936, 2852, 1626, 1598, 1484, 1400, 
1260, 1169, 764, 704; MS (EI, 70 ev): m/z 303, 221; Anal. Calcd. for C21H21NO: C, 
83.13; H, 6.98; Found: C, 83.00; H, 6.79. 
 
8.2.8. General Procedure for the Preparation of o-iodophenyl-3-enaminones. 
An oven-dried Schlenk tube was charged with α,β-enones (1.5 mmol), the substituted o-
iodoaniline (1 mmol) and anhydrous MeOH (1 mL). The tube was sealed and stirred at 
120 °C. The reaction mixture was cooled to room temperature, the solvent was 
evaporated and the residue was purified by silica gel, eluting with hexane/ethyl acetate 
mixtures. 
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8.2.9. General Procedure for the Preparation of 2,3-disubstituted indoles. 
An oven-dried Schlenk tube was charged with o-iodophenyl-3-enaminone (1 equiv.), 
CuI (5 mol%), 1,10-phenantroline (5 mol%), K2CO3 (2 equiv.), and DMF (0.1 M). The 
tube was sealed and stirred at 100 °C. The reaction mixture was cooled to room 
temperature, diluted with diethyl ether and washed twice with HCl (1 N) and with a 
saturated NaCl solution. The organic phase was separated, dried over Na2SO4, filtered 
and concentrated under reduced pressure. The residue was purified by silica gel, eluting 
with hexane/ethyl acetate mixtures. 
 
N
H
O
 
phenyl(2-phenyl-1H-indol-3-yl)methanone, white solid, m.p.: 223-224 °C; 1H NMR 
(DMSO-d6) δ 12.19 (bs, 1H), 7.75 (d, J = 7.9 Hz, 1H), 7.54-7.51 (m, 3H), 7.40-7.35 (m, 
3H), 7.26-7.10 (m, 7H); 13C NMR (DMSO-d6) δ 192.6, 144.6, 140.3, 136.3, 132.1, 
131.8, 130.1, 129.6, 129.0, 128.7, 128.5, 128.3, 123.4, 121.9, 121.1, 112.7, 112.4; IR 
(KBr) 3425, 3055, 1593, 1564, 1450, 1421 cm-1. 
 
N
H
O
 
biphenyl-4-yl(5-methyl-2-phenyl-1H-indol-3-yl)methanone, white solid, m.p.: 209-210 
°C; 1H NMR (CDCl3) δ 8.80 (bs, 1H), 7.88 (s, 1H), 7.70 (d, J = 7.9 Hz, 2H), 7.54-7.35 
(m, 10H), 7.18-7.14 (m, 4H), 2.48 (s, 3H); 13C NMR (CDCl3) δ 193.2, 140.3, 134, 0, 
136.4, 133.0, 132.3,130.2, 129.3, 129.7, 128.8, 128.4, 128.1, 128.0, 127.9, 127.5, 127.7, 
125.9, 123.7, 120.1, 118.4, 111.4, 24.7; IR (KBr) 3055, 1595, 1570, 1450, 1423 cm-1. 
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(3-fluorophenyl)(2-phenyl-1H-indol-3-yl)methanone, white solid, m.p.: 201-202 °C; 1H 
NMR (DMSO-d6) δ 12.29 (bs, 1H), 7.90 (d, J = 7.9 Hz, 1H), 7.53 (d, J = 8.0 Hz, 1H), 
7.37 (m, 2H), 7.32-7.14 (m, 9H); 13C NMR (DMSO-d6) 191.0, 162.5, (d, JCF = 249 Hz), 
145.5 (d, JCF = 4 Hz), 142.8 (d, JCF = 8 Hz), 136.4, 132.0, 130.3, 130.2, 130.1, 129.1, 
128.6, 128.5, 125.6 (d, JCF = 2 Hz), 123.6, 122.2, 121.2, 118.3 (d, JCF = 22 Hz), 115.9 
(d, JCF = 22 Hz), 112.4, 112.6; 19F NMR (DMSO-d6) δ: -110.1; IR (KBr) 3166, 1570, 
1450, 1419 cm-1. 
 
N
H
O
CF3
 
(2-phenyl-1H-indol-3-yl)(3-(trifluoromethyl)phenyl)methanone, white solid, m.p.: 231-
232 °C; 1H NMR (DMSO-d6) δ 12.33 (bs, 1H), 8.00 (d, J = 7.9 Hz, 1H), 7.79 (d, J = 8.0 
Hz, 1H), 7.64 (m, 2H), 7.53 (d, J = 7.9 Hz, 1H), 7.44 (t, J = 7.9 Hz, 1H), 7.34-7.17 (m, 
7H); 13C NMR (DMSO-d6) 190.9, 146.0, 141.2, 136.5, 133.1, 131.8, 130.4, 129.5, 
129.1, 128.6, 128.9 (q, JCF = 32 Hz), 128.4, 127.8, 126.0, 124.6 (q, JCF = 271 Hz), 
123.8, 122.4, 121.3, 112.4, 112.2; 19F NMR (DMSO-d63) δ: -61.1; IR (KBr) 3178, 1597, 
1568, 1450, 1421, 1328 cm-1. 
 
N
H
O
OMe
F
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(4-fluorophenyl)(2-(3-methoxyphenyl)-1H-indol-3-yl)methanone, white solid, m.p.: 
184-185 °C; 1H NMR (DMSO-d6) δ 12.22 (bs, 1H), 7.84 (d, J = 7.9 Hz, 1H), 7.60-7.57 
(m, 2H), 7.52 (d, J = 7.9 Hz, 1H), 7.27 (t, J = 7.9 Hz, 1H), 7.18 (t, J = 7.8 Hz, 2H), 
7.04-6.92 (m, 4H), 6.85 (d, J = 7.6 Hz, 1H), 3.67 (s, 1H); 13C NMR (DMSO-d6) 191.2, 
164.3 (d, JCF = 251 Hz), 159.3, 144.4, 137.1 (d, JCF = 22 Hz), 136.3, 133.2, 132.2 (d, 
JCF = 9 Hz), 129.7, 128.7, 123.5, 122.5, 122.0, 121.1, 115.4, 115.3, 115.1 (d, JCF = 4 
Hz), 112.6, 112.4, 55.6; 19F NMR (DMSO-d6) δ: -108.6; IR (KBr) 2927, 1601, 1435, 
1223 cm-1. 
 
N
H
O
Cl
 
(2-(4-chlorophenyl)-1H-indol-3-yl)(phenyl)methanone, white solid, m.p.: 245-246 °C; 
1H NMR (DMSO-d6) δ 12.28 (bs, 1H), 7.32 (d, J = 7.4 Hz, 1H), 7.53 (d, J = 7.5 Hz, 
2H), 7.42-7.40 (m, 2H), 7.33-7.25 (m, 5H), 7.16 (t, J = 7.6 Hz, 1H); 13C NMR (DMSO-
d6) δ 192.5, 143.2, 140.3, 136.4, 133.8, 132.0, 131.7, 131.0, 129.6, 128.7, 128.4, 123.6, 
122.0, 121.2, 113.0, 112.5; IR (KBr) 3159, 1601, 1570, 1450, 1419 cm-1. 
 
N
H
O
F
CF3
 
(5-fluoro-2-phenyl-1H-indol-3-yl)(3-(trifluoromethyl)phenyl)methanone, white solid, 
m.p.: 270-271 °C; 1H NMR (DMSO-d6) δ 12.46 (bs, 1H), 7.78-7.73 (m, 2H), 7.64-761 
(m, 2H), 7.56-7.53 (m, 1H), 7.42 (t, J = 7.7 Hz, 1H), 7.32-7.14 (m, 6H); 13C NMR 
(DMSO-d6) 190.7, 159.2 (d, JCF = 242 Hz), 147.7, 141.0, 133.0, 131.5, 131.4, 130.0 (q, 
JCF = 32 Hz), 129.3, 128.2, 127.8 (q, JCF = 3 Hz), 126.2 (q, JCF = 3 Hz), 123.5 (q, JCF = 
269 Hz), 121.9, 115.4 (d, JCF = 3 Hz), 115.3, 115.1 (d, JCF = 4 Hz), 112.6 (d, JCF = 2 
Hz), 112.4, 106.6 (d, JCF = 2 Hz); 19F NMR (DMSO-d6) δ: -61.3, -121.1; IR (KBr) 
3149, 1599, 1568, 1456, 1423, 1327 cm-1. 
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N
H
O
F
Cl
 
(2-chlorophenyl)(5-fluoro-2-phenyl-1H-indol-3-yl)methanone, white solid, m.p.: 293-
294 °C; 1H NMR (DMSO-d6) δ 12.45 (bs, 1H), 7.64 (d, J = 8.9 Hz, 1H), 7.48-7.52 (m, 
1H), 7.33-7.04 (m, 10H); 13C NMR (DMSO-d6) 189.6, 159.4 (d, JCF = 243 Hz), 160.5, 
158.2, 149.0, 140.9, 132.9, 131.2 (d, JCF = 23 Hz), 130.4, 130.0, 129.7, 129.3, 128.5 (d, 
JCF = 11 Hz), 128.0, 127.1, 115.3, 113.8 (d, JCF = 10 Hz), 113.3 (d, JCF = 4 Hz), 111.9 
(d, JCF = 26 Hz), 106.6 (d, JCF = 26 Hz); 19F NMR (DMSO-d6) δ: -120.6; IR (KBr) 
3009, 1595, 1448, 1423 cm-1. 
 
N
H
O
Cl
 
(4-chlorophenyl)(5-methyl-2-phenyl-1H-indol-3-yl)methanone, white solid, m.p.: 248-
249 °C; 1H NMR (DMSO-d6) δ 12.13 (bs, 1H), 7.68 (s, 1H), 7.47 (d, J = 7.9 Hz, 2H), 
7.40 (d, J = 7.9 Hz, 1H), 7.33 (d, J = 7.4 Hz, 2H), 7.28-7.21 (m, 5H), 7.09 (d, J = 7.7 
Hz, 1H); 13C NMR (DMSO-d6) δ 191.3, 145.1, 139.2, 136.3, 134.7, 132.0, 131.3, 131.0, 
130.2, 129.0, 128.9, 128.5, 128.2, 125.1, 120.8, 112.1, 122.1, 21.9; IR (KBr) 3164, 
1595, 1448, 1419, cm-1. 
 
N
H
O
OMe
 
(3-methoxyphenyl)(5-methyl-2-phenyl-1H-indol-3-yl)methanone, white solid, m.p.: 
190-191 °C; 1H NMR (DMSO-d6) δ 12.08 (bs, 1H), 7.66 (s, 1H), 7.41-7.35 (m, 3H), 
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7.25-7.23 (m, 3H), 7.12-7.07 (m, 3H), 7.01 (s, 1H), 6.90 (m, 1H), 3.60 (s, 3H), 2.40 (s, 
3H); 13C NMR (DMSO-d6) δ 192.3, 159.1, 144.6, 141.8, 134.7, 132.3, 130.7, 130.0, 
129.4, 129.0, 128.9, 128.5, 124.9, 122.1, 120.9, 118.1, 114.1, 112.3, 112.0, 55.5, 21.9; 
IR (KBr) 3107, 1597, 1560, 1489, 1448, 1417 cm-1. 
 
N
H
O
Cl
CN
 
4-(3-benzoyl-5-chloro-1H-indol-2-yl)benzonitrile, white solid, m.p.: 307-308 °C; 1H 
NMR (DMSO-d6) δ 12.25 (bs, 1H), 7.75-7.71 (m, 3H), 7.58-7.50 (m, 5H), 7.41 (t, J = 
7.2 Hz, 1H), 7.31 (d, J = 8.0 Hz, 1H), 7.24 (t, J = 7.6 Hz, 2H); 13C NMR (DMSO-d6) δ 
192.1, 143.8, 139.9, 136.2, 135.1, 132.3, 132.2, 130.9, 129.6, 129.5, 128.5, 126.9, 
124.1, 120.4, 118.9, 114.3, 113.4, 111.5; IR (KBr) 3132, 2231, 1597, 1429 cm-1. 
 
N
H
O
Cl
OMe
 
(5-chloro-2-phenyl-1H-indol-3-yl)(3-methoxyphenyl)methanone, white solid, m.p.: 
253-254 °C; 1H NMR (DMSO-d6) δ 12.43 (bs, 1H), 7.84 (d, J = 1.7 Hz, 1H), 7.53 (d, J 
= 8.4 Hz, 1H), 7.37 (m, 2H), 7.31-7.23 (m, 4H), 7.15-7.09 (m, 2H), 6.99 (s, 1H), 6.92-
6.89 (m, 1H), 3.60 (s, 3H); 13C NMR (DMSO-d6) δ 192.0, 159.1, 146.2, 141.4, 134.9, 
131.7, 130.1, 129.9, 129.5, 129.3, 128.5, 126.7, 123.5, 122.0, 120.3, 118.4, 114.0, 
112.4, 55.5; IR (KBr) 3165, 1595, 1560, 1450, 1411 cm-1. 
 
N
H
O
F
Me
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(5-fluoro-2-phenyl-1H-indol-3-yl)(m-tolyl)methanone, white solid, m.p.: 252-253 °C; 
1H NMR (DMSO-d6) δ 12.32 (bs, 1H), 7.54-7.50 (m, 2H), 7.37-7.32 (m, 3H), 7.24 (m, 
4H), 7.13-7.08 (m, 3H), 2.11 (s, 3H); 13C NMR (DMSO-d6) 192.4, 158.4 (d, JCF = 233 
Hz), 157.5, 146.5, 139.9, 137.4, 132.9, 132.2 (d, JCF = 30 Hz), 130.4, 130.0, 129.2 (d, 
JCF = 11 Hz), 129.1, 128.5, 128.2, 126.6, 113.5 (d, JCF = 10 Hz), 112.9 (d, JCF = 5 Hz), 
111.6 (d, JCF = 26 Hz), 105.9 (d, JCF = 25 Hz), 21.1; 19F NMR (DMSO-d6) δ: -121.6; IR 
(KBr) 3145, 1597, 1568, 1444, 1419 cm-1. 
 
N
H
O
 
(2-pentyl-1H-indol-3-yl)(phenyl)methanone, white solid, m.p.: 102-103 °C; 1H NMR 
(CDCl3) δ 9.40 (bs, 1H), 7.80 (d, J = 8.1 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.48 (t, J = 
7.8 Hz, 2H), 7.32-7.28 (m, 2H), 7.17 (t, J = 7.9 Hz, 1H), 7.08 (t, J =7.8 Hz, 1H), 2.94 (t, 
J = 7.9 Hz, 2H), 1.70 (m, 2H), 1.26 (m, 4H), 0.84 (m, 3H); 13C NMR (CDCl3) δ 193.7, 
148.7, 141.5, 134.9, 131.6, 128.9, 128.4, 127.7, 122.4, 121.5, 121.0, 113.4, 111.0, 31.6, 
29.3, 28.0, 22.4, 14.0; IR (KBr) 3176, 2956, 1595, 1568, 1450, 1429 cm-1. 
 
8.2.10. General Procedure for the Preparation of N-Arylenaminones. 
An oven-dried Schlenk tube was charged with α,β-enones (1 mmol), the substituted 
aniline (1 mmol) and anhydrous MeOH (1 mL). The tube was sealed and stirred at 80 
°C. The reaction mixture was cooled to room temperature, the solvent was evaporated 
and the residue was purified by silica gel, eluting with hexane/ethyl acetate mixtures. 
 
8.2.11. General Procedure for the Preparation of 2,3-disubstituted indoles. 
An oven-dried Schlenk tube was charged with the corresponding N-Arylenaminones (1 
equiv.), CuI (5 mol%), 1,10-phenantroline (17.5 mol%), Li2CO3 (2 equiv.), and DMF 
(0.1 M). The tube was sealed and stirred at 100 °C. The reaction mixture was cooled to 
room temperature, diluted with diethyl ether and washed twice with HCl (1 N) and with 
a saturated NaCl solution. The organic phase was separated, dried over Na2SO4, filtered 
and concentrated under reduced pressure. The residue was purified by silica gel, eluting 
with hexane/ethyl acetate mixtures. 
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N
H
O
 
(5-methyl-2-phenyl-1H-indol-3-yl)(phenyl)methanone, white solid, m.p.: 210-211 °C; 
1H NMR (DMSO-d6) δ 12.08 (bs, 1H), 7.60 (s, 1H), 7.51 (d, J = 7.4 Hz, 2H), 7.40 (d, J 
= 8.1 Hz, 1H), 7.37-7.33 (m, 3H), 7.24-7.18 (m, 5H), 7.08 (d, J = 7.9 Hz, 1H); 13C 
NMR (DMSO-d6) δ 192.7, 144.6, 140.4, 134.7, 132.2, 131.7, 130.7, 130.0, 129.6, 
129.0, 128.8, 128.5, 128.2, 124.9, 120.8, 112.3, 112.0, 21.9; IR (KBr) 3155, 1597, 1456, 
1419 cm-1. 
 
N
H
O
MeO
 
(6-methoxy-2-phenyl-1H-indol-3-yl)(phenyl)methanone, white solid, m.p.: 247-248 °C; 
1H NMR (DMSO-d6) δ 12.02 (bs, 1H), 7.63 (d, J = 8.1 Hz, 1H), 7.51 (d, J = 7.9 Hz, 
2H), 7.37-7.33 (m, 3H), 7.24-7.18 (m, 5H), 6.98 (d, J = 2.1 Hz, 1H), 6.82 (dd, J = 7.9 
Hz, J = 2.2 Hz, 1H); 13C NMR (DMSO-d6) δ 192.6, 157.0, 143.6, 140.4, 137.2, 132.2, 
131.8, 129.9, 129.5, 128.7, 128.5, 128.2, 122.8, 121.9, 112.6, 111.9, 55.8; IR (KBr) 
3141, 1595, 1440, 1402 cm-1. 
 
N
H
OOMe
 
(4-methoxy-2-phenyl-1H-indol-3-yl)(phenyl)methanone, white solid, m.p.: 261-262 °C; 
1H NMR (DMSO-d6) δ 11.95 (bs, 1H), 7.70 (d, J = 7.9 Hz, 2H), 7.54 (m, 3H), 7.44-7.30 
(m, 5H), 7.15-7.10 (m, 2H), 6.51 (dd, J = 7.9 Hz, J = 1.2 Hz, 1H); 13C NMR (DMSO-
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d6) δ 194.9, 153.2, 140.2, 137.4, 137.3, 132.9, 132.0, 129.3, 129.1, 128.7, 128.6, 128.3, 
124.1, 118.4, 112.6, 105.4, 101.5, 55.3; IR (KBr) 3100, 1588, 1442, 1412 cm-1. 
 
N
H
O
MeO
 
(4-methoxyphenyl)(2-phenyl-1H-indol-3-yl)methanone, white solid, m.p.: 232-233 °C; 
1H NMR (DMSO-d6) δ 12.13 (bs, 1H), 7.58-7.64 (m, 3H), 7.52 (d, J = 7.9 Hz, 1H), 7.45 
(m, 2H), 7.30 (m, 3H), 7.23 (t, J = 7.8 Hz, 1H), 7.13 (t, J = 7.9 Hz, 1H), 6.79 (d, J = 8.4 
Hz, 2H), 3.84 (s, 3H); 13C NMR (DMSO-d6) δ 191.5, 162.6, 143.1, 136.3, 132.6, 132.2, 
132.0, 129.8, 128.9, 128.7, 123.2, 121.6, 120.9, 113.7, 112.9, 112.3, 55.8; IR (KBr) 
3158, 1566, 1453, 1444, 1410 cm-1. 
 
N
H
O
MeO
 
(5-methoxy-7-methyl-2-phenyl-1H-indol-3-yl)(phenyl)methanone, white solid, m.p.: 
218-219 °C; 1H NMR (DMSO-d6) δ 11.86 (bs, 1H), 7.48 (d, J = 7.4 Hz, 2H), 7.37-7.30 
(m, 3H), 7.23-7.15 (m, 6H), 6.73 (s, 1H), 3.73 (s, 3H), 2.55 (s, 3H); 13C NMR (DMSO-
d6) δ 192.7, 155.8, 145.3, 140.6, 132.3, 131.5, 131.0, 130.4, 129.5, 129.2, 128.7, 128.3, 
128.1, 123.1, 113.9, 113.1, 100.4, 55.6, 17.4; IR (KBr) 3143, 1508, 1431, 1447cm-1. 
 
N
H
O
NC
 
4-(2-phenyl-1H-indole-3-carbonyl)benzonitrile, white solid, m.p.: 268-269 °C; 1H NMR 
(DMSO-d6) δ 12.36 (bs, 1H), 7.98 (d, J = 7.6 Hz, 1H), 7.61-7.53 (m, 5H), 7.33-7.13 (m, 
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7H); 13C NMR (DMSO-d6) δ 191.1, 146.4, 144.6, 136.4, 132.1, 131.8, 130.5, 130.0, 
129.2, 128.5, 128.5, 123.8, 122.5, 121.4, 118.8, 113.3, 112.4, 112.3; IR (KBr) 3109, 
2232, 1454, 1400 cm-1. 
 
N
H
O
CN
 
4-(3-benzoyl-1H-indol-2-yl)benzonitrile, white solid, m.p.: 277-278 °C; 1H NMR 
(DMSO-d6) δ 12.43 (bs, 1H), 7.72 (m, 3H), 7.60-7.54 (m, 5H), 7.43 (t, J = 7.2 Hz, 1H), 
7.31-7.25 (m, 3H), 7.18 (d, J = 7.7 Hz, 1H); 13C NMR (DMSO-d6) δ 192.5, 142.1, 
140.2, 136.7, 136.6, 132.3, 132.2, 130.8, 129.6, 128.5, 128.4, 124.0, 122.2, 121.3, 
119.0, 113.9, 112.6, 111.2; IR (KBr) 3200, 2230, 1441, 1433 cm-1. 
 
N
H
O
OMe
 
(2-(4-methoxyphenyl)-1H-indol-3-yl)(phenyl)methanone, white solid, m.p.: 222-223 
°C; 1H NMR (DMSO-d6) δ 12.10 (bs, 1H), 7.43 (d, J = 7.9 Hz, 1H), 7.58-7.46 (m, 3H), 
7.40-7.33 (m, 3H), 7.23 (t, J = 7.6 Hz, 3H), 7.14 (t, J = 7.3 Hz, 1H), 6.81 (d, J = 8.2 Hz, 
2H), 3.70 (s, 3H); 13C NMR (DMSO-d6) δ 192.6, 160.0, 144.7, 140.4, 136.3, 131.8, 
131.4, 129.6, 128.9, 128.3, 124.4, 123.1, 121.8, 121.0, 114.1, 112.2, 112.1, 55.7; IR 
(KBr) 3165, 1564, 1540, 1433, 1400cm-1. 
 
N
H
O
CF3
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(5,7-dimethyl-2-phenyl-1H-indol-3-yl)(3-(trifluoromethyl)phenyl)methanone, white 
solid, m.p.: 266-267 °C; 1H NMR (CDCl3) δ 9.04 (bs, 1H), 7.82 (s, 1H), 7.77 (d, J = 7.6 
Hz, 1H), 7.70 (s, 1H), 7.48 (d, J = 7.7 Hz, 1H), 7.30-7.23 (m, 3H), 7.16-7.07 (m, 3H), 
7.01 (s, 1H), 2.58 (s, 3H), 2.48 (s, 3H); 13C NMR (CDCl3) 191.9, 144.9, 140.5, 133.7, 
132.6, 132.4, 131.6, 130.0 (q, JCF = 30 Hz), 129.5, 128.8, 128.5, 128.3, 127.5 (q, JCF = 4 
Hz), 126.6 (q, JCF = 4 Hz), 126.4, 123.5 (q, JCF = 270 Hz), 120.3, 119.0, 113.4, 21.6, 
16.7; 19F NMR (CDCl3) δ: -62.6; IR (KBr) 3099, 1588, 1507, 1440, 1409 cm-1. 
 
N
H
O
OMe
Cl
 
(4-chlorophenyl)(7-methoxy-2-phenyl-1H-indol-3-yl)methanone, white solid, m.p.: 
241-242 °C; 1H NMR (CDCl3) δ 9.00 (bs, 1H), 7.60-7.50 (m, 3H), 7.36 (d, J = 7.1 Hz, 
2H), 7.10-7.28 (m, 6H), 6.77 (d, J = 7.6 Hz, 1H), 4.00 (s, 3H); 13C NMR (CDCl3) δ 
191.8, 145.9, 143.3, 138.1, 137.7, 131.6, 131.1, 129.9, 129.3, 129.0, 128.5, 128.0, 
126.1, 122.9, 114.2, 113.9, 103.6, 55.6; IR (KBr) 3144, 1557, 1441, 1411cm-1. 
 
N
H
O
Br
MeO
OMe
MeO
 
(4-bromophenyl)(4,5,6-trimethoxy-2-m-tolyl-1H-indol-3-yl)methanone, white solid, 
m.p.: 279-280 °C; 1H NMR (DMSO-d6) δ 11.79 (bs, 1H), 7.70 (m, 4H), 7.32 (s, 1H), 
7.25 (m, 2H), 7.12 (m, 1H), 6.78 (s, 1H), 3.86 (s, 3H), 3.78 (s, 3H), 3.38 (s, 3H), 2.28 (s, 
3H); 13C NMR (DMSO-d6) δ 193.7, 152.1, 145.5, 139.1, 138.2, 137.4, 137.2, 132.9, 
132.0, 131.8, 131.3, 129.1, 129.0, 128.7, 127.0, 125.4, 115.9, 90.9,61.2, 60.3, 56.5, 
21.5; IR (KBr) 3167, 1589, 1440, 1422 cm-1 
 
 125
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H
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(5-fluoro-2-(6-methoxynaphthalen-2-yl)-7-methyl-1H-indol-3-yl)(m-tolyl)methanone, 
white solid, m.p.: 245-246 °C; 1H NMR (DMSO-d6) δ 12.16 (bs, 1H), 7.93 (s, 1H), 7.77 
(d, J = 8.2 Hz, 1H), 7.62 (d, J = 8.4 Hz, 1H), 7.41-7.23 (m, 5H), 7.15 (d, J = 8.2 Hz, 
1H), 6.97 (m, 3H), 3.92 (s, 3H), 2.61 (s, 3H), 1.97 (s, 3H); 13C NMR (DMSO-d6) δ 
192.6, 158.7 (d, JCF = 268 Hz), 158.4, 146.8, 137.3, 134.4, 132.6, 132.1, 130.3, 130.1, 
129.7, 128.5 (d, JCF = 11 Hz), 128.3, 128.0 (d, JCF = 5 Hz), 127.2, 126.4 (d, JCF = 6 Hz), 
124.0 (d, JCF = 10 Hz), 119.5, 113.5 (d, JCF = 4 Hz), 112.1 (d, JCF = 26 Hz), 106.5, 
103.3 (d, JCF = 25 Hz), 55.7, 20.9, 17.4; 19F NMR (DMSO-d6) δ: -121.6; IR (KBr) 
3140, 1511, 1439, 1409 cm-1 
 
8.2.12. General Procedure for the One-pot preparation of 2,3,4-trisustituted quinolines. 
An oven-dried Schlenk tube was charged with α,β-ynones (1.5 mmol), the 
phenylethynylbenzenamine (1 mmol) and anhydrous MeOH (1 mL). The tube was 
sealed and stirred at 120 °C for 48 h. The reaction mixture was cooled to room 
temperature, the volatile materials was evaporated at reduced pressure; then DMF and 
Cs2CO3 were added and the reaction was stirred at 80 °C for the indicated period of 
time. The reaction mixture was cooled to room temperature, the solvent was evaporated 
and the residue was purified by silica gel, eluting with hexane/ethyl acetate mixtures. 
 
N
O
 
(4-benzyl-2-phenylquinolin-3-yl)(phenyl)methanone, light brown solid, mp 137-139 °C; 
1H NMR (CDCl3) δ 8.31-8.29 (m, 1 H), 8.11-8.08 (m, 1 H), 7.80-7.78 (m, 1 H), 7.63-
7.54 (m, 5 H), 7.38-7.36 (m, 1 H), 7.29-7.13 (m, 10 H), 4.49-4.41 (m, 2 H); 13C NMR 
(CDCl3) δ 198.0, 156.4, 148.1, 144.4, 140.0, 138.6, 137.4, 133.3, 133.2, 130.4, 130.1, 
 126
129.3, 128.6, 128.5, 128.4, 128.21, 128.17, 127.2, 126.3, 126.0, 125.0, 35.3; IR (KBr) 
3059, 2924, 1662 cm-1;Anal. Calcd. for C29H21NO: C, 87.19; H, 5.30; Found: C, 87.25; 
H, 5.36. 
 
N
O
OMeCl
 
(4-(4-chlorobenzyl)-2-phenylquinolin-3-yl)(3-methoxyphenyl)methanone, white solid, 
mp 167-169 °C; 1H NMR (CDCl3) δ 8.30-8.28 (m, 1 H), 8.02-8.00 (m, 1 H), 7.82-7.78 
(m, 1 H), 7.63-7.56 (m, 3 H), 7.29-7.28 (m, 3 H), 7.17-7.09 (m, 6 H), 7.03-7.01 (m, 1 
H), 6.96-6.94 (m, 1 H), 4.43-4.32 (m, 2 H), 3.73 (s, 3 H); 13C NMR (CDCl3) δ 197.8, 
159.5, 156.4, 148.1, 143.7, 139.9, 138.7, 137.1, 133.2, 132.2, 130.6, 130.2, 129.8, 
129.31, 129.28, 128.7, 128.6, 128.2, 127.4, 125.7, 124.7, 122.5, 120.1, 113.0, 55.3, 
34.7; IR (KBr) 3072, 2943, 1664 cm-1; Anal. Calcd. for C30H22ClNO2: C, 77.66; H, 
4.78; Found: C, 77.52; H, 4.70. 
 
N
O
Cl
F
 
biphenyl-4-yl(4-(4-chlorobenzyl)-6-fluoro-2-phenylquinolin-3-yl)methanone, white 
solid, mp 206-208 °C; 1H NMR (CDCl3) δ 8.33-8.29 (m, 1 H), 7.66-7.53 (m, 8 H), 7.47-
7.39 (m, 5 H), 7.31-7.27 (m, 3 H), 7.18 (d, J = 8.4 Hz, 2 H), 7.11 (d, J = 8.3 Hz, 2 H), 
4.37-4.32 (m, 2 H); 13C NMR (CDCl3) δ 197.4, 161.1 (d, J = 247.9 Hz), 155.92, 155.90, 
146.3, 145.4, 143.3 (d, J = 5.7 Hz), 139.8, 139.5, 136.7, 135.9, 133.9, 133.2 (d, J = 9.2 
Hz), 132.6, 130.0, 129.9, 129.4, 129.0, 128.9, 128.8, 128.5, 128.4, 127.3, 127.1, 120.6 
(d, J = 25.6 Hz), 108.4 (d, J = 22.8 Hz), 35.0; 19F NMR (CDCl3) δ -110.5; IR (KBr) 
 127
3057, 1660 cm-1; Anal. Calcd. for C35H23ClFNO: C, 79.61; H, 4.39; Found: C, 79.54; H, 
4.42. 
 
N
O
Cl
 
(4-(4-chlorobenzyl)-6-methyl-2-pentylquinolin-3-yl)(phenyl)methanone, yellow solid, 
mp 123-125 °C; 1H NMR (CDCl3) δ 8.05-8.03 (m, 1 H), 7.76-7.74 (m, 2 H), 7.66 (m, 1 
H), 7.61-7.56 (m, 2 H), 7.47-7.36 (m, 2 H), 7.12 (d, J = 8.3 Hz, 2 H), 7.00 (d, J = 8.2 
Hz, 2 H), 4.26-4.11 (m, 2 H), 2.74 (m, 2 H), 2.49 (s, 3 H), 1.77-1.71 (m, 2 H), 1.28- 
1.20 (m, 4 H), 0.82 (t, J = 6.7 Hz, 3 H); 13C NMR (CDCl3) δ 198.5, 157.6, 146.7, 141.3, 
137.2, 137.1, 136.6, 134.1, 133.6, 132.2, 132.1, 129.7, 129.6, 128.9, 128.6, 125.4, 
123.3, 37.4, 34.7, 31.8, 29.2, 22.4, 22.0, 14.0; IR (KBr) 2922, 1666 cm-1; Anal. Calcd. 
for C29H28ClNO: C, 78.80; H, 6.39; Found: C, 78.94; H, 6.35. 
 
N
O
MeO
Br
 
(4-(4-methoxybenzyl)-2-phenylquinolin-3-yl)(2-bromophenyl)methanone, pale yellow 
solid, mp 164-166 °C; 1H NMR (CDCl3) δ 8.26-8.24 (m, 1 H), 8.19-8.16 (m, 1 H), 7.80 
(m, 1 H), 7.60 (m, 1 H), 7.51-7.49 (m, 2 H), 7.40-7.38 (m, 1 H), 7.30-7.23 (m, 3 H), 
7.18 (d, J = 8.5 Hz, 2 H), 7.06-6.97 (m, 3 H), 6.77 (d, J = 8.5 Hz, 2 H), 4.52 (s, 2 H), 
3.74 (s, 3 H); 13C NMR (CDCl3) δ 196.7, 158.2, 157.0, 148.2, 146.6, 140.2, 138.0, 
134.7, 133.1, 132.7, 132.3, 131.0, 130.55, 130.47, 129.7, 129.1, 128.6, 128.4, 127.4, 
126.6, 126.3, 125.5, 121.9, 114.0, 55.3, 34.4; IR (KBr) 3068, 3008, 2922, 1672, 1510 
cm-1; Anal. Calcd. for C30H22BrNO2: C, 70.87; H, 4.36; Found: C, 70.74; H, 4.31. 
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(4-methoxyphenyl)(4-(3-methylbenzyl)-2-phenylquinolin-3-yl)methanone, orange wax; 
1H NMR (CDCl3) δ 8.31-8.29 (m, 1 H), 8.09-8.07 (m, 1 H), 7.80-7.77 (m, 1 H), 7.66-
7.65 (m, 2 H), 7.58-7.53 (m, 3 H), 7.31-7.26 (m, 3 H), 7.09-7.06 (m, 1 H), 6.94-6.92 (m, 
3 H), 6.69 (d, J = 8.7 Hz, 2 H), 4.45-4.33 (m, 2 H), 3.78 (s, 3 H), 2.22 (s, 3 H); IR (KBr) 
3060, 2924, 2841, 1651 cm-1; Anal. Calcd. for C31H25NO2: C, 83.95; H, 5.68; Found: C, 
84.10; H, 5.71. 
 
N
O
Cl
 
(4-(4-chlorobenzyl)-6-methyl-2-phenylquinolin-3-yl)(m-tolyl)methanone, white solid, 
mp 205-207 °C; 1H NMR (CDCl3) δ 8.20-8.18 (m, 1 H), 7.79 (m, 1 H), 7.65-7.59 (m, 3 
H), 7.31-7.08 (m, 11 H), 4.41-4.30 (m, 2 H), 2.55 (s, 3 H), 2.21 (s, 3 H); 13C NMR 
(CDCl3) δ 198.4, 155.6, 146.8, 143.0, 140.2, 138.1, 137.47, 137.46, 137.3, 134.3, 133.4, 
132.6, 132.2, 130.4, 129.91, 129.89, 129.4, 129.0, 128.6, 128.2, 126.8, 125.9, 123.6, 
34.6, 22.2, 21.1; IR (KBr) 1664, 1491 cm-1; Anal. Calcd. for C31H24ClNO: C, 80.59; H, 
5.24; Found: C, 80.42; H, 5.21. 
 
N
O
OMe Cl
 
(4-(3-methoxybenzyl)-2-phenylquinolin-3-yl)(4-chlorophenyl)methanone, white solid, 
mp 159-161 °C; 1H NMR (CDCl3) δ 8.30-8.28 (m, 1 H), 8.14-8.12 (m, 1 H), 7.81-7.79 
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(m, 1 H), 7.61-7.58 (m, 3 H), 7.43 (d, J = 8.5 Hz, 2 H), 7.29-7.26 (m, 3 H), 7.15 (d, J = 
8.6 Hz, 2 H), 7.11-7.07 (m, 1 H), 6.73-6.65 (m, 3 H), 4.48-4.41 (m, 2 H), 3.69 (s, 3 H); 
13C NMR (CDCl3) δ 197.0, 159.7, 156.3, 148.2, 144.7, 140.03, 139.99, 139.8, 135.9, 
132.7, 130.7, 130.6, 130.5, 129.6, 129.4, 128.9, 128.6, 128.4, 127.5, 126.1, 125.0, 
121.0, 114.9, 111.5, 55.1, 35.1; IR (KBr) 3012, 2931, 1666 cm-1; Anal. Calcd. for 
C30H22ClNO2: C, 77.66; H, 4.78; Found: C, 77.50; H, 4.71. 
 
N
O
CN
F
 
4-(4-benzyl-6-fluoro-2-phenylquinoline-3-carbonyl)benzonitrile, white solid, mp 131-
133 °C; 1H NMR (CDCl3) δ 8.31-8.29 (m, 1 H), 7.75 (m, 1 H), 7.61 (m, 1 H), 7.52-7.50 
(m, 2 H), 7.46-7.40 (m, 4 H), 7.26-7.25 (m, 3 H), 7.15-7.07 (m, 5 H), 4.42 (s, 2 H); 19F 
NMR (CDCl3) δ -110.2; IR (KBr) 3060, 2925, 2229, 1672, 1493 cm-1;Anal. Calcd. for 
C30H19FN2O: C, 81.43; H, 4.33; Found: C, 81.55; H, 4.31. 
 
N
O
F OMe
 
(4-(4-fluorobenzyl)-2-phenylquinolin-3-yl)(3-methoxyphenyl)methanone, pale yellow 
solid, mp 132-134 °C; 1H NMR (CDCl3) δ 8.30-8.28 (m, 1 H), 8.05-8.03 (m, 1 H), 7.80 
(m 1 H), 7.63-7.58 (m, 3 H), 7.29-7.28 (m, 3 H), 7.17-7.08 (m, 4 H), 7.03-7.01 (m, 1 H), 
6.96 (m, 1 H), 6.90-6.86 (m, 2 H), 4.45-4.33 (m, 2 H), 3.72 (s, 3 H); 13C NMR (CDCl3) 
δ 198.0, 161.5 (d, J = 243.4 Hz), 159.6, 156.5, 148.2, 144.2, 140.1, 138.9, 134.4 (d, J = 
3.1 Hz), 133.3, 130.5 (d, J = 31.9 Hz), 130.0 (d, J = 7.9 Hz), 129.43, 129.37, 128.8, 
128.3, 127.4, 125.9, 124.8, 122.7, 120.2, 115.5, 115.3, 113.1, 55.4, 34.6; 19F NMR 
(CDCl3) δ -116.5; IR (KBr) 3059, 2924, 1655 cm-1; Anal. Calcd. for C30H22FNO2: C, 
80.52; H, 4.96; Found: C, 80.68; H, 5.01. 
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N
O
CF3
 
(4-(3-methylbenzyl)-2-phenylquinolin-3-yl)(3-(trifluoromethyl)phenyl)methanone, pale 
yellow solid, mp 111-113 °C; 1H NMR (CDCl3) δ 8.33-8.31 (m, 1 H), 8.22-8.20 (m, 1 
H), 7.87-7.83 (m, 1 H), 7.66-7.54 (m, 6 H), 7.28-7.22 (m, 4 H), 7.03-6.99 (m, 1 H), 
6.89-6.85 (m, 3 H), 4.50 (s, 2 H), 2.14 (s, 3 H); 19F NMR (CDCl3) δ -62.9; IR (KBr) 
2922, 1668 cm-1; Anal. Calcd. for C31H22F3NO: C, 77.33; H, 4.61; Found: C, 77.25; H, 
4.58. 
 
N
O
CF3
 
(4-(3-(trifluoromethyl)benzyl)-2-phenylquinolin-3-yl)(phenyl)methanone, yellow wax;; 
1H NMR (CDCl3) δ 8.33-8.30 (m, 1 H), 8.05-8.03 (m, 1 H), 7.83 (m, 1 H), 7.63-7.61 
(m, 3 H), 7.50-7.48 (m, 2 H), 7.43 (s, 1 H), 7.37-7.19 (m, 9 H), 4.59-4.47 (m, 2 H); 19F 
NMR (CDCl3) δ -62.6; IR (KBr) 3062, 2927, 2854, 1664 cm-1Anal. Calcd. for 
C30H20F3NO: C, 77.08; H, 4.31; Found: C, 77.15; H, 4.31. 
 
N
O
CO2Et F
OMe  
 131
ethyl 3-((3-(4-fluorobenzoyl)-2-(3-methoxyphenyl)quinolin-4-yl)methyl)benzoate, 
orange wax; 1H NMR (CDCl3) δ 8.30-8.28 (m, 1 H), 8.08-8.06 (m, 1 H), 7.86-7.79 (m, 
3 H), 7.61-7.52 (m, 3 H), 7.31-7.30 (m, 1 H), 7.25-7.17 (m, 4 H), 6.87-6.79 (m, 3 H), 
4.36-4.35 (m, 2 H), 4.32 (q, J = 7.1 Hz, 2 H), 3.75 (s, 3 H), 1.37 (t, J = 7.2 Hz, 3 H); 13C 
NMR (CDCl3) δ 196.5, 166.4, 165.7 (d, J = 254.8 Hz), 159.4, 156.1, 148.2, 144.1, 
141.2, 138.9, 133.9, 133.0, 132.9, 132.1 (d, J = 9.5 Hz), 130.7, 130.6, 130.5, 129.6 (d, J 
= 23.9 Hz), 128.7, 127.7, 127.6, 126.0, 124.8, 122.0, 115.6, 115.4 (d, J = 4.3 Hz), 114.3, 
61.0, 55.3, 34.9, 14.3; 19F NMR (CDCl3) δ -103.7; IR (KBr) 3068, 2935, 2837, 1714, 
1666 cm-1; Anal. Calcd. for C33H26FNO4: C, 76.29; H, 5.04; Found: C, 76.35; H, 5.09. 
 
N
O
CF3
Cl
 
(4-benzyl-6-chloro-2-phenylquinolin-3-yl)(3-(trifluoromethyl)phenyl)methanone, white 
solid, mp 113-115 °C; 1H NMR (CDCl3) δ 8.25-8.23 (m, 1 H), 8.15 (s, 1 H), 7.79-7.76 
(m, 1 H), 7.60-7.53 (m, 5 H), 7.28-7.24 (m, 4 H), 7.17-7.08 (m, 5 H), 4.46 (s, 2 H); 19F 
NMR (CDCl3) δ -63.0; IR (KBr) 3064, 3030, 2927, 1672 cm-1;Anal. Calcd. for 
C30H19ClF3NO: C, 71.79; H, 3.82; Found: C, 71.86; H, 3.86. 
 
N
O
Cl
MeO
 
(4-(4-methoxybenzyl)-2-phenylquinolin-3-yl)(4-chlorophenyl)methanone, white solid, 
mp 165-167 °C; 1H NMR (CDCl3) δ 8.30-8.28 (m, 1 H), 8.15-8.13 (m, 1 H), 7.83-7.79 
(m, 1 H), 7.62-7.58 (m, 3 H), 7.41 (d, J = 8.4 Hz, 2 H), 7.29-7.24 (m, 3 H), 7.15 (d, J = 
8.2 Hz, 2 H), 7.04 (d, J = 8.3 Hz, 2 H), 6.70 (d, J = 8.5 Hz, 2 H), 4.40-4.36 (m, 2 H), 
3.71 (s, 3 H); 13C NMR (CDCl3) δ 197.0, 158.2, 156.3, 148.3, 145.3, 140.0, 139.7, 
135.9, 132.6, 130.7, 130.6, 130.4, 129.6, 129.4, 128.9, 128.6, 128.4, 127.4, 126.1, 
 132
125.0, 114.0, 55.2, 34.2; IR (KBr) 3064, 2929, 1666 cm-1; Anal. Calcd. for 
C30H22ClNO2: C, 77.66; H, 4.78; Found: C, 77.50; H, 4.79. 
 
N
O
Me
 
1-(4-benzyl-2-phenylquinolin-3-yl)ethanone, yellow wax, 1H NMR (CDCl3) δ 8.25-8.23 
(m, 1 H), 8.11-8.09 (m, 1 H), 7.78-7.73 (m, 3 H), 7.59-7.50 (m, 4 H), 7.28-7.15 (m, 5 
H), 4.55 (s, 2 H); IR (KBr) 3062, 3028, 2924, 2852, 1697 cm-1; Anal. Calcd. for 
C24H19NO: C, 85.43; H, 5.68; Found: C, 85.57; H, 5.70. 
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Oral Comunication: “Valorizzazione di composti presenti nei reflui agroindustriali. 
Sintesi Fenantridinoni, Benzossazoli, Indoli e Carbazoli”. 
 
INTERNATIONAL SCHOOL OF ORGANOMETALLIC CHEMISTRY. Camerino, 
Italy, 8-12 September 2007. 
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XXXI Corso Estivo “A. Corbella”, Seminari di Chimica Organica, 19-23 June 2006, 
Gargnano del Garda, Italy. 
 
COST Meeting 2006, 6-8 October 2006, Rome, Italy. 
Oral Comunication: “4-Aryl-2-quinolones via a domino Heck reaction/cyclization 
process”. 
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